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ABSTRACT 
Despite its study since the 1960's, very little is known regarding the 
regulation of the multiple catalytic activities performed by protein disulfide 
isomerase (PDI).  A variety of conserved residues have been implicated as either 
important or vital for activity.  This work ventures to identify a functional role for 
the highly conserved CGHC-flanking residues Lys57 and Lys401 of human PDI in 
vitro.  Site-directed mutagenesis studies have revealed a role for the active site 
lysine residues in modulating the oxidoreductase activity of PDI in a pH-dependent 
manner.  The effects of mutagenesis indicated that, along with the oxidoreductase 
activity, the kinetics of thiol-reductase and thiol-oxidase catalysis were also 
attenuated.  Substitution of the aforementioned residues to glutamine, alanine or 
glutamic acid resulted in an enzyme variant 20 to 35% as efficient as wild type.  
This was found to translate to the decreased rate of electron shuttling between PDI 
and ERO1α to as little as 54% that of wild type.  Consistent with this, molecular 
dynamic simulations suggest a role for Lys57 and Lys401 in differentially mediating 
the accessibility of the nucleophilic cysteine of each active site. 
The possibility of lysine acetylation at residues Lys57 and Lys401 was 
assessed by in vitro treatment using Aspirin, coupled with mass spectrometry.  A 
total of 18 acetyllysine (acK) residues were identified reproducibly, including 
acK57 and acK401.  Altered enzyme kinetics as a result of acetylation by Aspirin 
corroborate with site-directed mutagenesis data.  This provides a strong indication 
that acetylation of residues Lys57 and Lys401 is a potential modulator of the 
catalytic activities of PDI. 
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CHAPTER 1 
 
INTRODUCTION 
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1.1   Thiol-Disulfide Chemistry in Biological Systems 
1.1.1   The Biochemistry of Thiols and Disulfides: Implications in Cellular 
Homeostasis and Protein Folding 
There are 21 naturally occurring amino acids that can be incorporated into 
polypeptides during the process of translation in mammals.  Cysteine (Cys, C) is one of 
the least abundant of these building blocks at only about 2.26% [1], yet it is the only 
residue containing the thiol functional group (R-SH); exhibiting the vital 
physicochemical properties associated with such.  Despite its low abundance in relation 
to other amino acids, its prevalence and incorporation in the mammalian proteome is vast 
and believed to be an evolutionarily driven phenomenon of miscoding [1-4].  Cysteine 
residues are essential for a variety of biochemical processes such as protein folding, 
enzymatic redox reactions, multiprotein complex formation, as well as acting as key 
centers for modulation of enzymatic activity via posttranslational modifications that 
extend far past disulfide bond formation. 
Biological thiols and disulfides do not only present themselves in the form of 
protein cysteine residues.  Low molecular weight (LMW) thiols make up a large family 
of compounds that bear one or more thiol functional groups.  These compounds define 
the redox potential of the cellular environment, protect the cell from oxidative stress, and 
facilitate the execution of many physiological pathways.  In particular, some such 
molecules are able to carry out reversible S-thionylation of active cysteine residues in 
proteins to effectively protect against irreversible thiol-overoxidation to sulfinic and/ or 
sulfonic acid moieties [5].  Some of the most common LMW thiols- cysteine, glutathione 
and Coenzyme A are presented in Figure 1.1. 
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Figure 1.1: The most common low molecular weight (LMW) thiols found in eukaryotic 
organisms. 
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Cysteine predominantly exists in the free reduced state, with the ability to form a 
symmetric redox couple through metal-catalyzed autoxidation to cystine using O2 as the 
oxidant [6, 7].  Total cysteine concentrations (Cystot = cysteine + cystine) have been 
measured at about 150 µM in human HT29 cells and up to 60 µM in human plasma [8, 
9].  Another ubiquitous LMW thiol is glutathione.  Glutathione is by and large the most 
prevalent LMW thiol in eukaryotes.  It is an atypical tripeptide of glutamine, cysteine and 
glycine.  Like cysteine, it exists in either a free reduced state (GSH) or in a symmetric 
oxidized form (GSSG).  The ratio of GSH to GSSG is what defines the redox state of a 
particular cellular environment as this couple is the primary redox buffer of the cell (refer 
to section 1.1.2 for more information).  The GSH:GSSG ratio is maintained 
enzymatically primarily through the work of glutathione reductase which functions to 
reduce GSSG to GSH [10].  Reports have shown the presence of glutathione in plasma at 
about 3 µM [11] and up to 10 mM in the secretory compartments, such as the lumen of 
the endoplasmic reticulum (ER) [12].  A last vital LMW thiol of note is Coenzyme A 
(CoA).  In mammalian metabolism CoA is a widely used enzyme cofactor and substrate.  
The free thiol termini is often charged with functional moieties in the form of a thioester- 
i.e. acetyl-CoA, propionyl-CoA, succinyl-CoA, malonyl-CoA, among many others (refer 
to section 1.3 for more information) [13].  The thiol functional group of CoA is primarily 
recognized for its role in making the molecule an acyl carrier, with little relevant 
implications to redox homeostasis within the cell.  Although, in various prokaryotic 
organisms lacking GSH, CoA has been implicated in performing intracellular redox 
functions in conjunction with a widely distributed bacterial and archaeal enzyme, 
NAD(P)H-dependent CoA disulfide reductase (CoADR) [6]. 
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In terms of protein folding, disulfide bond formation (R-S-S-R') is a reversible 
crosslink between two non-contiguous cysteine residues of a polypeptide chain or 
constituent polypeptides [14].  In conjunction with the non-covalent forces- van der 
Waals interactions, salt bridges, hydrogen bonds and the hydrophobic effect, this covalent 
interaction drives the formation of a three-dimensionally (3D) structured polypeptide; 
wherein the 3D conformation is directly related to its intrinsic function [15].  It is 
important to note that not all proteins contain cysteine residues, and even those that do 
contain two or more, will not always harbour a structural disulfide bond.  It is a feature 
most prevalent in proteins of the secretory pathway and recycled membrane proteins in 
order to confer added stability in the presence of the extracellular milieu and acidic 
endocytic vesicles, respectively [16, 17]. 
Structurally, disulfide bonds are thought to be advantageous in two ways.  First, by 
promoting structural constraints such that the most thermodynamically stable 
conformation is attained- thereby destabilizing non-native or unfolded states.  Although, 
it is possible that disulfide bonds of a native protein be those that restrict the dynamics of 
even entropically favourable fluctuations [18, 19].  Nonetheless, a second advantage is 
their ability to enhance stability by protecting against oxidative damage or proteolytic 
degradation, effectively increasing a protein's half-life [14].  This is an aspect that is very 
pertinent to the biotechnology and pharmaceutical industries as many batch processes and 
therapeutics work through the use of oligopeptides and proteins- for example, insulin, 
oxytocin, antibodies, papain, to name a few [20].  Even still, the way in which disulfide 
bonds bring about structural stability is not well understood, and introducing engineered 
disulfides into a recombinant protein does not always result in enhanced stability.  In a 
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natively folded protein the arrangement of disulfide bonds often represents intramolecular 
linkages (or intermolecular in the case of multi-subunit proteins) that have achieved their 
most thermodynamically favourable state in relation to a myriad of less favourable 
configurations.  Figure 1.2 illustrates a general free energy profile or funnel diagram for 
the landscape of protein folding leading to a stable native conformation [21].  It is 
assumed that under set conditions the native state of a protein is at the energy minimum 
of the landmark; this is regarded as the folding funnel hypothesis [22].  It should be 
understood that many non-native conformations may exist in local energy minima.  This 
is because the native state is a dynamic- not static- ensemble of many sub-states [23-25]. 
Despite folding being largely driven by the hydrophobic effect, for those proteins 
requiring the formation of disulfide bonds, it is the work of intracellular chaperones, 
foldases and dithiol-disulfide oxidoreductase enzymes that facilitate the native fold.  One 
such enzyme being protein disulfide isomerase (PDI), found within the lumen of the ER.  
The activity of PDI during oxidative protein folding (refer to section 1.2) is to optimize 
the kinetics of both the introduction of disulfide bonds and the rearrangement of 
mispaired disulfides in a misfolded protein substrate [26].  It is understood that the rate 
limiting process of protein folding is the direct thiol-disulfide interchange reactions that 
take place, where appropriate [27].  PDI along with other PDI family members provide a 
catalytic architecture that is optimized to provide a minimization of the folding timescale. 
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Figure 1.2: Landscape of protein folding as depicted by an energy funnel diagram of 
conformational state vs. free energy.  The native conformation is regarded as the lowest 
energy state at the bottom of the funnel.  The bottom of the folding funnel is populated by 
multiple energy minima representing distinct native and stable non-native conformations. 
(adapted from [21]) 
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1.1.2   Biochemical Considerations for Thiol-Disulfide Exchange Reactions 
Disulfide bonds exist as either structural or functional elements of a protein.  
Functional disulfides are either catalytic centers or allosteric switches [14].  The ability of 
functional and structural disulfides (and their free thiol counterparts) to participate in 
chemical reactions is not surprisingly dependent on factors that are dictated by the 
microenvironment at any given time- such as pH, ionic strength, electrostatic interactions 
with neighbouring groups, accessibility, etc. [26-28].  These factors have a direct 
influence on thiol pKa and ionization state, as well as the disulfide redox potential (E); 
intrinsically linked properties for any thiol-disulfide couple.  Protein microenvironments 
work exceptionally well at controlling these factors and as a result, modulating thiol and 
disulfide reactivity.  It is common to observe biological thiols with pKa values in the 
range of 3 to 11, markedly different from the pKa of ca. 8.6 for the thiol of free cysteine 
[29, 30]. 
Thiol-disulfide exchange is a widely used enzymatic process that, as the name 
implies, is the exchange of thiol and disulfide groups between two reacting molecules.  
The process is a simple 1-step SN2 reaction whereby a nucleophilic thiolate (R-S-) attacks 
an oxidized sulfur of a target disulfide [26, 27, 31].  The nucleophile is recognized as the 
deprotonated thiol functional group, a thiolate anion, as it has been demonstrated that R-
SH is essentially unreactive as a nucleophile under standard conditions with nearly 1010-
fold slower rates [31, 32].  For exchange to occur, the attacking thiolate must approach 
in-plane with the disulfide axis.  The collinearity of thiol-disulfide exchange results in a 
trisulfide transition state with a delocalized electron (Figure 1.3).  This is an oft-forgotten 
consideration to the chemistry of thiol-disulfide exchange that defines an extremely 
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important steric requirement for the kinetics of the reaction [26].  Furthermore, the 
concerted mechanism showcases negatively charged species in both the initial ground 
state and the transition state, making it apparent that the rate be greatly affected by 
electrostatic and through-bond inductive effects [28].  
Thiol pKa and nucleophilicity are not mutually exclusive traits in terms of thiol-
disulfide exchange rates.  Rather, they are intrinsically linked as it has already been 
discussed that the thiolate anion is a 1010-fold more reactive nucleophile.  Considering 
this, it is logical to state that under set (standard) conditions, increasing the pKa of a 
nucleophile (thiol) will result in a decrease of reaction rate; a direct result of the existence 
of only a small proportion of thiolate anion (when pKa > pH).  Meaning, the rate of thiol-
disulfide exchange is expected to be inversely proportional to the pKa of the attacking 
thiol.  Contrary to this, it is understood that the ability of a sulfur atom to retain its proton 
is somewhat representative of its inherent nucleophilicity [28, 31].  The linear-free energy 
relationship shows that thiolate nucleophilicity actually increases with pKa, leading to 
enhanced reaction rates [27, 33].  This has been demonstrated in research using model 
systems with both small-molecule and peptide-based thiols [28].  Furthermore, one must 
consider the charge transfer that occurs within the transition state itself.  The attacking 
nucleophile must pass its charge to the leaving-group sulfur about the trisulfide 
intermediate.  Thus, the pKa of the leaving-group thiol is another factor influencing thiol-
disulfide exchange rates.  Research has shown that a more acidic (lower pKa) leaving-
group thiol mediates a greater rate of exchange [28, 33, 34].  This is due to a drop in the 
transition state energy as a lower pKa of the leaving-group thiol stabilizes the thiolate 
state in relation to the oxidized state [27].   
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Figure 1.3: Representative reaction coordinates for a simple bimolecular thiol-disulfide 
exchange reaction, highlighting the SN2 type nucleophilic substitution along with the 
dependence on a thiolate nucleophile and a collinear orientation about the disulfide axis. 
(adapted from [27]) 
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To further appreciate the mechanism of thiol-disulfide exchange it is useful to 
examine the correlation between thiol pKa, nucleophilicity and reaction rate.  This can be 
achieved using the pseudo-Brønsted correlation.  Given by Equation 1.1, this is a linear 
relationship between the common logarithm of reaction rate, k, and the pKa of the 
participating sulfur atoms: nuc, nucleophile; c, central; lg, leaving group.  The Brønsted 
coefficient of basicity is given by β.  This defines the slope of the line, where a larger 
value (between 0 and 1) defines the extent of charge-transfer about the transition state.  In 
this equation, the pKa of the attacking nucleophilic thiol (nuc) and the leaving-group thiol 
(lg) are most influential on rate, consolidating the idea that thiol-disulfide exchange is a 
finely tuned process of optimized nucleophilicity of the attacking thiolate and a depressed 
pKa of the lg thiol [27].  log 𝑘 = 	𝛽)*+p𝐾𝑎,𝑛𝑢𝑐 + 𝛽+p𝐾𝑎,𝑐 + 𝛽45p𝐾𝑎,𝑙𝑔 + C	
                                                          Equation 1.1 
Because β is directly related to the transfer of charge about the transition state, any 
apparent differences in the value of this coefficient when comparing various reacting 
thiol-disulfide couples is believed to be useful in indicating differences in the transition 
states themselves [28].  A caveat to this arises when studying ever more complex 
systems, such as those brought about by enzyme active sites.  Authors have expressed 
that apparent Brønsted correlations do not reflect purely the electronic structure of the 
transition state.  They can be skewed by nearby charges and the interactions between the 
reacting molecules of the bimolecular reaction itself [28].  For instance, if two reacting 
molecules undergoing thiol-disulfide exchange are more likely to form an encounter-
complex because the charge of one is net positive while the other is net negative 
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(opposites attract; like-charges tend to repel), this will lead to artificially high β values 
that are irrespective of any actual changes to transition state dynamics [28]. 
Nagy elegantly described a situation where lowering the pKa of an attacking thiol 
does not always correspond with enhanced nucleophilicity (reaction rate, Figure 1.4) 
[27].  Using β = 0.5 for the reaction of various thiols with GSSG at pH 7.0, it is apparent 
that a nucleophilic thiol with a pKa ca. 6-7 holds ideal nucleophilic power for optimized 
thiol-disulfide exchange rates.  Nagy stated that under these conditions, decreasing the 
pKa of the attacking thiol will only increase the overall rate until the thiolate becomes the 
dominant species.  Past this point the nucleophilicity of the sulfur center will decrease 
such that the rate slows [27].  Many enzymes that partake in the catalysis of thiol-
disulfide exchange reactions, such as PDI, have abnormally low thiol pKa values.  These 
would seemingly go against the characteristics of optimizing exchange rate (the 
proportion of thiolate vs. nucleophilicity).  In such cases it is apparent that these enzymes 
rely on additional means to optimize both the kinetics and thermodynamics of their 
catalytic mechanisms.  A hallmark of many thiol-disulfide oxidoreductases that perform 
thiol-disulfide exchange mechanisms is the presence of one or more CxxC motifs.  It is 
the strategic spatial arrangement of these motifs that provide the catalytic power and 
tuning for these enzymes. 
Thus far the kinetics of thiol-disulfide exchange have been addressed with little 
regard for the thermodynamics of the reaction.  For a bimolecular thiol-disulfide 
exchange reaction an equilibrium may be established, directly related to free energy 
(Equation 1.2): 
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Figure 1.4: Representation of the dependence of the thiol-GSSG exchange rate on the 
pKa of the attacking thiol at pH 7.0.   
(adapted from [27])	
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𝑎A:;< + 𝑏B?@ ⇌B 𝑐A?@ + 𝑑B:;< 
K = A?@ +[B:;<]GA:;< H[B?@]I ΔG = ΔG? + RT𝑙𝑛𝐾 
                                                           Equation 1.2 
Now, one may describe the equilibrium (or non-equilibrium steady state) of a redox 
environment as defined by the redox couple.  Schafer and Buettner stated that the redox 
environment is a sum of the reduction potential and the reducing capacity of a couple 
[35].  They went on to express that the redox potential can be estimated using the Nernst 
equation, and the reducing capacity be estimated by determining the concentration of the 
reduced species of the couple [35].  The Nernst equation can be used to find the voltage 
potential (Equation 1.3) and relate it to the Gibb's free energy change (Equation 1.4):  
Δ𝐸 = Δ𝐸?O − RT𝑛𝐹 𝑙𝑛Q 
                                                          Equation 1.3 ΔG = −𝑛𝐹Δ𝐸 
                                                          Equation 1.4 
Where n is the number of exchanged electrons, F is the Faraday constant, R is the gas 
constant, T is temperature, ΔEo' is the change in the reduction potential under standard 
conditions (pH = 7.0, T = 298 K, 1 atmosphere), and Q is the reaction quotient 
(reminiscent of the equilibrium constant, K).  It is apparent that the more positive ΔE 
becomes the more exergonic the reaction, where a positive value represents a 
spontaneous reaction.  For thioredoxin-like enzymes, the reduction potential of the active 
site vicinal thiol couple varies markedly due to the architecture of the protein and the 
intervening residues of the CxxC motif having a direct impact on the pKa of the thiols 
(see section 1.2.4).  Lower pKa's result in more positive values of E; a tendency towards 
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being reduced [35].  Because the redox poise of the cell is convoluted with its many 
intertwined pathways, it is difficult to observe true equilibria.  Furthermore, in the 
complex system of the cell, the kinetic pathways (previously discussed) dominate 
reaction dynamics more so than the thermodynamic driving forces [26, 35, 36].    
 
1.2   Protein Disulfide Isomerase (PDI) 
The pioneering work by independent researchers Straub [37-39] and Anfinsen [40] 
in the 1960's allowed for the discovery and characterization of an enzyme with the ability 
to correctly fold and reactivate reduced ribonuclease A (RNase A).  This enzyme was 
later named protein disulfide isomerase (PDI) [41].  PDI (EC 5.3.4.1) has since been 
studied extensively in literature, affording it its own gene family of 21 orthologues and 
paralogues dubbed the PDI family of proteins (Figure 1.5) [42, 43].  The PDI family as a 
whole is part of the thioredoxin (TRX) superfamily of enzymes.  This classification is 
based on the presence of at least one TRX-like domain with the secondary element 
sequence: βαβαβαββα, and often the subsequent presence of the CxxC thioredoxin motif 
[44].  The definition of a PDI family member has been altered to specify the need for not 
only a TRX-like domain, but also the exhibition of redox-reactivity and/ or chaperone-
like activity [45].  There is little sequence homology amongst the PDI family members, 
with comparisons between any two members resulting in reported sequence identities 
ranging from 15 to 65% [42], along with variations in domain organization.  It is believed 
that the multi-domain arrangement of PDI proteins is a result of evolutionary gene 
duplication [42, 46].  Some speculate that the existence of so many enzymes with PDI 
activity is indicative of a specialization each has with specific substrates [26].  Although, 
	16 
	
PDI has been described as a promiscuous enzyme with few known bona fide substrates 
[47].  
Herein, focus will be placed on the PDI family member PDIA1, the gene product of 
P4HB; said to comprise up to 1% of the cell's total protein content [43].  For simplicity, 
PDIA1 will be referred to as PDI or hPDI (human PDI) synonymously.  Residue 
numbering is based on the accepted sequence for PDI from Homo sapiens (Uniprot: 
PDIA1, P07237). 
 
1.2.1   The Structure and Localization of Human PDI 
PDI is a 57 kDa horseshoe-shaped monomer that is comprised of 4 discretely 
folded TRX domains: a, b, b', and a'.  Separating domains b' and a' is a 19-residue long 
interdomain loop denoted as the x-linker.  A 29-residue region at the C-terminus of PDI 
makes up the c-extension (a highly disordered and unstructured segment- referring to this 
as a domain is a misnomer).  Thus, the fully mature enzyme takes on an a-b-b'-x-a'-c 
configuration and is 491 residues in length (Figure 1.6) [43].  Full-length PDI has yet to 
be crystalized in its entirety.  The currently available structures of hPDI are of 
individually isolated domains (a [48], b [49], and a') or of the partial-length polypeptide 
(b'-x [50], b-b' [51], and b-b'-x-a' [52]).  Only recently have Wang and coworkers been 
successful in crystalizing nearly full-length PDI, with the exception of the highly flexible 
c-extension, in both the reduced and oxidized states (PDB entries: 4EKZ and 4EL1, 
respectively. See later) [53].  This has since made it possible to study PDI to much 
greater depths than ever before. 
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Figure 1.5: Schematic representation of the PDI family of proteins.  Domain 
organization is given along with the CxxC motifs where applicable.  Domains a and a' 
represent catalytic domains based on the presence of the CxxC oxidoreductase active site 
motif.  Domains b and b' are the non-catalytic domains. 
(reference [43]) 
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Figure 1.6: Structure and features of PDI.  (A) Crystal structure of PDI in the reduced 
state.  The four thioredoxin domains are indicated, along with the conserved CGHCK 
active motifs of the a-type domains.  Ball and stick representation of the active site 
vicinal thiols (yellow) and the highly conserved neighbouring lysine (red).  PDB: 4EKZ 
[53].  Image generated using Visual Molecular Dynamics software (VMD) [54].  (B) 
Simplified schematic of PDI.   
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The existence and configuration of the a, b, b', and a'-domains of PDI are central to 
its many enzymatic and non-enzymatic functions.  The a-type domains are designated as 
such due to the presence of the catalytically active CxxC motif.  There is only 33.6% 
sequence identity between these domains, and each harbours the conserved active site 
motif: FYAPWCGHCK [43, 55].  The arrangement of the vicinal active site thiols is 
quite different, with the N-terminal cysteinyl thiol (Cys53 and Cys397) being more solvent 
exposed than the corresponding C-terminal cysteinyl thiol (Cys56 and Cys400) [43].  The 
a' active site also differs from that of a as it is shielded by a hydrophobic tunnel when 
PDI is in the reduced state [53].  Both active site regions are similar in displaying a 
hydrophobic surface [53]. 
The non-catalytic b-type domains are placed between the a-type, rendering PDI in 
the aforementioned U-shape, and show only 16.5% sequence identity [43].  It is this 
overall conformation that allows PDI to bind large protein substrates using a continuous 
hydrophobic surface along the inside of its structure [53].  In particular, the b'-domain 
exhibits a hydrophobic pocket that is believed to help PDI distinguish between unfolded 
and folded substrates- perhaps owing to the fact that in unfolded protein substrates there 
is a larger propensity of surface exposed hydrophobic regions [56]. 
The structural dynamics of PDI are extensive, and redox-regulated [53].  When PDI 
is in the reduced state (i.e., both CxxC active sites bearing free thiols) the enzyme takes 
on a non-planar U-shape with an inter-domain distance between the CxxC active sites of 
about 28 Å.  Once oxidized (i.e., intramolecular disulfide between the CxxC vicinal 
thiols) the a'-domain rotates about 45O in plane with domains a, b and b', rendering an 
inter-domain distance of about 41 Å [53].  This redox-state dependent conformational 
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change occurs about the flexible x-linker, and indicates that PDI has a much more open 
conformation when oxidized. 	
The highly acidic C-terminal extension of PDI has the classical tetrapeptide ER-
retention signal KDEL.  Because of this, PDI is primarily localized to the ER lumen and 
regularly recycled from the cis Golgi network back to the ER via a retrograde pathway 
[44, 57].  Despite this, it is found almost ubiquitously on the subcellular level, including 
the cytosol, cell surface and extracellular space.  It was once speculated that specialized 
secretory cells underwent saturation of the KDEL receptors of the Golgi membranes, 
leading to an apparent leakage of PDI [44].  This has since been deemed slightly 
inaccurate with the realization that the secretion of PDI is likely mediated by the KDEL 
retention motif itself, and that such an event is specific and regulated [58].  Although, the 
mechanism of secretion is still under investigation. 
	
1.2.2   The Enzymatic and Non-Enzymatic Activity of PDI and Methods of Detection 
PDI is a multifunctional enzyme capable of performing both enzymatic and non-
enzymatic activities.  Non-enzymatically, PDI functions as a chaperone and anti-
chaperone.  Enzymatically, PDI is able to reduce, oxidize and isomerize disulfide bonds; 
making it a thiol-reductase, thiol-oxidase and thiol-disulfide isomerase (Figure 1.7). 
The catalytic activities of PDI are centered on its two CxxC active site motifs.  For 
hPDI, this sequence is CGHC.  Each active site performs independent of the other in vitro 
[43, 59, 60] (refer to results- Chapter 3), although research has demonstrated that upon 
reduction of the a-domain, the a'-domain will subsequently re-oxidize it in vivo [56, 61] 
(see later).  When in the reduced state PDI is capable of reducing the disulfide bond of 
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some substrate, rendering itself oxidized.  The opposite can be said for when PDI 
oxidizes a substrate's dithiols.  As for isomerization, this does not result in a change of 
the redox-state of PDI. 
For thiol-disulfide exchange to occur the N-terminal cysteine (Cys53 of the a-
domain and Cys397 of the a'-domain: CxxC) is required for the initial nucleophilic attack 
of a substrate disulfide.  It has been described to have a pKa in the range of 3.8 [62] to 5.6 
[63, 64].  The highly acidic nature of these thiols as compared to the typical cysteinyl-
thiol pKa (ca. 8.6) is a result of the architecture of PDI.  Each is found at the N-cap of the 
α2 helix of the discretely folded TRX domain.  As well, there are contributions from the 
intervening histidine residue of the CGHC motif (His55 of the a-domain and His399 of the 
a'-domain) [65].   
The C-terminal active site cysteine residue (Cys56 of the a-domain and Cys400 of the 
a'-domain: CxxC) is recognized as the resolving cysteine as it functions to release PDI 
from a mixed-disulfide intermediate state following the initial nucleophilic attack of a 
substrate disulfide via the N-terminal vicinal thiol.  The pKa of the C-terminal cysteine is 
largely transient and dependent on the state of the PDI ensemble.  When PDI is in a free 
reduced state (i.e., not in an intermediate complex with substrate) the C-terminal active 
site thiol is reported to have a pKa between 8.6 [63] and >10 [62].  When PDI is 
occupying a mixed-disulfide state, the pKa has been observed to be as low as 6.1 [62, 63].  
The transient nature of this thiol pKa has been shown to be mediated by the strategic 
movement of an arginine residue (Arg120 of the a-domain and Arg461 of the a'-domain) to 
the active site; facilitating direct electrostatic interactions with the C-terminal- but not the 
N-terminal, cysteinyl thiol [63].  Unfortunately, the ability of the resolving cysteine to be 
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regioselective and form an intramolecular disulfide with the N-terminal vicinal active site 
thiol rather than an intermolecular disulfide with the substrate is not understood.  Many 
researchers attempt to describe the observed regioselectivity using the hard-soft acids and 
bases (HSAB) principle [66].  
Computational analyses have helped to further characterize the potential specificity 
of PDI based on the dihedral angles about a substrate's disulfide bond [58, 67].  Chiu and 
coworkers noted that of the implicated disulfide targets of PDI (substrates of thrombosis, 
refer to section 1.2.4), all harbour a disulfide conformation that is indicative of an 
allosteric linkage [58].  There are 20 characterized disulfide conformations found in 
protein crystal structures (Figure 1.8 A), three have been correlated as being allosteric 
disulfides- two of such showing enhanced bond strain about the S-S bond, resulting in it 
being "pre-stressed" [67].  This leads to accelerated rates of reduction.  An example of a 
pre-stressed disulfide is given in Figure 1.8 B.    
The ability of PDI to distinctly assign a nucleophilic cysteine (CxxC) and a 
resolving cysteine (CxxC) in its catalytic mechanism provides assurance that that the 
enzyme will not be trapped in a mixed-disulfide intermediate state for extended periods 
of time, particularly during protein folding.  This characteristic has been deemed the 
"scan and escape" mechanism [68].  Liberation of the mixed-disulfide intermediate is the 
rate-limiting step [68].  Gilbert and coworkers indicated that because disulfide bond 
rearrangement within a protein is slow, it is advantageous for PDI to liberate itself from 
the covalent complex and initiate isomerization successively anew [68].  The process 
continues until the most stable disulfide remains, one by which PDI cannot act to reduce; 
a disulfide with sufficient kinetic and thermodynamic stability [68, 69]. 
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Figure 1.7: The enzymatic dithiol-oxidoreductase activities of PDI.  Illustrating the 
ability of PDI to reduce substrate disulfides, oxidize substrate thiols and isomerize 
different configurations of disulfides on a substrate.  PDI is initially depicted as being in a 
mixed-disulfide intermediate state with the substrate.  For simplicity only the a-domain 
active site is depicted. 
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Figure 1.8: Disulfide bond configurations identified in proteins.  (A) The 20 possible 
disulfide bond configurations of proteins, highlighting the three configurations that 
represent allosteric disulfides in yellow, orange and blue.  (B) An example of the 
geometry of a pre-stressed disulfide configuration with inter-sulfur distance (d) and the 
disulfide bending angles (α). 
(adapted from [58]) 
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Should the resolving cysteine be sufficiently slow in releasing the intermediate complex, 
there is a possibility that a thiolate from the substrate attack the mixed disulfide instead.  
This can potentially lead to an unproductive catalytic cycle should the now free substrate 
be back to its original disulfide state.         
When these reactions occur, there is a need for the regeneration of the PDI active 
sites back to their original states- the oxidized state when considering oxidative protein 
folding.  In vitro, many small molecule electron donors (dithiothreitol, DTT; GSH) and 
electron acceptors (GSSG) are used to reduce or oxidize PDI active sites, respectively.  
Within the ER it is the resident oxidase, a flavo-enzyme, that preferentially mediates the 
oxidation of PDI.  This enzyme is endoplasmic reticulum oxidoreductin-1 (ERO1).  
Depending on the mode of protein folding, PDI may act in a PDI-1st or a PDI-2nd manner.  
PDI-1st pathways see PDI perform the initial oxidation of substrate thiols, then the 
subsequent reduction and isomerization.  In PDI-2nd pathways, PDI is purely an 
isomerase, as other enzymes such as quiescin-sulfhydryl oxidase (QSOX), catalyze the 
initial oxidation of substrate thiols [26].  Therefore, the reliance on ERO1 comes from 
PDI-1st pathways.  When the a-domain active site of PDI is reduced during PDI-1st 
oxidative protein folding, the a'-domain is required to subsequently re-oxidize it, 
rendering itself reduced [70].  In order for the a'-domain active site to be re-oxidized, 
ERO1 facilitates the oxidation using molecular oxygen as the oxidant, forming hydrogen 
peroxide as a by-product (H2O2, refer to section 1.2.3 for more details) [43, 56].  
Irrespective of the catalytic CxxC motifs is the chaperone activity PDI performs.  
The presence of a large hydrophobic groove on the b'-domain facilitates the interaction 
with unfolded nascent polypeptides or misfolded proteins.  PDI has been shown to 
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prevent the aggregation of unfolded proteins that do not bear disulfide bonds [71, 72].  
Using reduced, denatured lysozyme, Puig and Gilbert demonstrated that PDI functions as 
both a chaperone at high concentrations and an anti-chaperone when at low 
concentrations [73].  They speculated that this concentration-dependence be linked 
directly to the chaperone capacity and folding capacity of the ER, where PDI is highly 
expressed to near millimolar quantities [74, 75]. 
Although it may appear that domain-related activity be relatively independent, it 
has been demonstrated that there is cooperativity that occurs amongst them.  The a and 
a'-domains are required for the binding of larger substrates, while the b and b'-domains 
actually enhance reductase activity [76-79].  
 Seeing as PDI is such a multifunctional protein it is unsurprising to realize that 
there exists a plethora of techniques to monitor each of its respective functions (Figure 
1.9).  Each assay developed comes with its own inherent advantages and limitations.  
Although, when used in conjunction with one another, these techniques provide powerful 
tools for elucidating the mechanism of PDI and providing a means for potential drug 
discovery.  Depending on the initial state of the substrate and PDI itself (i.e., reduced or 
oxidized), one type of PDI activity will be biased in relation to the others [80]. 
To measure PDI reductase activity, reduced PDI (redPDI) and an oxidized substrate 
are required.  Advances in the measurement of reductase activity have brought about the 
development of small molecule and protein substrates with an emphasis on UV-Vis and 
fluorescence detection methods.  The most cost-effective reductase assay is the insulin 
turbidity assay.  Here, PDI catalyzes the reduction of insulin using GSH or DTT as the 
electron donor source, resulting in the liberation of free A and B chains- thereby 
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increasing the solution's turbidity (OD600, Figure 1.9 A) [43].  This method may be 
continuously monitored by coupling it to the formation of GSSG- making it an indirect 
assay.  A less cost-effective, but direct and continuous method to measure PDI reductase 
activity is through the use of fluorescently-quenched probes.  Mutus and coworkers 
developed a fluorimetric assay using GSSG as a means to link two identical fluorescent 
molecules in close proximity in order to take advantage of fluorescence self-quenching 
(FSQ); diaminobenzoyl-GSSG (Figure 1.9 C) [81] and dieosin-GSSG [82].  When PDI 
catalyzes the reduction of diabz/dieosin-GSSG, two free abz/eosin-GSH molecules result, 
leading to a loss of fluorescence quenching and an increase in signal proportional to PDI 
activity.  This fluorescence turn-on assay is capable of reaching detection limits of 1 nM 
PDI.  DTT is often used as the source of electrons to regenerate redPDI as it has no 
impact on the stability of the probe itself. 
To measure thiol-oxidase activity, PDI must initially be in the oxidized state 
(oxPDI) and the substrate be reduced.  Using RNase A, it is possible to measure the thiol-
oxidase activity of PDI by monitoring the rate of hydrolysis of cyclic cytidine 
monophosphate (cCMP) to CMP (Figure 1.9 D).  An increase in the absorbance at 296 
nm is proportional to the oxidative renaturation of RNase A [43].  To regenerate oxPDI, 
GSSG is used as the oxidant.  Another method, based on fluorescence quenching, uses a 
synthetic decapeptide substrate (Figure 1.9 F).  Designed by Freedman and coworkers 
[83], it contains two cysteine residues separated by a flexible linker, a fluorescent 
tryptophan residue adjacent one of the cysteines, and a protonatable arginine adjacent the 
other.  The tryptophan and arginine residues allow for the rate of PDI-catalyzed peptide 
oxidation to be measured by monitoring the quenching of tryptophan fluorescence (λex: 
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280 nm, λem: 360 nm) due to the close proximity with arginine, i.e. fluorescence turn-off 
[83].  Again, GSSG is used to regenerate oxidized enzyme active sites. 
Measuring the isomerase activity of PDI requires the use of substrates containing 
mispaired disulfides.  Some such examples include the scrambled RNase (scRNase) assay 
and the refolding of bovine pancreatic trypsin inhibitor (BPTI).  Here, PDI catalyzes the 
rearrangement of disulfide bonds until the native conformation of the substrate is 
attained.  In each case, that would be one displaying native activity as for the scRNase 
assay (Figure 1.9 E), or the correct disulfide arrangement as determined by mass 
spectrometry as for the BPTI refolding assay (Figure 1.9 G).  The scRNase assay is a 
time-consuming reaction that indirectly measures PDI isomerase activity.  The BPTI 
refolding assay is also very time consuming in-part due to the requirement of sample 
preparation for mass spectrometry.  Thus, these methods are inadequate as high 
throughput techniques [43]. 
Monitoring the chaperone-like activity of PDI requires the use of completely 
denatured substrates by which refolding follows a pathway that does not require disulfide 
bond formation [80].  Of note is the acid-denatured green fluorescent protein (GFP) 
refolding assay (Figure 1.9 I).  The refolding of GFP by PDI results in a native 
conformation exhibiting an increase of fluorescence over time.  This allows for the 
determination of rates directly [43]. 
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Figure 1.9: The various methods for detecting the different PDI activities in vitro.  
Boxed in red are those methods used for monitoring reductase activity (A, insulin 
turbidity assay; B, insulin degradation assay; C, fluorimetric di-abz-GSSG assay).  In 
blue are methods of detecting PDI thiol-oxidase activity (D, RNase oxidation assay; F, 
peptide dithiol oxidation assay).  In green are techniques used to detect PDI isomerase 
activity (E, scrambled RNase assay; G, bovine pancreatic trypsin inhibitor (BPTI) 
refolding assay).  Boxed in purple are the common methods of measuring PDI chaperone 
activity (H, rhodanese aggregation assay; I, acid-denatured green fluorescent protein 
(GFP) refolding assay). 
(adapted from [43]) 
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The reader should note that for the assays described capable of monitoring the 
enzymatic activities of PDI (reductase, thiol-oxidase and isomerase), there is often the 
presence of an electron donor or acceptor molecule to mediate the regeneration of the 
PDI active sites.  This is especially meaningful when considering reductase and thiol-
oxidase assays.  It means that no matter the method employed, the rates obtained 
represent the oxidoreductase activity of PDI, and often not purely the respective 
reductase or thiol-oxidase rates.  The process of active site regeneration can at times be 
rate-limiting, and unless this caveat be addressed, reported rates of catalysis may be 
inherently skewed (refer to sections 3.3 and 3.4). 
 
1.2.3   Interactions Between PDI and ERO1  
Thiol-disulfide redox reactions performed by PDI directly affect the redox state of 
the active sites.  When PDI is oxidized (bearing an intramolecular disulfide between the 
CxxC vicinal thiols) it functions to oxidize substrate thiols, thereby rendering the CxxC 
reduced (dithiol CxxC motif).  The opposite can be said for PDI-mediated substrate 
reduction.  This change of redox state indicates a need for mechanisms able to regenerate 
PDI active sites to either their reduced or oxidized forms.  During oxidative protein 
folding within the lumen of the ER, the oxidized a-domain active site of PDI has been 
found to introduce disulfides into reduced nascent substrates.  The now reduced a-domain 
active site is re-oxidized via a thiol-disulfide exchange reaction with the a'-domain 
disulfide.  With the regeneration of the oxidized a-domain achieved, there is now a need 
for the re-oxidation of the a'-domain CxxC; catalyzed by ERO1 [61, 84]. 
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ERO1 is an ER-resident oxidase with two isoforms: ERO1α and ERO1β.  Research 
has demonstrated that the in vitro sulfhydryl oxidase activity of the β isoform be 
approximately 2-fold greater, likely owing to the variation in sequence of the first CxxC 
active site (CFKC and CDKC for α and β isoforms, respectively) [85].  ERO1α is 
expressed in many different cell types in a near ubiquitous fashion, whilst ERO1β has 
been described as pancreas-specific with expression being inducible via ER-stress, such 
as the unfolded protein response (UPR) [86-88].  A β-hairpin of ERO1 binds the 
hydrophobic pocket of the b'-domain of redPDI allowing it to selectively oxidize it over 
other PDI family members [89, 90]. 
ERO1α contains regulatory disulfides that occur between various catalytic and non-
catalytic cysteines.  The catalytic cysteines constitute two distinct regions required for 
activity: C94xxxxC99 and C394xxC397.  The two primary redox states ERO1α takes on in 
living cells is Ox1 and Ox2 [91, 92].  Ox1 is an active form that exhibits intramolecular 
disulfides about the CxxxxC and CxxC motifs.  Ox2 is the inactive form where C94-C131 
and C99-C104 disulfides exist.  Ox2 is the predominant form of ERO1α, with Ox1 levels 
being enhanced upon PDI over-expression and PDI binding [92-94].  The C94-C99 
disulfide is located on a flexible loop (the regulatory loop) and is referred to as the shuttle 
disulfide.  During sulfhydryl oxidation, it passes electrons to the active site C394-C397 
disulfide which is proximal the Flavin adenine dinucleotide (FAD) cofactor.  Reduction 
of FAD to FADH2 leads to the reduction of molecular oxygen (O2), forming hydrogen 
peroxide (H2O2). 
The detailed molecular mechanisms are as follows.  When active ERO1α (Ox1) 
binds the b'-domain of redPDI, it selectively oxidizes the a' active site via a dithiol-
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disulfide exchange reaction- that being a transfer of two electrons from PDI to ERO1.  
The electrons from PDI are accepted by the regulatory loop cysteines, C94 and C99 
(C94xxxxC99) of ERO1α.  Residue C99 effectively acts as the shuttle cysteine by 
performing internal dithiol-disulfide exchange with the active site disulfide C394-C397, 
rendering the regulatory loop re-oxidized [61, 95, 96].  Electron transfer to the active site 
leads to a reduced dithiol state that is in close proximity with bound FAD.  The electron 
flow is furthered by transfer from C397 to FAD, resulting in the reduced form, FADH2.  
This occurs via a charge-transfer complex between the C397 thiolate anion and the carbon 
C(4a) of FAD.  The covalent adduct is liberated by the subsequent nucleophilic attack by 
the C394 thiolate.  The result is a regenerated C394-C397 disulfide and the aforementioned 
FADH2 [92].  The terminal electron acceptor is O2, where a single molecule accepts one 
of the two electrons of the exchange pathway, therefore reduction of two O2 molecules 
occurs.  Reduction of two equivalents of O2 by FADH2 yields two superoxide molecules 
and FADH2 being re-oxidized to FAD.  Superoxide dismutates to H2O2 and O2  (Figure 
1.10) [27].   
 
1.2.4   Influence of CxxC Intervening Residues on PDI Activity 
The specific sequence of the CxxC motif is widely understood to directly influence 
the redox characteristics of the active site.  For instance, PDI bears two CGHC motifs and 
thioredoxin (TRX) contains a single CGPC motif sequence.  This results in PDI being a 
better thiol-oxidase, while TRX is a better thiol-reductase.  The reason being the effect of 
the intervening residues on the thermodynamic stability (redox potential: E) of the vicinal 
thiol couple. 
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Figure 1.10: Electron flow during oxidative protein folding mediated by the PDI-ERO1α 
interaction pathway of thiol-disulfide exchange.  The a-domain of PDI oxidizes a reduced 
substrate, thereby becoming reduced (accepting two electrons denoted in red as e-).  The 
a'-domain of PDI re-oxidizes the a-domain resulting in electron flow between PDI active 
sites.  ERO1α binds the b'-domain of redPDI and selectively oxidizes the a'-domain by 
facilitating electron transfer to its regulatory loop disulfide.  The electrons are 
subsequently shuttled to the active site CxxC of ERO1α, which ultimately results in the 
reduction of FAD to FADH2.  FADH2 reduces molecular oxygen to form hydrogen 
peroxide- regenerating oxidized ERO1α.  
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The presence of histidine electrostatically stabilizes the reduced state of the active site in 
relation to the oxidized (intramolecular disulfide) state- thereby increasing E (−160 to −180 mV: a better oxidizer/ tendency to be reduced).  On the other hand, a proline in the 
same position with respect to TRX results in a decrease of E (−270 mV: a better reducer/ 
tendency to be oxidized) [97-100].  The impact on E is correlated directly with a change 
of thiol pKa, dependent on the xx-intervening dipeptide sequence.  The CGHC motif of 
PDI primes it as a better thiol-oxidase, in-part due to the His-CysN (N-terminal Cys thiol) 
interactions.  The electrostatic stabilization of the CysN-S- consequently results in a low 
thiol pKa of about 4.5 [64].  Substitution to proline (reminiscent of TRX) increases the 
pKa to 6.6, rendering the enzyme a better reductase as the oxidized form is now more 
stable [64, 99].  The requirement of positively charged, ionizable groups at intervening 
positions for thiolate stabilization is not absolute.  Aromatic residues also mediate 
thiolate stabilization by ring-edge (δ+) interactions [101-105]. 
The redox activity of enzymes functioning through a CxxC motif do not rely solely 
on the motif sequence itself (as discussed).  Using the E. coli thioredoxin DsbA (a potent 
oxidizer with motif sequence: CPHC, E = −121 mV [105]) and TRX, Bardwell and 
coworkers demonstrated that mutations to TRX that resulted in either complementation 
or non-complementation to the intervening sequence of DsbA consistently resulted in 
increased E values, with no discernable correlation in DsbA-like activity [101].  They 
went on to conclude that although the CxxC motif sequence is extremely important for 
biasing redox activity by affecting E, this is only a "prerequisite."  The activity of thiol-
disulfide oxidoreductases is largely impacted by other specific interactions that occur in 
vitro and in vivo, likely a result of protein architecture [101].  Even so, the intermediate 
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redox potential of PDI as compared to TRX and DsbA allows for its participation in a 
wider variety of thiol-disulfide exchange reactions [100].  The glutathione redox pool of 
the ER lumen has been most accurately estimated to average −225 mV, allowing for the 
prediction of a GSH:GSSG ratio of 35:1 [26].  This is in contrast to earlier reports 
estimating the redox poise of the ER lumen as being much more oxidizing with 
GSH:GSSG ratios of 1:1 to ~5:1 [26].  This would suggest that upon equilibration, 
redPDI would predominate over oxPDI within the ER lumen, purely from a 
thermodynamics standpoint [26].  Indeed, this is observed [12, 90, 106-109].  
 
1.2.5   Physiological and Pathophysiological Roles of PDI 
The physiological and pathophysiological events by which PDI has been found to 
be associated include NAD(P)H oxidase regulation [110], thrombus formation [111], and 
nitric oxide (NO) transport from red blood cells to the endothelium tissue in an oxygen-
dependent manner [56, 112], among many others.  Moreover, PDI has garnered much 
attention in view of its postulated roles in the promotion of pathogen internalization [113, 
114], cancer [115], coagulation disorders [116, 117], and SNO-PDI (S-nitrosylated PDI) 
mediated protein aggregation in neuronal diseases including Alzheimer's, Parkinson's and 
Amyotrophic Lateral Sclerosis (ALS) [118].  The involvement of PDI in such an array of 
cellular processes renders it infeasible to appreciably review all current literature on the 
matter.  Thus, a few primary examples will be briefly addressed herein. 
Only recently has PDI become realized for its role in cancer progression.  Neamati 
and coworkers assessed the upregulation of PDI in various cancer types using published 
microarray data in their most recent review [43].  Their findings indicated that in 
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comparison to normal, healthy cells, PDI is upregulated with a >2-fold change in brain, 
lymphoma, kidney, prostate, and lung cancers [43].  Furthermore, cell surface PDI has 
been linked to cancer invasion and metastasis, an event that can be inhibited through the 
use of PDI inhibitors and antibodies [43].  It is very possible that the onset of disease is 
not so much associated with PDI itself, rather it could be that the metabolic load of 
proliferating cancer cells is so high that it requires more PDI to facilitate the need for 
more protein folding.  Neamati stated that because of this fact, cancer cells are much 
more sensitive to PDI inhibition [43]. 
Cell surface PDI is particularly important when it comes to thrombus formation and 
coagulation.  Upon vascular injury, platelets and endothelial cells secrete PDI.  One such 
role for PDI in thrombosis stems from its ability to influence the binding of von 
Willebrand factor of the injured vessel wall with the α-subunit of glycoprotein 1b 
(GP1bα) of the GP1b-IX-V receptor complex of activated platelets [58, 119].  On the cell 
surface of platelets or nucleated cells PDI catalyzes thiol-disulfide exchange to mediate 
the cleavage of disulfide bonds of GP1bα.  Furthermore, PDI has been implicated in 
tissue factor decryption [120], factor XI activation [121] and the activation of integrin 
[58, 122, 123].  Recent findings using substrate-trapping mutants of PDI identified 
thrombus-specific substrates, such as plasma vitronectin [124], and others [99].          
Neurodegenerative diseases such as ALS, Alzheimer's and Parkinson's are common 
in that they exhibit an abnormal accumulation of misfolded proteins.  These misfolded 
proteins aggregate and form large inclusion bodies within and outside of cells, leading to 
plaques (aggregates of β-amyloid in Alzheimer's, α-synuclein in Parkinson's, and mutant 
superoxide dismutase (mtSOD1), in ALS disease patients).  PDI, along with many other 
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chaperones, is used to prevent the aggregation of terminally misfolded proteins, primarily 
via a response called the unfolded protein response (UPR); an up-regulation of PDI [118, 
125].  It has been shown that overexpression of PDI in neurodegenerative cell models of 
Parkinson's and ALS results in a decrease of respective aggregates, but overexpression in 
cancerous hepatocytes did not alleviate the levels of α1-antitrypsin inclusions [125].  This 
lead Grek and Townsend to suggest that cellular protection by PDI is disease and protein-
specific [125].  Furthermore, the protective effects of PDI have been shown to be largely 
influenced by its localization [126] and oxidative stress levels within the cell [56, 125, 
127].  PDI is primarily cell-protective for these reasons, but it has been speculated that its 
over-accumulation in response to stress initiates cell-death pathways [125, 128]. 
Events that lead to ER-stress, such as the accumulation of misfolded proteins, can 
initiate the UPR in two distinct ways.  If the stress is transient and reversible, the 
response will be pro-protective.  If the stress is chronic and irreversible the response will 
be pro-apoptotic.  Neurodegeneration tends to follow the latter case [129].  Even though 
PDI has been classically described as cell-protective, S-nitrosylation is prevalent in 
neurodegenerative disease, a modification which acts to limit and even prevent its 
protective functions [127].  The pro-apoptotic role of PDI is furthered by its discovered 
ability to induce oxidative stress [130], as well as results that have indicated reduced 
cytotoxicity in Huntington's disease models via the selective inhibition of PDI [128, 131]. 
 
1.2.6   Recent Advances in PDI-Targeted Therapeutics and Activity Regulation 
The role of PDI in disease is indicative of a need for commercially available potent 
and selective inhibitors.  To date, no such therapeutics exist in the clinical setting [43].  
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Because PDI functions through its CxxC motifs and/ or the hydrophobic surface about its 
U-shaped structure (especially via the b' hydrophobic cleft), inhibitors will often aim to 
target these sites.  It is well understood that the catalytic activity of PDI may be 
attenuated or inhibited by reversible or irreversible thiol-modifying compounds.  In vivo, 
increased levels of nitric oxide (NO) leads to the S-nitrosylation (Cys-SNO, see previous) 
of the thiols of PDI.  This has been linked to neurodegenerative disorders [125].  As well, 
there are implications that the thiols of cellular PDI may be nitro-alkylated by 
nitroarachadonic acid [132]- but further investigations are required.  Detailed in this 
section are some common inhibitors of PDI activity.  The reader is directed to a recent 
publication by Neamati and coworkers for a more extensive review [43]. 
There exists a plethora of thiol-modifying small-molecules for the inhibition of 
PDI.  Due to the chemistry of such compounds, they exhibit little to no specificity, but 
their ability to modify the active site thiols renders PDI catalytically inactive.  Commonly 
used in vitro are iodoacetamide (IAM), N-ethylmaleimide (NEM) and 5,5'-dithio-bis-(2-
nitrobenzoic acid) (DTNB), which function to irreversibly alkylate free thiols.  IAM and 
NEM are cell permeable [43].  Slightly more specific is phenylarsine oxide (PAO).  This 
compound is cell permeable and targets CxxC motifs exclusively by forming an 
irreversible complex with the vicinal thiols.  The family of propynoic acid carbamoyl 
methyl amides (PACMA) are able to react with the thiols of PDI and alter its secondary 
structure.  PACMA 31 was found to have potency towards ovarian cancer in vitro and in 
vivo, with little cytotoxicity to normal, healthy cells [43, 133]. 
Antibodies, antibiotics and plant metabolites have also been shown to exude PDI 
inhibition.  The very first reported inhibitor of PDI activity was bacitracin, a cyclic 
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dodecapeptide isolated from Bacillus subtilis [43, 134].  Isolation results in a complex 
mixture of bacitracin analogs, where bacitracin F has the lowest reported IC50 at 20 µM.  
Bacitracin does not significantly inhibit PDI reductase, thiol-oxidase or isomerase 
activities [135].  This compound binds to the b'-domain of PDI through disulfide bond 
formation with the domain thiols of C312 and C343, resulting in attenuated chaperone 
activity [43, 136, 137].  Furthermore, the monoclonal anti-PDI antibody (RL90) has been 
shown to inhibit PDI activity with great specificity [80]. 
Even though PDI is implicated in many disease states, with its inhibition being cell-
protective in certain cases, its role in physiological processes such as thrombus formation 
indicates that therapeutics need not only focus on its inhibition.  Recent work by 
Flaumenhaft and coworkers has demonstrated a class of reversible therapeutics that 
paradoxically enhance PDI activity via binding to the b'-domain [76].  These compounds, 
bepristats, target the b' binding cleft, acting as allosteric switches to enhance the rate of 
reductive cleavage of di-E-GSSG, yet inhibit the reduction of insulin [76].  Researchers 
indicate that the mode of action be the movement of the x-linker from the "capped 
position" (blocking the hydrophobic cleft) to the "uncapped position."  This result 
correlated strongly with other b'-directing agonists such as somatostatin, indicating that 
the conformational control of PDI is not only influenced by the redox environment (see 
section 1.2.1), but also the binding events at the b'-domain [76].  It is speculated that the 
augmented rate of oxidoreductase activity be a result of the conformational change 
promoting the reduced state of the PDI active sites.  This is a recent example of how there 
remains a need to fully understand the means by which PDI functions both in vitro and in 
vivo with its various substrates. 
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1.3   Nε-lysine Acetylation 
Posttranslational modifications (PTMs) further the central dogma by effectively 
expanding structural and functional characteristics of any single gene product (protein).  
A hallmark of protein modifications is O-phosphorylation.  Of the 461 reported PTMs, 
phosphorylation is the most well-studied and abundant [138].  The addition and removal 
of a charged phosphate to and from the hydroxyl-O of serine, threonine and tyrosine 
residues is mediated by the vast family of protein kinases and protein phosphatases, 
respectively.  An emerging PTM newly found to rival that of phosphorylation in terms of 
abundance is lysine acylation [139-141].  Acetylation, one such form of acylation 
(Figure 1.11), was first discovered in 1964 on histone lysine residues [142].  Since then 
the existence of lysine acetylation on thousands of proteins beyond histone and nuclear 
proteins has been described, leading to the realization of the acetylome [143]. 
Nε-lysine acetylation is the transfer of an acetyl moiety from acetyl-CoA to the side 
chain amine (ε-amine) of a protein's lysine residue.  This results in a neutralization of the 
positive charge and added steric bulk.  Acetylation is a very pertinent signalling event 
that works through the activity of "writers," "readers" and "erasers" [138].  The process 
occurs either enzymatically through the activity of lysine acetyltransferases (KATs, the 
"writers"), or non-enzymatically [144].  There are five distinct families of KATs: HAT1, 
Rtt109, Gcn5-related N-acetyltransferases (GNATs), E1A-associated protein of 300 kDa 
(p300)/CREB-binding protein (CBP), and MYST proteins.  The MYST and GNAT 
families showcase an acetyl-CoA binding motif, while the p300/CBP family proteins do 
not [145].  "Readers" are any proteins influenced by acetylation, leading to an 
intracellular signaling event/ response. 
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Figure 1.11: Nε-lysine acylation is a reversible modification that takes on many different 
forms.  Acyl-CoA acts as the donor substrate for acylation to occur either non-
enzymatically or via lysine acyltransferases to modify acceptor substrate lysine residues.  
Acyl-modification of lysine residues is reversed by the Sirtuin family of deacylase 
enzymes. 
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Proteins containing a bromodomain may be able to recognize acetylated residues, as has 
been implicated in histone and chromatin regulation [138].  "Erasers" mediate the 
removal of the acetyl moiety, such as the sirtuin family of deacetylases, akin to 
phosphatases with respect to dephosphorylation.  The mechanism of deacetylation varies 
depending on the deacetylase enzyme: NAD+-dependent or zinc-containing [146]. 
Each KAT has a common structural core region for acetyl-CoA and substrate 
binding (β-sheet-helix), but there is little sequence homology amongst them.  
Furthermore, KAT substrate specificity is defined by the flanking regions about the 
common core [147].  It has been found that the various KATs also employ very different 
enzymatic mechanisms for the acetylation of their respective acceptor substrate proteins 
[147]. 
Only recently has acetylation been identified specifically to occur within the ER.  
Research has demonstrated the presence of two ER-resident KATs of the GNAT family 
[148].  These isoforms, N-acetyltransferase 8B (ATase-1) and N-acetyltransferase 8 
(ATase-2) are ER luminal transmembrane KATs containing a single transmembrane 
domain.  They may exist as monomers, homodimers or heterodimers [148].  The 
mechanism of catalysis is not understood for these KATs, but an estimation can be made 
based on their relation to other GNAT family proteins such as Gcn5/ PCAF. 
The reaction likely initiates once both acetyl-CoA and the substrate protein are 
bound to the enzyme (a bi-bi ternary complex, and not through a ping-pong mechanism).  
The acceptor lysine is deprotonated by a general base catalytic mechanism, rendering it a 
suitable nucleophile for accepting the electrophilic carbonyl carbon of the acetyl moiety 
[144, 147].  Substrate recognition cannot be speculated due to structural variance among 
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the family members.  Proteomic efforts have explored the possibility of there being a 
recognition motif for acetylation, though more research is required [149, 150].  
Acetylation as a PTM does not solely rely on the work of "writers."  The process has 
been described as occurring non-enzymatically due to the inherent reactivity of the 
thioester linkage present in acetyl-CoA (or any acyl-CoA for that matter) [144]. 
 
1.4   Research Objectives and Rationale 
There is increasing evidence regarding the importance of PDI in physiology and 
disease.  Despite its scrutiny since the 1960's little is known regarding the regulation of 
this enzyme.  Recently unpublished work performed by our group showed that the lysine-
directing fluorophore, eosin-5-isothiocyanate (EITC), abolished PDI oxidoreductase 
activity when carrying out in vitro treatment at as low as a 2:1 molar ratio (EITC: PDI).  
In conjunction with these findings, Kimura et al. highlighted the presence of a highly 
conserved lysine residue found neighbouring immediately downstream the CxxC motif of 
many PDI family members [55] (refer to Figures 1.5 and 1.6).  In the same work, they 
showed that a CxxCK active site motif resulted in enhanced rates of isomerase activity.  
The human PDI family member PDIA6, regarded as hP5, has two CxxC motifs- the first 
is CGHCQ and the second is CGHCK.  Interestingly, they demonstrated that substitution 
of Gln in the first active site to Lys resulted in a 45% increase of isomerase activity [55].  
Involvement in such an array of cellular processes tends to be indicative of a need for 
posttranslational regulation and subsequently, the modulation of activity.  This is 
especially true for PDI when considering its ubiquitous nature, lengthy half-life and high 
expression levels at up to 1% the total cellular protein content of certain cell types [43]. 
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The goal of this research project is to characterize the oxidoreductase, thiol-
reductase and thiol-oxidase activities of hPDI in relation to the conserved active site 
lysine residues Lys57 and Lys401.  Site directed mutagenesis of these residues will be 
performed individually and simultaneously to the non-conservative amino acids 
glutamine (Gln), alanine (Ala) and glutamic acid (Glu).  A focus will be placed on the 
Gln mutants of PDI as it is believed that this mutation most closely mimics the highly 
abundant and physiologically relevant posttranslational modification of Ne-lysine 
acetylation (a neutral, yet still polar acetyllysine residue: acK).  That being the case 
whilst limited to canonical amino acid substitution.  Research in the lab of Dr. Luigi 
Puglielli has linked lysine acetylation to the ER and Golgi intermediate complex [151], 
where it has been shown that an acetyl-CoA transporter and two distinct ER-luminal 
transmembrane acetyltransferases are expressed [148, 152].  Proteomic assessment has 
identified PDI and many other ER-resident proteins as being targets of lysine acetylation 
[153, 154].   
Physiological significance will be addressed by assessing the interaction of ERO1α 
with wild type and mutant PDI enzymes.  Furthermore, the acetylation of PDI will be 
performed using acetylsalicylic acid- the active ingredient in Aspirin.  Mass spectrometry 
will elucidate the target residues of in vitro acetylation, complemented by steady state 
activity assays to discern the general impact of this modification.  Structural analyses will 
be performed in order to propose a mechanism by which lysine acetylation of residues 
Lys57 and Lys401 affects the catalytic activity of PDI, with reference to other PDI family 
member proteins. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
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2.1   Chemicals and Materials Tabulated 
Product Catalogue No. Distributer 
Anti-acetyllysine (7F8), primary, Msa monoclonal ab61384 
Abcam 
Anti-PDI (RL90), primary, Msa monoclonal ab2792 
Anti-Rabbit IgG HRP-conjugate, secondary, goat 1706515 BioRad 
HAT Inhibitor Screening Assay Kit 10006515 Cayman Chemicals 
Amicon® Ultra Centrifugal Filter Units UFC903008 
EMD Millipore RosettaTM (DE3) pLysS E. coli 70956 
ZipTips® C18 Pipette Tips ZTC18S096 
Amylose Resin E8021 
New England 
BioLabs 
BL21 (DE3) E. coli C2527 
BL21 (DE3) pLysS E. coli C3010 
NEB® 5-alpha Competent E. coli C2987 
Q5® Site Directed Mutagenesis Kit E0554 
Polyethyleneimine (PEI), Linear, Mr: 25 kDa 23966 Polysciences, Inc. 
Glu-C Sequencing Grade V165A Promega 
Formic acid (FA) A11750 
ThermoFisher 
PageRuler Plus Prestained Protein Ladder 26619 
PierceTM ECL Western Blotting Substrate 32109 
PVDF Western Blotting Membrane 88518 
Trifluoroacetic acid (TFA) A116-50 
ZebaTM Spin Desalting Columns 89882 
Acetic anhydride (AA) 320102 
4-aminophenylmercuric acetate A9563  
 
 
 
 
 
Sigma Aldrich 
 
 
 
 
Acetyl-CoA 101019070001 
Acetylsalicylic acid (ASA) A5376 
Ampicillin (Amp) A0166 
Anti-Actin, primary, Rabbit monoclonal A2066 
Anti-FLAG M2 Magnetic Beads M8823 
Anti-Mouse IgG HRP-conjugate, secondary, goat A4416 
Bicinconinic acid (BCA) B9643 
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Chloramphenicol (Cam) C0378  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sigma Aldrich 
Cyanogen bromide (CNBr) C91492 
Dithiothreitol (DTT) D0632 
DMEM/ F-12 Ham D8437 
DNAse D4527 
Eosin-5-isothiocyanate (EITC) 45245 
Epichlorohydrin (Epi) E1055 
Fetal bovine serum (FBS) F1051 
Flavin adenine dinucleotide (FAD) F6625 
Glutathione, oxidized (GSSG) G4376 
Glutathione, reduced (GSH) G4521 
Gold (III) chloride trihydrate 520918 
HIS-Select® Ni-Affinity Resin H0537 
Hydroxylamine hydrochloride (HA) 159417 
Iodoacetamide (IAM) I1149 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) I6758 
Kanamycin sulfate (Kan) K1377 
Lysozyme L6876 
Maltose 63418 
Polyethylene glycol maleimide (PEG-maleimide) 63187 
Nicotinamide (NAM) N0636 
Phenol:Chloroform:Isoamyl alcohol, 25:24:1 P2069 
Protease Inhibitor Cocktail P8340 
Sephadex G-25, fine G2580 
Sepharose ® 6B 6B100 
Sodium butyrate (NaBut) 303410 
Sodium citrate dihydrate W302600 
Tricostatin A (TSA) T1952 
TWEEN-20 P9416 
Maxi-Prep Plasmid Kit 12162 Qiagen 
a Ms: Mouse 
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2.2   Methods 
2.2.1   Site Directed Mutagenesis 
Mutagenesis of residues Lys57 and Lys401 was carried using the Q5â site-directed 
mutagenesis kit (NEB).  Primers were designed end-to-end wherein the forward 
contained the mutagenic sequence that resulted in a single amino acid substitution to 
either Ala, Gln, or Glu.  Similarly, mutagenesis of the active site vicinal thiols (Cys53 and 
Cys56; Cys397 and Cys400) followed similar principles.  The polymerase chain reaction 
(PCR) conditions were optimized for each primer set (appendix A Table A.1).  Thermal 
cycling was performed using a BioRad® T-100 Thermal Cycler carrying out 25 cycles of 
denaturation at 98 OC for 10 seconds, primer annealing (variable temperatures; appendix 
A Table A.1) for 30 seconds, and plasmid elongation and extension at 72 OC for 4.5 min.  
The resulting PCR products were treated with a kinase-ligase-DpnI (KLD) enzyme mix 
as per the manufacturer's instructions.  Plasmids were transformed into NEB® 5-alpha 
competent E. coli cells using the heat-shock method.  Transformed cells were then plated 
onto LB agar containing kanamycin antibiotic (LB-Kan 50 µg/mL) and grown overnight 
at 37 OC.  Individual colonies were selected, inoculated in liquid LB-Kan for overnight 
growth, then used for plasmid isolation via a standard phenol-chloroform bacterial 
miniprep procedure (Qiagen, see below).   Isolated plasmids were sequenced by Robart's 
Research Institute (London Regional Genomics Center, London, Ontario, Canada) to 
identify the successful mutagenesis of the doubly His6-tagged (N- and C-termini) hPDI 
gene present in a pET-28b(+) vector.  The resulting mutants were as follows; K57A, 
K57Q, K57E, K401A, K401Q, K401E, K57/401A, K57/401Q, and K57/401E for the 
kinetic analysis of hPDI activity in relation to a CxxC-neighbouring lysine residue.  As 
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well, the vicinal active site thiols of each active site (a and a'-domain) were substituted to 
alanine residues for the determination of the reductive potential on a per-active site basis.  
These consisted of CxxC(K/Q)57-AxxA(K/Q)57 and CxxC(K/Q)401-AxxA(K/Q)401 mutant 
enzymes, as well as a control CxxCK-AxxAK mutation to both active sites 
simultaneously resulting in a catalytically inactive enzyme. 
 
2.2.2   Bacterial Plasmid Miniprep 
Isolation of plasmid DNA from E. coli was adapted from a standard protocol 
(Qiagen).  1.5 mL of previously transformed cells were harvested by centrifugation at 12, 
000 ´g for 1 min.  The cell pellet was resuspended in 100 µL of buffer P1 (25 mM Tris-
HCl pH 8, 50 mM glucose, 10 mM EDTA).  To this, 200 µL of buffer P2 (0.2 M NaOH, 
1% SDS) was added, followed by neutralisation with 150 µL buffer P3 (3 M NaOAc pH 
5.2).  The solution was kept on ice for 20 min prior to centrifugation at 12, 000 ´g for 10 
min at 4 OC.  The supernatant was collected and 400 µL of phenol:chloroform 
isoamylalcohol was added.  The solution was vortexed and centrifuged at 12, 000 ´g for 
1 min.  The aqueous phase layer was collected and 800 µL ice cold anhydrous EtOH was 
added to it.  The sample was vortexed and centrifuged at 12, 000 ´g for 10 min at 4 OC.  
The pelleted plasmid DNA was rinsed with 70% ice cold EtOH, dried, then reconstituted 
in TE buffer (10 mM Tris-HCl pH 8, 1 mM EDTA).  Purity and concentration was 
assessed using a NanoDrop 2000 spectrophotometer (ThermoFisher).  
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2.2.3   Protein Purification and Standardization 
     2.2.3.1   Human Protein Disulfide Isomerase (hPDI)- WT and Mutants 
WT and mutated hPDI plasmid constructs, as described previously, were used to 
transform competent BL21 (DE3) E. coli cells (NEB) via the heat-shock method.  
Successfully transformed cells were grown overnight at 37 OC in 100 mL 2×YT media 
containing kanamycin (2×YT-Kan: 50 µg/mL).  Fresh 1.5 L of 2×YT-Kan was inoculated 
with overnight culture and grown at 37 OC until a cell density (O.D600) of 0.6 was 
reached.  Expression of PDI was then induced via the addition of 1 mM IPTG with 
incubation for 4 hours at 37 OC.  Cells were harvested and resuspended in lysis buffer (50 
mM Tris pH 8.0, 1mM NaCl, 2 mM EDTA, 1% Triton X-100, 2 mM PMSF, 125 µg/mL 
lysozyme, and 75 µg/mL DNase) followed by 10 rounds of sonication on ice at 20 second 
pulses (Sonic Dismemberator, Fisher Scientific).  Cellular lysates were clarified by 
centrifugation at 12, 000 ×g for 30 min.  Clarified lysates were passed over a gravity-fed 
HIS-SelectÔ Ni-affinity resin (Sigma) with a 5 mL bed volume and subsequently washed 
with 3 column volumes of wash buffer (50 mM phosphate pH 8, 150 mM NaCl) 
containing 10 mM imidazole, followed by another wash using 2 column volumes of 
buffer containing 40 mM imidazole.  His6-PDI was eluted using a 500 mM imidazole 
buffer.  The eluted sample was incubated with 100 mM DTT for 20 min on ice, then 
desalted and buffer exchanged with PDI assay buffer (0.1 M potassium phosphate pH 7.4, 
0.1 mM DTPA) using Amicon® ultracentrifuge filter units (MWCO: 30 kDa) as per the 
manufacturer's instructions (EMD).  Protein concentration was determined using the 
BCA assay [155], and purity was assessed via SDS-PAGE (refer to appendix A Figure 
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A.2).  Enzyme preparations were aliquoted, snap-frozen in liquid nitrogen and stored at −80 OC. 
For kinetic studies of PDI, the functional concentration of all enzymes was 
determined through the use of the di-E-GSSG assay (see below) by analyzing the burst 
phase kinetics.  Under standard conditions, 10 µL of affinity purified PDI was incubated 
with 800 nM di-E-GSSG in PDI assay buffer and allowed to react for 20 min, or until 
maximum fluorescence was reached (indicating that all catalytically active enzyme had 
reduced di-E-GSSG to EGSH.  Refer to appendix A Figure A.3).  The resulting 
fluorescence was plotted against a standard curve to determine the concentration of active 
(functional) PDI on a per-active site basis. 
For the determination of successful mutagenesis of the active site vicinal thiols of 
the CxxC-AxxA mutant enzymes, the di-E-GSSG assay was employed.  In relation to WT 
PDI, the activity of the CxxCK57-AxxAK57, CxxCK401-AxxAK401 and CxxCK57/401-
AxxAK57/401 mutants was determined.  This involved measuring the activity of 10 nM of 
PDI with 800 nM of the di-E-GSSG substrate.  In a similar fashion, the activity of the 
CxxCQ57-AxxAQ57 and CxxCQ401-AxxAQ401 mutants was assessed in relation to the 
K57/401Q variant bearing all intact active site thiols, the template to which the 
aforementioned mutants were engineered (appendix A Figure A.4).  
	
     2.2.3.2   Endoplasmic Reticulum Oxidoreductin-1α (ERO1α) 
Recombinant His-tagged ERO1α was graciously provided by Dr. Nagata.  In this 
study, a constitutively active human ERO1α mutant (C104/131A) was used [84].  
Purification followed an adapted protocol from both Araki and Nagata [84] and that of 
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the hPDI purification procedure described.  BL21 (DE3) pLysS E. coli cells (NEB) 
containing the his-tagged ERO1α plasmid construct were grown overnight in the dark in 
100 mL 2´YT media containing ampicillin and chloramphenicol antibiotics (2´YT-
AmpCam; 100 and 25 µg/mL, respectively) and 10 µM FAD.  1.5 L of fresh 2´YT-
AmpCam media (ampicillin: 50 µg/mL, chloramphenicol: 12.5 µg/mL, and 10 µM FAD) 
was inoculated at 37 OC with the overnight culture.  At a cell density (OD600) of 0.8, 
ERO1α expression was induced using 0.5 mM IPTG for 16 hours at room temperature in 
the absence of light.  Cells were harvested, lysed in the presence of 5 µM FAD, and 
Ero1α was isolated and purified as per the methods described previously for the 
purification of hPDI.  Once eluted from the Ni-affinity chromatography column, Ero1α 
was completely oxidized using 20 mM potassium ferricyanide (KFe(CN)6) for 20 min on 
ice.  After desalting and buffer exchange the isolated enzyme was stored at -80 OC in 
storage buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 10% glycerol).  Protein 
concentration was determined using the BCA assay [155], and purity was assessed via 
SDS-PAGE (appendix A Figure A.5). 
To determine the relative purity of the holoenzyme (FAD-bound ERO1α) an 
absorbance spectrum of the purified protein was taken in 6 M guanidine-HCl.  Using the 
characteristic absorbance peak at 440 nm and (ε: 12.5 mM-1 cm-1) [92], purity of the 
FAD-bound enzyme was determined to be > 92%.   
 
     2.2.3.3   Green Fluorescent Protein (GFP) 
Recombinant His-tagged GFP was prepared as per the protocol described for hPDI 
with some modifications.  The entirety of the procedure was performed in the dark to 
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maintain the integrity of the intrinsic GFP fluorescence.  Briefly, BL21 (DE3) E. coli 
cells were grown in fresh 2´YT media containing 100 µg/mL ampicillin to a density 
(OD600) of 0.6.  His-GFP expression was induced for 4 hours at 37 OC using 1 mM IPTG.  
After isolation and purification of his-GFP using Ni-affinity chromatography, the protein 
preparation was desalted and buffer exchanged to GFP storage buffer (50 mM Tris-HCl 
pH 7.4, 0.3 mM EDTA) using Amicon® ultracentrifuge filter units (MWCO: 10 kDa).  
Protein concentration was determined using the BCA assay [155], and purity was 
assessed via SDS-PAGE.  UV-Vis and fluorescence spectra of the purified protein were 
recorded (appendix A Figure A.6). 
 
     2.2.3.4   N-acetyltransferase-1 and -2 (ATase-1 and ATase-2) 
Maltose Binding Protein (MBP) fusion proteins of ATase-1 and ATase-2 were 
graciously provided by Dr. Luigi Puglielli.  Purification of MBP-ATase followed the 
procedure previously described with some modifications [156].  Rosetta (DE3) pLysS E. 
coli cells were grown at 37 OC overnight in 100 mL of fresh 2´YT media containing 
ampicillin and chloramphenicol antibiotics (2´YT-AmpCam; 100 and 25 µg/mL, 
respectively) and 0.2% glucose.  1.5 L of fresh 2´YT AmpCam media (with 0.2% 
glucose) was inoculated with the overnight culture and grown at 37 OC until a density 
(OD600) of 1.0.  MBP-ATase expression was induced by adding 0.5 mM IPTG followed 
by incubation for 18 hours at room temperature.  Cells were harvested by centrifugation 
at 4 OC and lysed as described previously for the purification of hPDI.  Whole cell lysates 
were incubated with 3 mL of amylose resin for 2 hours at 4 OC.  The lysate-amylose 
mixture was transferred to a glass-walled Econo-Column® (BioRad) for the purposes of 
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gravity-fed washing and elution of MBP-ATase.  Amylose resin was washed with 5 
column volumes of AT buffer (20 mM HEPES pH 8, 150 mM NaCl, 1 mM EDTA).  
MBP-ATases were eluted from the resin using AT buffer containing 30 mM maltose.  
The enzyme preparation was then desalted and buffer exchanged to AT buffer using 
Amicon® ultracentrifuge filter units (MWCO: 30 kDa).  Protein concentration was 
determined using the BCA assay [155], and purity was assessed via SDS-PAGE 
(appendix A Figure A.7). 
Acetyltransferase activity was assayed using a commercially available histone 
acetyltransferase (HAT) inhibitor screening kit (Cayman Chemicals).  The adapted 
method involved using affinity purified MBP-ATase enzyme as donor of the acetyl group 
from acetyl-CoA to an acceptor substrate, that being a human histone H3 peptide.  The 
assay consisted of incubating various concentrations (10 nM to 2 µM) of ATase-1 or 
ATase-2 with 50 µM acetyl-CoA and the H3 peptide (appendix A Figure A.7).  
Reactions were carried out for 1 hour at 30 OC, quenched with ice cold isopropanol, and 
activity was quantified using a thiol-reactive CPM molecule that becomes fluorescently 
active upon reaction with free CoASH (see manufacturer's notes).     
 
2.2.4   Dieosin Glutathione Disulfide (di-E-GSSG) Synthesis and Standardization 
Synthesis of the dieosin glutathione disulfide (di-E-GSSG) self-quenching pseudo 
substrate of PDI was performed using an adapted protocol from Raturi et al. [82].  All 
steps were performed in the dark to limit photo bleaching of the eosin fluorophore.  30 
mg of oxidized glutathione (GSSG) was dissolved in 1.5 mL of 100 mM ammonium 
bicarbonate buffer (pH 9) containing 2 mM EDTA.  A 5-fold excess of eosin-5-
isothiocyanate (EITC; 173 mg) was dissolved in 5 mL of DMSO and added to the GSSG 
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solution dropwise with stirring.  The reaction was then brought to a final volume of 15 
mL through the addition of 100 mM ammonium bicarbonate (pH 9) containing 2 mM 
EDTA.  Protected from light, the reaction proceeded overnight at 4 OC.  The labelling 
reaction was quenched by snap freezing in liquid nitrogen, then lyophilized to a dry, red, 
flakey powder.  This was then dissolved in a minimal amount of milli-Q grade water (1-2 
mL).  The concentrate was then applied to a long-body sephadex G-25 column (~123 mL 
bed volume; height: 25 cm, diameter: 2.5 cm) with a flow rate of 0.5 mL per min 
(controlled by a Model EP-1 EconoPump, BioRad) using milli-Q grade water as the 
eluent.  The progress of gel-filtration was monitored by observing the elution profile 
using the BioLogic LP system (BioRad) by which fractions of the first elution peak were 
collected as product di-E-GSSG.  It should be noted that free, unreacted EITC binds to 
the sephadex resin resulting in convenient isolation of the desired product.  Furthermore, 
G-25 gel filtration is an appropriate means of sample workup as separation based on 
hydrodynamic volume means di-E-GSSG may be reliably obtained as the first eluate.  A 
total of 192 fractions of 1 mL volume were collected.  The presence of di-E-GSSG was 
confirmed by assessing both the self-quenching properties and the fold-increase of 
fluorescence for each fraction.  Using black, opaque fluorescence-optimized 96-well 
plates (CorningTM), the fluorescence of 50 µL of each fraction was analyzed before and 
after the addition of 1 M DTT (λex: 525 nm; λem: 545 nm) using a Wallac 1420 Victor3 
Microplate Reader (Perkin Elmer).  Incubation with DTT was for 30 min to ensure 
complete reduction of the probe.  Fractions that exhibited a >30-fold increase of 
fluorescence were pooled, snap-frozen in liquid nitrogen, and lyophilized.  The resulting 
dry powder was then reconstituted in milli-Q water to a stock concentration of 375 µM 
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(using ε: 176, 000 M-1 cm-1 at 525 nm).  Aliquots of the stock solution were then snap-
frozen in liquid nitrogen and stored at −80 OC.  
 
2.2.5   Synthesis of Gold Nanoparticles (AuNPs) 
Synthesis of AuNPs followed the procedure described by Freeman et al. [157].  
Briefly, 200 mg of gold (III) chloride trihydrate was dissolved in 500 mL of high purity 
milli-Q water in a 1 L double-neck round bottom flask.  The solution was left to reflux 
with vigorous stirring for 1 hour in a hot oil bath (100 OC).  Next, 600 mg of sodium 
citrate dihydrate was dissolved in 50 mL of milli-Q water then added quickly to the gold 
chloride solution.  The reaction was allowed to proceed for 10 min before being removed 
from the heat and cooled to room temperature.  The formation of a colloidal solution was 
realized by the change in colour from clear to deep purple, exhibiting a characteristic 
absorbance maxima at 529 nm (appendix A Figure A.8).  
 
2.2.6   Preparation of CNBr-activated and Epichlorohydrin-activated Mercury 
Sepharose  
Generation of activated sepharose herein was performed by Milosz Brzozowski of 
the Mutus research group (University of Windsor, Windsor, Ontario, Canada). 
The preparation of cyanogen bromide (CNBr) activated organomercurial sepharose 
(Hg-sepharose) followed an adapted procedure from Wilchek et al. and Sluyterman and 
Wijdenes [158, 159].  First, 10 mL of packed Sepharose 6B was washed with 100 mL 
ddH2O and then suspended in a beaker on ice with 20 mL ddH2O to maintain the reaction 
temperature at 15 OC.  To the suspension was added 1 g of CNBr and a pH of 11 was 
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maintained throughout the reaction with the drop wise addition of 2 M NaOH.  Once the 
pH was stabilized the CNBr-activated Sepharose 6B beads were washed with 200 mL of 
0.1 M NaHCO3 by vacuum filtration.  The beads were then suspended in 20 mL of a 10% 
DMSO solution and 0.15 g of 4-aminophenylmercuric acetate (APMA) dissolved in 
DMSO was added to the activated bead solution.  The CNBr-activated Sepharose 6B and 
APMA were tumbled gently overnight at 4 OC to ensure completion of the reaction.  The 
resulting CNBr-activated Hg-sepharose was then brought to room temperature and 
washed with 20% DMSO to remove any remaining unreacted APMA, and then washed 
with 200 mL of 100mM EDTA (pH 8.0) to chelate any free mercury.  Lastly, the beads 
were washed with 200 mL ddH2O.  This procedure was repeated four times to produce 
approximately 50 mL of packed CNBr-activated Hg-sepharose. 
An alternative approach was taken, utilizing the activating compound 
epichlorohydrin (Epi) in place of the more expensive and toxic CNBr reagent.  
Preparation of Epi-activated Hg-sepharose followed the synthesis as performed by 
Matsumoto et al. with some alterations [160].  First, 12 mL of packed Sepharose 6B was 
washed with 100 mL ddH2O and suspended in 35 mL of a 0.4 M NaOH solution.  The 
Sepharose 6B solution was then reacted with 1.5 mL Epi and tumbled gently at 40 OC for 
2 hours in order to encourage homogeneous mixing of the Epi reagent.  The Epi-activated 
Sepharose 6B beads were brought to room temperature before washing with 200 mL 
ddH2O.  The resin was then suspended in 15 mL of 0.1 M NaOH (pH 10.5) and reacted 
with 0.15 g APMA (dissolved in DMSO) by tumbling gently for 24 hours at 40 OC.  The 
resulting Epi-activated Hg-sepharose was washed with 200 mL ddH2O.  This procedure 
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was repeated three times to produce approximately 40 mL of packed Epi-activated Hg-
sepharose.  
 
2.2.7   In Vitro Kinetic Assays 
Herein, all respective kinetic assays described were performed at 22 ± 2 OC using 
fresh enzyme having gone through no more than 1 freeze-thaw cycle.  Furthermore, each 
respective assay was performed in parallel with the WT or untreated control to add to the 
validity of the results.  Data are reported as the mean and standard deviation (± S.D.) of n 
replicates.  All fluorescence data was collected using a Cary Eclipse fluorescence 
spectrophotometer (5 nm slit width and medium gain settings; Agilent Technologies), 
unless otherwise stated. 
 
     2.2.7.1   Steady State Oxidoreductase di-E-GSSG Assay   
The kinetic assay used to measure the oxidoreductase activity of PDI was 
performed in PDI assay buffer of varying pH at a final volume of 500 µL.  PDI (10 nM) 
was added to a cuvette containing 10 µM dithiothreitol (DTT) and varying concentrations 
of di-E-GSSG (25 nM to 5 µM).  The reduction of di-E-GSSG was monitored for 60 
seconds and the initial rate of EGSH production was determined from the linear portion 
of the curve (RFU vs. time; lex: 525 nm, lem: 545 nm).  Kinetic data was fitted to a 
Michaelis-Menten hyperbolic curve (Equation 2.1) using non-linear regression analysis 
[161] in Excel with the Solver data analysis tool. 
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v? = VUV@[S]KX + S 	
                                                        Equation 2.1 
pH-dependence experiments were performed under steady state conditions using a 
single di-E-GSSG concentration of 800 nM.  The data was fitted to a two-pKa bell shaped 
curve (Equation 2.2).    
v = 10[\][^_(1 + 10[\][^_) − 10[\][^b(1 + 10[\][^b)	
																																																					Equation	2.2 
Where v represents the rate of fluorescence increase at any given pH. 
Mathematical simulations of the pH-dependence of PDI activity were performed 
using Equation 2.3.  Here, pK1 represents the average value of the experimentally 
determined macroscopic pKa of the ascending limb of all PDI variants tested (Figure 
3.1), x is the factor (between 0 and 1) of relative contribution to di-E-GSSG reduction 
kinetics with respect to the active site lysine residues (where 0 would represent no 
alteration and 1 would represent complete removal, i.e. mutation),  pKx is the average 
value of the experimentally determined pKa of the descending limb of the 
K57/401(Q/A/E) mutants studied, and pKK is the value of pK2 of WT PDI as determined 
experimentally using Equation 2.2.    
 
v = 10[\][^_(1 + 10[\][^_) − (𝑥) ∙ 10[\][^e1 + 10[\][^e + 1 − 𝑥 ∙ 10[\][^f1 + 10[\][^f 	
Equation 2.3 
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     2.2.7.2   Single Turnover Thiol-reductase di-E-GSSG Assay 
The single-turnover rate of PDI was measured under pseudo-first order conditions; 
80 nM of PDI was incubated with 1 µM di-E-GSSG in the absence of DTT.  The reaction 
was monitored until completion at varying pH.  A time-course fluorescence increase was 
related to the consumption of di-E-GSSG over time, resulting in exponential decay plots 
which were fit to Equation 2.4. di − E − GSSG j = di − E − GSSG ?e]lmnop	
                           Equation 2.4 
Where [di-E-GSSG]f and [di-E-GSSG]o represent the final and initial concentrations of 
the substrate over the course of the reaction, respectively.  The observable rate, kobs, was 
taken as the slope of the natural log of the integrated rate law above (Equation 2.4). 
 
     2.2.7.3   Thiol-oxidase Assay 
PDI-catalyzed dithiol-oxidation was monitored using the assay described by 
Ruddock et al. [83].  The synthetic decapeptide substrate; NRCSQGSCWN, was 
synthesized by CPC Scientific (Sunnyvale, California, USA) as a trifluoroacetic acid 
(TFA) salt (MW: 1154.3, purity: 97.4%).  A stock solution was made at 1.71 mM 
(confirmed by absorbance at 290 nm; ε = 5600 M-1 cm-1) by reconstituting the peptide in 
30% acetonitrile with 0.1% TFA and stored at -80 OC.  PDI enzymes were oxidized with 
10 mM GSSG for 1 hour at room temperature prior to performing the experiment.  
Removal of excess GSSG was performed using ZebaTM Spin Desalting columns as per 
the manufacturer's instructions.  A 250 µL reaction volume was utilized.  In a cuvette, 2 
µΜ PDI and 1 mM GSSG were mixed in PDI assay buffer of varying pH.  The reaction 
was initiated by the addition of 50 µM of the peptide substrate and the rate of oxidation 
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was monitored by fluorescence (λex: 280 nm, λem: 360 nm).  Data analysis was performed 
as previously described [83].  The rate of oxidation was determined as the inverse half-
time of reaction; that is, the inverse of the time at which mid-point fluorescence was 
reached.  The mid-point fluorescence of the reaction was taken as the mean of the initial 
and final fluorescence outputs. 
 
     2.2.7.4   ERO1α Oxidase Assay 
ERO1α activity was measured using an oxygen consumption assay monitored by an 
Oxygraph Plus oxygen electrode unit (Hansatech) with a stirrer speed of 70%.  The 
electrode was calibrated as per the manufacturer's instructions.  Experiments were 
performed in air-saturated ERO1α assay buffer (50 mM HEPES, 150 mM NaCl, 2 mM 
EDTA) at pH 7.4 in a final reaction volume of 800 µL.  Air-saturation of the buffer was 
completed by bubbling with air for 30 min prior to each experiment.  Catalytic oxygen 
consumption was initiated by the addition of 2 µM ERO1α to a reaction mixture 
containing 5 µM PDI and 20 mM GSH.  The time-course of the reactions were reported 
as a percentage of oxygen in solution to provide a semi-quantitative analysis of the 
interaction between ERO1α and the PDI enzymes.  Reactions were performed in the dark 
to prevent the photo-degradation of the FAD cofactor.  The initial linear portion of the 
curve was used to report observable rates as determined by the absolute slope of the best-
fit line (R2 ³ 0.99). 
 
2.2.8   pH-Induced Substrate Trapping 
To trap PDI in a mixed disulfide state with the fluorescent eosin-glutathione 
substrate (EGSH), iodoacetamide (IAM)-mediated thiol blocking was utilized.  Under 
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similar steady state conditions as employed previously, 150 nM PDI was incubated with 
5 µM di-E-GSSG in PDI assay buffer of varying pH containing 10 µM DTT.  The 
reaction was quenched at defined time points by the addition of 30 mM IAM for a 20 min 
incubation at room temperature.  Samples were desalted and buffer exchanged to PDI 
assay buffer pH 7.4 using ZebaTM Spin Desalting columns (MWCO: 7 kDa) as per the 
manufacturer's instructions.  Samples were then loaded to a black, opaque fluorescence-
optimized 96-well plate (CorningTM) for fluorescent measurements using a SpectraMax® 
M5E microplate reader.  The fluorescence readings were related to an EGSH standard 
curve to quantify the amount of PDI trapped in a mixed-disulfide intermediate state. 
 
2.2.9   Chemical Acetylation of PDI 
Nε-lysine acetylation of PDI was carried out using acetic anhydride (AA) and 
acetylsalicylic acid (ASA).  For acetylation by AA, 2 µM PDI was diluted in 100 mM 
sodium bicarbonate buffer pH 8.5 and incubated with 450 µM AA (7 mM stock solution 
in acetonitrile) for 1 hour at room temperature in the presence of 0.5 mM DTT.  This 
reaction represents ~1:1 molar ratio between PDI lysine residues and AA.  The use of 
ASA for acetylating PDI was performed at 37 OC for 4 hours in a 0.1 M Tris-HCl buffer 
pH 8.5 using 0.1 to 15 mM ASA in the presence of 0.5 mM DTT. 
To quench the acetylation of primary amines and to revert undesirable O-
acetylation, hydroxylamine (HA) was added [162-167].  HA-mediated acyl removal was 
accomplished by adding 100 mM HA to the acetylation mixture and allowing it to react 
for 30 min at room temperature.  Acetylated PDI was desalted and buffer exchanged to 
50 mM ammonium bicarbonate (ABC) buffer using ZebaTM Spin Desalting columns 
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(MWCO: 7 kDa).  Lysine acetylation was confirmed by Western blot analysis and ultra-
high-performance liquid chromatography mass spectrometry. 
 
2.2.10   Western Blotting 
All primary and secondary antibodies were utilized as dilutions in 1X TBST (tris-
buffered saline 0.1% Tween-20) containing 1% skim milk.  Primary antibodies (mouse 
IgG, see section 2.1) used to probe for acetylated lysine residues (acK) and PDI were 
used at 1:1000 and 1:3000 dilutions, respectively.  Secondary antibody conjugated to 
horseradish peroxidase (HRP; goat α-mouse, see section 2.1) was used at a dilution of 
1:5000. 
Western blotting was performed on 10% or 12% SDS-PAGE with transfer to a 
PVDF membrane.  Membranes were blocked with 5% skim milk in 1X TBST for 1 hour 
at room temperature.  Primary antibodies were then added and incubated overnight at 4 
OC with gentle rocking.  Before the addition of the secondary antibody, membranes were 
washed for 5 min with 1X TBST at room temperature, this was repeated 3 times.  
Secondary antibody incubation was for 1 hour at room temperature with gentle rocking.  
Prior to imaging, the membranes were washed with 1X TBST as described previously.  
Detection of chemiluminescence was performed using a FluoroChem® Q quantitative 
imaging system (Alpha Innotech).   
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2.2.11   High Performance Liquid Chromatography Electrospray Ionization Mass 
Spectrometry (HPLC-ESI MS) 
2.2.11.1    Proteolysis and Sample Preparation 
Digestion of affinity purified hPDI followed an in-solution protocol using Glu-C 
endopeptidase.  100 µg of PDI was diluted 1:1 with 50 mM ammonium bicarbonate 
buffer pH 8.0 (ABC, unadjusted) containing 4 M urea.  To this, 2 mM DTT was added 
and allowed to fully reduce PDI disulfides for 30 min and 60 OC. The fully reduced PDI 
preparation was desalted and buffer exchanged to 25 mM ABC pH 8.0 using ZebaTM 
Spin Desalting columns (MWCO: 7 kDa).  Lyophilized Glu-C (10 µg; Promega) was 
reconstituted in 25 mM ABC pH 8.0 to 0.1 µg/µL.  30 µg of PDI was then digested with 
Glu-C at a protein:protease ratio of 10:1 for 16 hours at room temperature with shaking.  
Proteolysis was quenched by the addition of 1% formic acid (FA) and the peptides were 
desalted using C18 ZipTips® (EMD Millipore) according to the manufacturer.  Peptides 
were dried and resuspended in 0.1% FA for ESI-MS analysis.  An unquenched fraction of 
the digest was saved for the purpose of enrichment of thiol-containing peptides.	
For the enrichment of thiol-containing peptides, a procedure was first used to test 
the efficiency thiol-protein binding of the prepared AuNPs and Hg-sepharose [168].  
Briefly, 500 µL of AuNPs were collected by centrifugation at 15 000 ´g for 15 min.  
Similarly, 100 µL of a ~50% slurry of Hg-sepharose (Epi- or CNBr-activated) and 100 
µL of unmodified sepharose 6B (~60% slurry; control) was collected by centrifugation at 
5000 ´g for 1 min.  The supernatant was removed from the collected AuNPs and 
sepharose supports and 30 µg of native redPDI (50 µL of a 0.6 µg/µL stock) was added 
and incubated for 30 min at 37 OC.  The solutions were then appropriately centrifuged to 
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isolate the supernatants.  The pelleted matrices (AuNPs and sepharose) were washed 3 
times with 200 µL of 25 mM ABC buffer pH 8.0 (unadjusted).  To elute PDI from the 
AuNPs and sepharose beads, 25 µL of 100 mM DTT (in ddH2O) was added followed by 
sonication in a water bath for 5 min.  Following sonication, the suspensions were 
incubated with DTT for 30 min at 37 OC with occasional mixing.  The suspensions were 
centrifuged and the elution fraction saved for analysis.  This was repeated 2 times, with 
all eluted fractions being pooled.  Various fractions were assessed using SDS-PAGE, 
indicating the Epi-activated Hg-sepharose resin as being the most efficient method for 
isolation of PDI via thiol-enrichment (appendix A Figure A.9).  For the enrichment of 
thiol-containing peptides, a similar procedure was followed, except 30-50 µg of an 
unquenched Glu-C digest of redPDI was applied.    
                         
2.2.11.2   Data Acquisition 
Mass spectrometry was performed by Dr. Janeen Auld (University of Windsor, 
Windsor, Ontario, Canada).  
Samples were analyzed using a Waters SYNAPT G2-Si time-of-flight mass 
spectrometer configured for nano-ESI operated in positive-ion mode coupled to a Waters 
nanoACQUITY UPLC system (UPLC-ESI MS).  The UPLC was configured for 1D 
single pump trapping with a Waters ACQUITY UPLC Symmetry C18 2G V/M trap 
column coupled with a Waters ACQUITY Peptide BEH C18 with 0.5 to 1 µL sample 
injections.  Mobile phase buffer A was 0.1% formic acid (FA).  Mobile phase buffer B 
was acetonitrile with 0.1% FA.  Samples were loaded on the trap column for 3 min at a 
flow rate of 5 µL/ min in 97% buffer A, 3% buffer B.  A 7-step, 60 min gradient was run 
at a flow rate of 0.3 µL/ min where buffer A concentration was 97% at 0 min to 90% at 5 
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min, 75% at 33 min, 50% at 41 min, 15% at 42 min to 44 min, and 97% at 45 min to 60 
min.  Samples were first analyzed in MSe mode prior to MS/MS sequencing.  MS/MS 
followed a data-dependent acquisition (DDA) method by targeting the precursor ions of 
interest identified by MSe.    
 
2.2.12   Molecular Dynamics Simulations 
Computational analyses were performed by Wanlei Wei and Paul Meister of the 
Gauld research group (University of Windsor, Windsor, Ontario, Canada). 
The X-ray crystal structures of reduced (redPDI) and fully oxidized (oxPDI) PDI 
were obtained from the Protein Data Bank (PDB: 4EKZ and 4EL1, respectively) [53].  
The enzyme structures were hydrogenated in accordance with the protonation states of 
the various charged side chains using PROPKA [169].  Using the AMBER14 program 
package with the cuda-enabled version of the pmemd module [170, 171], the system was 
solvated with TIP3P [171] water molecules generating a cubic solvation space with edge 
length of ~105.9 Å.  Solvation achieved a density of 1.06 g/cm3 after equilibrium, 
containing 37 071 water molecules. 
Simulations were performed on WT and the K57/401Q double mutant PDI enzyme.  
All simulations were performed through the ff14SB [172] and TIP3P  [171] force fields 
for protein and water, respectively.  Periodic boundary conditions were applied, and an 
NVT ensemble was used with Anderson temperature coupling scheme [173].  The 
Particle-Mesh Ewald (PME) procedure was used to calculate long-range electrostatic 
interactions and a cut-off of 8 Å was applied in real space.  The SHAKE algorithm was 
used to restrain the bond stretches involving hydrogen atoms, which allowed a 2 fs time 
step to be used for both equilibration and production.  The equilibrations were conducted 
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in five stages after energy minimization.  (1) To ensure the proper geometry of the 
hydrogen atoms, all heavy atoms, including water oxygen, were restrained with a 
harmonic potential using a force constant of 50 kcal mol-1 Å-2 for 100 ps, at 10 K.  (2) 
The same potential and conditions were applied for an additional 100 ps, but with the 
removal of the restraint on the water oxygens to ensure optimized positions of water with 
respect to the protein environment.  (3) The harmonic potential constant was decreased to 
5 kcal mol-1 Å-2 for 100 ps. (4) Subsequently, the harmonic potential force constant was 
removed for 100 ps.  (5) The system was gradually heated to 300 K over 2000 ps.  The 
velocities were randomly updated every 10 steps for the equilibration stages 1-4 and 
every 100 steps for stages 5.  The production run was conducted for 50 ns following 
equilibration.  
To determine the pKa of the active site cysteinyl thiols (of redPDI) and lysine 
residues Lys57 and Lys401, the PROPKA feature within the MOE2016 program package 
was employed [174].  Predictions were done on a representative structure obtained from 
the MD simulation based on the most populated RMSD values of the protein over the 
course of the simulation. 
 
2.2.13   Statistical Analysis 
One-way ANOVA followed by Dunnett's multiple comparisons test was performed 
on all kinetic data using GraphPad Prism version 6.0e (GraphPad Software, La Jolla 
California, USA).  Differences were deemed significant if P < 0.05.  Significance is 
denoted with respect to WT control unless otherwise stated; * P < 0.05, ** P < 0.01, *** 
P < 0.005, **** P < 0.001.  No significance is denoted by ns where appropriate.   
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A total of nine hPDI mutants were designed and purified.  Successful mutagenesis 
was confirmed via cDNA sequencing.  Rational design involved targeting the highly 
conserved active site lysine residues Lys57 and Lys401 of the a and a'-domains, 
respectively [55, 62].  Amino acid substitution of the aforementioned residues was 
performed (appendix A Table A.1).  Residue numbering is based on the accepted 
sequence for PDI from Homo sapiens (Uniprot: PDIA1, P07237).  Sequential 
mutagenesis of Lys57 and Lys401 to the non-conservative amino acids glutamine (Gln), 
alanine (Ala), or glutamic acid (Glu) resulted in single mutant progenitor enzymes by 
which double mutant hPDI constructs were also generated (K57/401A, K57/401Q and 
K57/401E).  The purity of the isolated PDI proteins was assessed using SDS-PAGE 
(appendix A Figure A.2), and standardization of active enzyme was determined on a per-
active site basis by single turnover, burst-phase kinetic analysis using the dieosin-
glutathione disulfide (di-E-GSSG) assay, followed by interpolation of a standard curve 
(appendix A Figure A.3). 
 
3.1   Substitution of the CGHC-neighbouring Residues K57 and K401 Alters the pH-
Dependence of PDI Oxidoreductase Activity 
In order to assess the potential catalytic contributions of Lys57 and Lys401, these 
amino acids were substituted to neutral-polar glutamine (Gln), nonpolar alanine (Ala), or 
to negative-polar glutamic acid (Glu) residues via site-directed mutagenesis.  The pH 
profiles of the wild type (WT) and doubly-mutated PDI enzymes (10 nM) were 
determined at a constant concentration of di-E-GSSG (800 nM) in buffers of varying pH. 
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First, the structural integrity of PDI and the fluorescence properties of the di-E-
GSSG pseudo-substrate were assessed within the pH range studied.  For PDI structural 
integrity, the intrinsic tryptophan fluorescence spectrum was monitored as a simple 
reporter of pH-induced conformational changes.  The PDI-fluorescence spectrum was 
stable and consistent over the pH range of 5.5 to 9.5.  However, the emission peak began 
to increase at pH 4.5, an indication that the enzyme was undergoing substantial global 
conformational changes under acidic conditions (Figure 3.1 A).  The pH stability of the 
di-E-GSSG substrate (800 nM) was also tested by completely reducing the GSSG 
disulfide with excess dithiothreitol (DTT, 1 M) in the pH range employed.  At low pH, 
the apparent rate of reduction was significantly slower owing to the low amounts of 
ionized DTT, however, the substrate gave a consistent 56-fold fluorescence-enhancement 
upon disulfide reduction irrespective of pH (Figure 3.1 B). 
The WT enzyme and the mutants all exhibited bell-shaped activity vs. pH profiles. 
The activity vs. pH data was fit to a double-ionization model (Equation 2.2) which 
allowed for the estimation of 2 macroscopic pKa's (apppK1 and apppK2).  The pHmax (pH of 
maximum activity) as well as the maximum rate of EGSH formation were affected by the 
simultaneous substitutions of Lys57 and Lys401 to Gln, Ala or Glu.  The most obvious 
macroscopic effect of the double mutations was on the descending limb midpoints which 
were shifted to the left by ~0.5 pH units (apppK2, Table 3.1).  The net result of this was 
the shift of pHmax by ~0.3 pH units in comparison to WT (pHmax = 6.77, Table 3.1 and 
Figure 3.1 C).  The double mutant PDI variants also displayed activities at pHmax that 
were ~68%, 50% and 38% of the WT enzyme.  The mutation-dependent activity decrease 
was more dramatic at physiological pH (7.4) where Q, A and E double mutants had 
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oxidoreductase activities that were ~36%, 33% and 21% of the WT enzyme (Figure 3.1 
C). 
It is proposed that the ascending limb of all respective profiles represents enzyme 
activation as a result of active site thiol deprotonation.  Therefore, apppK1 is likely 
attributed to a combination of the deprotonation events of the N-terminal nucleophilic 
cysteine (CysN) and the C-terminal resolving cysteine (CysC) from both active sites of 
PDI, yielding the more reactive thiolate anion state.  The apppK1 from this was found to be 
independent of the residue at positions 57 and 401, with only nominal shifts occurring as 
a result of mutation (Table 3.1). 
Inactivation of the enzyme, as seen by the descending limb of the pH profiles, 
indicated that apppK2 was directly dependent on the residues at positions 57 and 401.  
Upon substitution of Lys57 and Lys401, PDI variants exhibited a narrower range of 
oxidoreductase activity (breadth of the pH profile).  The apparent enzyme inactivation 
may be attributed to the deprotonation of the intervening histidine residues His55 and 
His397 (a and a'-domain CGHC, respectively) in conjunction with other ionizable residues 
important to the catalytic function of PDI.  Furthermore, the fact that the ε-amine of Lys57 
and Lys401 (for WT) supports a wider range of enzyme activity; whereby substitution to 
Gln, Ala or Glu shifts apppK2 to lower pH, clearly indicates that an active site lysine is a 
player in determining the pH-dependence of enzyme inactivation.  Equation 2.3 provides 
a mathematical model by which this proposed scheme of ionization may be tested in 
relation to the experimentally generated results (Figure 3.1 C inset).  Considering the 
apparent contribution to apppK2 by residues Lys57 and Lys401, simulated curves (light 
purple, solid line) provided a fit that was unsurprisingly close to that of the experimental 
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data set for WT PDI (black dotted line).  However, decreasing the relative contribution 
provided by the active site Lys residues lead to simulated curves (darker purple, solid 
lines) that tended to mimic the mutants.  By eliminating the contribution of Lys entirely, 
i.e. mimicking mutation, the curve (darkest purple, solid line) most closely fit to that 
observed for the K57/401A mutant (green dotted line).  Both the Gln and Glu variants 
under study did not corroborate as closely with the theoretical model.  This may be an 
indication of other residue-specific effects occurring that cannot be concluded upon with 
the present data, potentially impacting the structural characteristics of PDI. 
 
3.2   Steady State Oxidoreductase Kinetics are Attenuated in the Absence of K57 
and K401 
The pH-dependent activity profiles at a single substrate concentration, as in Figure 
3.1 A, did not give a complete picture as to the pH effects on the kinetic parameters.  To 
circumvent this, the turnover number (kcat), KM and catalytic efficiency (kcat/KM) were 
determined as a titration of pH from 6.0 to 8.0.  Due to very low initial rates, steady state 
kinetic data could only be obtained at pH ≥ 6.0 (see later).  Data was collected for all nine 
mutant PDI variants in relation to WT (Figure 3.2 and appendix B Tables B.1 to B.5). 
The kcat for hPDI- WT and all mutant variants, was at a minimum at pH 6.0, with a 
gradual increase towards more physiological conditions at pH 7.0 and 7.4, before again 
declining under basic conditions of pH 8.0 (Figure 3.2 A and appendix B Tables B.1 to 
B.5).  The trend for the apparent KM was different, showing a gradual increase across the 
tested pH range; this held true of all PDI enzymes (Figure 3.2 B and appendix B Tables 
B.1 to B.5). 
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Figure 3.1: pH-dependent oxidoreductase activity of hPDI.  (A) Tryptophan fluorescence 
of redPDI (6.175 µM) was monitored over the indicated pH range as a reporter of pH-
induced conformational changes.  (B) The di-E-GSSG probe maintained its fluorescence 
properties over the tested pH range.  The fluorescence fold increase of 800 nM di-E-
GSSG was monitored after the addition of 1 M DTT (black arrow).  The retarded rate of 
reduction at pH 5.5 (black circles) is attributed to DTT being only ~0.02% deprotonated 
(more reactive thiolate form) as a result of its thiol pKa's (ca. 9.2).  (C) Activity profiles 
of WT (black), K57/401Q (blue), K57/401A (green) and K57/401E (red).  10 nM PDI 
was incubated with 800 nM di-E-GSSG in PDI assay buffer of varying pH. pH-dependent 
activity profiles represent the mean ± S.D. of n = 3 experiments fit to Equation 2.2.  (C 
inset) Simulated pH profiles generated using Equation 2.3 (purple curves: light to dark) 
as compared to experimentally observed curves for WT (black dotted lines) and the Q, A 
and E mutants (blue, green and red dotted lines, respectively).  
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Table 3.1: Apparent pKa values and the pH of maximum activity of WT and double-
mutant enzymes.  Data extracted from the fits seen in Figure 3.1. 
hPDI apppK1 apppK2 pHmax 
WT 6.16 ± 0.01 7.37 ± 0.02 6.77 ± 0.16 
K57/401Q 6.05 ± 0.01 ** 6.90 ± 0.00 **** 6.44 ± 0.00 ** 
K57/401A 6.11 ± 0.03 * 6.87 ± 0.04 **** 6.49 ± 0.04 ** 
K57/401E 6.20 ± 0.01 6.80 ± 0.01 **** 6.55 ± 0.01 * 
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Following this, the catalytic efficiency (kcat/KM) of the enzymes were found to be variable 
when comparing WT to any of the a or a'-domain single mutants, as well as the double 
mutant enzymes.  PDI WT as well as the K57A and K401A single substitution mutants 
were most efficient at pH 6.5 whilst all other enzymes were apparently most efficient 
oxidoreductases at pH 6.0 (Figure 3.2 C, appendix B Tables B.1 and B.2).  The pH 
dependence of kcat/KM was most notably influenced by the trend described for KM rather 
than kcat.  The increase of KM from pH 6.0 to 8.0 was greater than 165-fold for all 
enzymes.  This is in contrast to the ~5-fold variation in kcat.  This resulted in an overall 
trend of catalytic efficiency decreasing with increasing pH, with the exception of WT 
exhibiting a stark increase at pH 6.5 (Figure 3.2 C). 
To our knowledge, few studies to date that have assessed the pH-dependence of 
PDI activity.  Moreover, these studies fell short of describing PDI activity over such a 
wide range of pH.  A more efficient enzyme at lower pH seems counter intuitive in 
relation to the ionization states of the catalytic thiols, as well as those of DTT (present in 
excess, required for the regeneration of redPDI.  See later).  It would make sense for 
efficiency to increase with pH as this would promote a higher proportion of the more 
reactive thiolate state, but this was not seen.  This provides strong evidence for the 
interplay between nucleophilicity and pKa- indicating that PDI is optimized to perform 
oxidoreductase catalysis at a neutral to slightly acidic pH, such as that observed in the ER 
and advanced secretory compartments of the Golgi apparatus [175]. 
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Figure 3.2: pH-dependent kinetic parameters for the oxidoreductase kinetics of WT 
(black) and double mutant PDI enzymes (K57/401Q, blue; K57/401A, green; K57/401E, 
red) towards the di-E-GSSG pseudo-substrate.  Data for (A) kcat, (B) KM and (C) kcat/KM 
are reported as the mean ± S.D. of n = 3 experiments.    
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When examining the Michaelis-Menten profiles at each pH it becomes apparent 
that KM (the substantiating factor in the pH-dependence of kcat/KM) may be biased as a 
result of enzyme saturation (Vmax) being approached at much lower substrate 
concentrations under acidic conditions (Figure 3.3 A).  This means that it is possible PDI 
appears most efficient at pH 6.0 or 6.5 under the in vitro conditions employed due to the 
extensively small values of KM, yet the neutral pH of the ER lumen may still be preferred 
with respect to the complex cellular environment in vivo. 
Another interesting phenomenon was seen as a result of acidity.  As mentioned, 
steady state kinetics could not be performed below pH 6.0 due to low initial rates.  At pH 
5.5 a rate which was independent of substrate concentration was observed (Figure 3.3 A 
and B).  Upon addition of PDI, fluorescence increased rapidly before plateauing to a 
negligible rate (Figure 3.3 B).  In comparison to the raw kinetic data at pH 7.4, this was 
surprising (Figure 3.3 B inset).  Based on this, an experiment was performed in order to 
identify if PDI was becoming trapped in a mixed-disulfide state for extended periods of 
time.  To test this, we mimicked the in vitro di-E-GSSG assay under similar steady state 
conditions as described previously, following it with a rapid thiol-quenching step using 
iodoacetamide (IAM).  After separating PDI from the unreacted di-E-GSSG, free EGSH, 
and excess IAM, any detectable fluorescence would be attributed to PDI being trapped in 
a mixed-disulfide state with eosin glutathione (see later, Figure 3.12).  Should 
fluorescence be absent, this would be indicative of a high turnover rate of the enzyme, 
thereby minimizing the time in which the enzyme-substrate complex exists- or, be 
evidence of a predominantly oxidized PDI active site. 
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By comparing the effects of substrate trapping at pH 5.5 and 7.4 it was observed 
that acidity did promote an enhanced level of the mixed-disulfide state of PDI (Figure 
3.3 C).  Between the time points of 0 and 20 seconds, ~92% of PDI active sites were 
occupying a mixed-disulfide state at pH 5.5, while only ~30% were determined to be at 
pH 7.4.  These findings were corrected in relation to a negative control which consisted 
of PDI alkylated by IAM prior to the addition di-E-GSSG.  This is suggestive of two 
things; (1) there is a greatly attenuated rate of substrate release under acidic conditions, 
while the initial nucleophilic attack is likely only marginally affected.  (2) PDI is 
adopting a stabilized intermolecular disulfide with substrate, rather than an 
intramolecular disulfide between the vicinal active site cysteines. 
The effectiveness of DTT as a reductant at such low pH is poor, but this is not a 
factor based on the observed results.  The detection of trapped PDI indicates that the 
resolving cysteine of the active site is unable to facilitate substrate release as efficiently.  
This may be from altered structural dynamics of the active site and/ or a small proportion 
of the reactive thiolate state at pH 5.5 in comparison to pH 7.4 (considering a CysC thiol 
pKa of about 6.1, see section 1.2.2).  This result was proven true for the WT PDI enzyme, 
but a similar trend is expected of all PDI variants herein. 
It has been demonstrated that pH is a major factor in defining PDI activity.  Acidic 
conditions seemed to promote a stabilized mixed-disulfide intermediate between PDI and 
eosin glutathione.  More importantly, optimal steady state oxidoreductase activity appears 
to be dependent on a WT CGHCK active site motif and mutant CGHC(Q/A/E) motifs 
support a less efficient enzyme. 
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Figure 3.3: PDI undergoes acid-induced substrate trapping via markedly attenuated 
substrate turnover.  (A) Representative plots of the Michaelis-Menten kinetic 
relationships over the range of pH tested for the reduction of di-E-GSSG by 10 nM PDI 
in the presence of 10 µM DTT.  (B) Raw data of the fluorescence (RFU) increase over 
time depicting a comparison of the initial rates of catalysis at pH 5.5 and 7.4 (inset).  The 
addition of WT PDI (10 nM) to the reaction mixture is indicated by an arrow.  (C) The 
impact of pH on PDI-substrate intermediate complex trapping was assessed under steady 
state conditions similar to those of the kinetic assays of A, with the addition of 
iodoacetamide (IAM) as the "trapping" reagent.  Results are reported as the fraction of 
trapped PDI active sites as determined by the fluorescence carry-over after protein 
desalting and reference to a standard curve of fluorescent signal vs. [EGSH].  Data from 
A and C represent the mean ± S.D. of n = 3 experiments.    
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3.3   Residues K57 and K401 Potentially Mediate Active Site Flexibility- A Case Study 
with Related PDI Family Members  
In an attempt to explain the shifted pH-profiles as a result of mutation, we sought to 
examine the structural aspects of related PDI family members naturally expressing a 
CxxC(K/Q/A/E) active site motif.  The focus here was on NMR solution structures 
because these provide a dynamic view of protein conformations as compared with X-ray 
crystallographic structures.  Interestingly, by analyzing the solution structures of 
homologous mammalian PDI family members PDIA3 (PDB: 2DMM [176]) and PDIA6 
(PDB: 2DML [177]) (refer to Figure 3.4) strong hints as to the potential role of Lys57 and 
Lys401 have been elucidated.  The PDB entry 2DMM contains 20 solution structures of a 
142-amino acid peptide from of the a'-domain of human PDIA3; naturally expressing a 
CGHCK active site motif (similar to PDIA1) [176].  Whereas the PDB entry 2DML 
represents 20 solution structures of a 130-amino acid peptide from the a-domain of 
mouse PDIA6; naturally expressing a CGHCQ active site sequence (similar to the 
K57/401Q PDI variants engineered here) [177]. 
A comparison of the overlaid structures of 2DMM (CGHCK) (Figure 3.4 A) to that 
of 2DML (CGHCQ) (Figure 3.4 B) shows that when Lys is the C-terminal amino acid to 
the CGHC motif, the residue's side chain is very mobile with little interaction between 
the ε-amine and the peptide backbone.  This notion is confirmed by previous reports 
demonstrating the short-lived, transient nature of backbone hydrogen bonds with lysine 
side chains [178].  This results in a seemingly flexible active site.  It is believed that the 
motion of the Lys side chain is translated through the conserved active site region to the 
intervening His, causing it to also be mobile and able to move away from the active site 
	81 
	
cysteines.  The minimum apparent distance was determined to be about 5.6 Å and 7.0 Å 
from the N- and C-terminal cysteinyl sulfurs, respectively (measurements taken from the 
imidazolium Nε of His).  This provides an indication that the intervening His is in closer 
proximity with CysN in the NMR solution structures.  Full or partial positive charges <6.5 
Å away are able to stabilize thiolate anions (decrease thiol pKa) [65, 102], thus the 
distance of 5.6 Å as measured here supports the role for His as a stabilizing factor for 
CysN-S- and not the CysC-S-. 
The presence of two nitrogen atoms on the imidazole ring of His (Nδ and Nε) means 
there are three relevant ionization states: HNδ, HNε or H2NδNε (cationic state), 
respectively representing the protonation of the Nδ, Nε, and both Nδ and Nε nitrogen 
atoms.  Although, the energetically favourable tautomeric state of the neutral imidazole 
moiety is the protonation of Nε and subsequently a lone-pair of electrons on Nδ [179, 
180].   To this end, the rotameric state of the imidazole ring largely dictates the influences 
on neighbouring side chains.  
In contrast to the structure observed for 2DMM (bearing a CGHCK motif, Figure 
3.4 A), when Lys is replaced with a Gln as in 2DML, the δ-amide group is seemingly 
immobilized by hydrogen bonding interactions with the backbone carbonyl oxygen of the 
upstream active site cysteine (n−4) and proline (n−6) residues (FYAPWCGHCQ), 
leading to an apparently more rigid active site (Figure 3.4 B).  Backbone hydrogen 
bonding by the Gln side chain is a well characterized feature of many protein motifs 
[181-183].  As a result, the motion of His is apparently restricted, potentially allowing it 
to interact via a salt bridge with the active site thiolates.  
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Figure 3.4: NMR solution structures of the active site CGHCK and CGHCQ motifs 
naturally expressed by the PDI family members PDIA3 and PDIA6, respectively.  (A) 
Superimposition of 20 solution structures of the a'-domain active site of PDIA3 
(APWCGHCK), PDB: 2DMM [176].  (B) Superimposition of 20 solution structures of 
the a-domain active site of PDIA6 (APWCGHCQ), PDB: 2DML [177].  Hydrogen 
bonding represented by dotted lines.  Visualized using UCSF Chimera software [184]. 
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The effect here is likely two-fold, where His causes a decrease of thiol pKa as well as a 
steric impedance to the active site.  A more acidic active site thiol would likely result in a 
concomitant decrease of activity due to the balance between thiol pKa, nucleophilicity 
and environment pH (refer to section 1.1.2). 
Measurements taken from the solution structure overlays indicate that the 
imidazolium Nε is about 2.6 Å and 3.7 Å from the N- and C-terminal cysteinyl sulfurs, 
respectively (Figure 3.4 B).  This again indicates that the intervening His is in closer 
proximity to CysN.  In contrast to 2DMM, His is within hydrogen bonding distance to 
CysN.  The activity vs. pH data may support this notion.  When substituting Lys to Gln, 
Ala or Glu in the double mutants, the activity at pHmax (where both His and Lys are likely 
protonated) decreased by ~32%, 50% and 62% in comparison to the WT enzyme, 
respectively.  For WT, as His deprotonates with increasing pH (likely represented by the 
descending limb, apppK2 Figure 3.1 C and Table 3.1) it no longer imparts as strong of a 
stabilization effect to the CysN thiolate, contributing to the apparent enzyme inactivation.  
The shifted maximum and apppK2 ultimately indicates a potential role for residues Lys57 
and Lys401 in providing active site flexibility such that the intervening His is incapable of 
forming unfavourably strong ion-pairs with the CysN thiolate, those that would lead to 
suboptimal nucleophilicity.  The active site flexibility is proposed to arise as a result of 
the apparent motions of the Lys side chain.  It has been shown that Gln is unable to 
impart such flexibility as it is strongly hydrogen bonded with the backbone.  As for a Glu 
mutation, this would be reminiscent of Gln, also able to hydrogen bond with the peptide 
backbone.  An Ala mutation results in the introduction of a small, immobile side chain 
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that also would not display the apparent flexibility required for optimal activity due to a 
more mobile His. 
 
3.4   Identification of Distinct Roles for K57 and K401 in Mediating Active Site 
Accessibility- An Alternative Explanation Uncovered by Molecular Dynamics   
In order to further characterize the proposed scheme above (see previous, section 
3.2) molecular dynamics (MD) simulations were performed using full-length hPDI in 
both the reduced (redPDI, PDB: 4EKZ  [53]) and oxidized (oxPDI, PDB: 4EL1 [53]) 
forms.  Four simulations were performed in total: redPDI WT, oxPDI WT, redPDI 
K57/401Q, and oxPDI K57/401Q.   Despite the previous data strongly indicating a role 
for residues Lys57 and Lys401 in enhancing activity by mediating a flexible active site, 
resulting in an apparently highly mobile intervening His, this was not found in our 
simulations.  Instead, it was interesting to observe Lys57 and Lys401 performing roles in 
apparently modulating active site accessibility in very distinct manners.  These dynamic 
changes of accessibility are viewed as open and closed active site conformations herein. 
The orientation of the a and a'-domain active sites are quite different.  As shown 
for redPDI, the a-domain active site is very surface-exposed on the posterior side of the 
PDI architecture (Figure 3.5).  In contrast, the a'-domain active site is less exposed, yet 
still visible from the anterior side, oriented at the b'-a' domain interface (see later, Figure 
3.8).  It was determined that for each active site region, the apparent accessibility/ 
exposure of CysN was differentially hindered by the dynamics of key hydrophobic 
residues.  A focus was placed on CysN as it is the residue responsible for initiating 
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catalysis, therefore its orientation is much more important with respect to PDI activity 
than is CysC, in comparison [60]. 
For the a-domain, this CysN accessibility was modulated via the movement of a 
conserved tryptophan residue, Trp52 (FYAPWCGHCK).  With regards to the a'-domain, 
this was a result of a phenylalanine, Phe440, found to reside n−1 in relation to a conserved 
cis-Proline, Pro441.  These residues effectively result in active site conformations that are 
either more or less accessible with respect to CysN; acting as lids to each respective active 
site. 
With respect to the a-domain, the dynamics of Trp52 were determined to be dictated 
by Lys57.  The MD simulations indicated the presence of a cation-π interaction between 
the ε-amine of Lys57 and the aromatic indole ring of Trp52.  This interaction apparently 
resulted in an open conformation of the active site as the side chain of Trp52 was directed 
away from CysN (Cys53, Figure 3.6).  By substituting Lys57 for Gln, this interaction was 
unsurprisingly lost, leading to an apparently closed active site as the Trp52 side chain was 
able to rotate and project towards the active site and hinder the apparent exposure of 
Cys53 (Figure 3.7).  Furthermore, the Gln side chain was determined to have a high 
propensity to hydrogen bond with the backbone carbonyl of an upstream proline, Pro51 
(FYAPWCGHCK, refer to appendix B Figure B.4 C).  This was not seen for the Lys 
side chain, indicating that the primary interaction likely dictating the accessibility of 
Cys53 is the specific cation-π interactions fulfilled by Lys57.  Previous research showed 
that a K-R mutation had only a nominal impact on PDI activity, this is likely because Arg 
may also fulfill the cation-π interaction determined here [185, 186]. 
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Figure 3.5: Surface structure of the a-domain active site of redPDI generated by 
molecular dynamics (MD).  Posterior view of the enzyme showing the accessibility of the 
active site thiol of the N-terminal nucleophilic cysteine, Cys53.  Arrows indicate plausible 
access points for small-to-intermediate sized substrates.  Residue Trp52 mediates 
exposure of Cys53 by acting as a lid, providing an open (upper panel, redPDI WT) or 
closed (lower panel, redPDI K57/401Q) configuration.  Visualized using Visual 
Molecular Dynamics software (VMD) [54].      	
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Figure 3.6: Residue Lys57 of the a-domain participates in cation-π interactions with the 
upstream Trp52.  The electrostatic cation-π interaction between Lys57 (α2-helix) and Trp52 
(α2-β3 loop) maintains an open active site conformation, rendering Cys53 more solvent 
exposed (arrows).  The Nε-amine of lysine is positioned 2.2 Å away from the aromatic 
center (lower panel).  A wire-frame space-filling model further highlights the interaction 
(upper panel).  In green, the conserved cis-Pro loop motif (Tyr99 and Pro100 shown).  
Hydrogen atoms have been omitted for simplicity.  Visualized using Visual Molecular 
Dynamics software (VMD) [54].   
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Figure 3.7: Mutation of residue Lys57 to Gln eliminates cation-π interactions with the 
upstream Trp52, resulting in a less accessible active site.  The mutant residue, Gln57, 
forms hydrogen bond interactions with the peptide carbonyl of Pro51 (upper left panel).  
In this conformation Trp52 acts as a lid, effectively limiting the accessibility of CysN: 
Cys53 (arrows).  In green, the conserved cis-Pro loop motif (Tyr99 and Pro100 shown).  
Hydrogen atoms have been omitted for simplicity.  Visualized using Visual Molecular 
Dynamics software (VMD) [54].   
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Stark differences between the orientation of the active sites lead to the realization 
that residues Lys57 and Lys401, although conserved with respect to the primary sequence, 
modulate CysN exposure distinctly.  In the a'-domain, Lys401 did not participate in cation-
π interactions with the equivalent tryptophan, Trp396 (contrary to that seen in the a-
domain).  Instead, Trp396 appeared to be fulfilling this with an arginine residue of the b'-
domain, Arg300 [53, 187].  As a result, the side chain of Lys401 projected freely into the 
solvent, with no indication of any bona fide interactions (Figure 3.9).  In this 
conformation, the active site appeared open, with CysN (Cys397) relatively solvent-
exposed.  Although, it is possible for Lys401 to form transient hydrogen bonds with the 
carbonyl oxygen of the peptide backbone of an upstream proline, Pro395 (refer to 
appendix B Figure B.4 B).  In doing so, there was an indication that the apparent access 
to Cys397 be hindered by Phe440 (Figure 3.10).  Furthermore, it was noted that the R300-
Trp396 cation-π interaction was abolished as a result.  With this, we examined the MD 
simulation for a mutated active site by introducing Gln in place of Lys401.  The propensity 
for Gln to hydrogen bond with the backbone of an upstream Pro was again determined to 
be high (akin to those results for the a-domain, refer to appendix B Figure B.4 D).  As a 
result, the a'-domain active site was apparently closed, as Phe440 projected toward Cys397 
rather than away as in the open configuration (Figure 3.11). 
These results indicate that, for redPDI, residues Lys57 and Lys401 differentially 
maintain the accessibility of the active site CysN.  Residue Lys57 of the a-domain does so 
via cation-π interactions with the conserved, upstream residue Trp52.  Mutation to Gln 
abolished this interaction, resulting in a rotation of the indole ring over Cys53, making an 
apparently closed a-domain active site.      
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Figure 3.8: Surface structure of the a'-domain active site of redPDI generated by 
molecular dynamics (MD).  Anterior view of the enzyme showing the accessibility of the 
active site thiol of the N-terminal nucleophilic cysteine, Cys397, situated near the b'-a' 
domain interface.  Arrows indicate plausible access points for small-to-intermediate sized 
substrates.  Residue Phe440 mediates access to Cys397 by acting as a lid, providing an open 
(upper panel, redPDI WT) or closed (lower panel, redPDI K57/401Q) configuration.  
Visualized using Visual Molecular Dynamics software (VMD) [54].      	
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Figure 3.9: Residue Lys401 of the a'-domain freely projects into the solvent.  The 
upstream Trp (Trp396, α2-β3 loop) is incapable of participating in electrostatic cation-π 
interactions with Lys401 (α2-helix) contrary to that observed in the a-domain active site.  
Residue Arg300 of the b'-domain forms strong cation-π interactions with Trp396 (right 
panel), likely sequestering it from Lys401.  In this conformation, the N-terminal active site 
thiol, Cys397, is apparently solvent accessible in two general directions (arrows).  In 
green, the conserved cis-Pro loop motif (Phe440 and Pro441 shown).  Note, Phe440 of the 
cis-Pro loop projects away from the active toward the interior of the b'-a' domain 
interface.  Hydrogen atoms have been omitted for simplicity.  Visualized using Visual 
Molecular Dynamics software (VMD) [54].   	
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Figure 3.10: Residue Lys401 of the a'-domain may form hydrogen bonds with upstream 
residues.  The carbonyl oxygen of the upstream Pro (Pro395, α2-β3 loop) provides a 
hydrogen bond acceptor site by which the ε-amine of Lys401 may interact (dotted line; 2.8 
Å, left panel).  Hydrogen bonding results in a loss of the cation-π interaction between 
Arg300 and Trp396.  This, in turn, results in a 3.2 Å translation of Phe440 to a position that 
partially impedes access to Cys397.  Hydrogen atoms have been omitted for simplicity.  
Visualized using Visual Molecular Dynamics software (VMD) [54].   	
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Figure 3.11: Mutation of residue Lys401 to Gln introduces hydrogen bonding to the a'-
domain active site, leading to a less accessible N-terminal thiol.  Hydrogen bonding by 
the mutant residue Gln401 and the peptide carbonyl of Pro395 (dotted line and right panel) 
causes Phe440 of the cis-Pro loop to sterically hinder access to Cys397 (arrows).  In green, 
the conserved cis-Pro loop motif (Phe440 and Pro441 shown).  Hydrogen atoms have been 
omitted for simplicity.  Visualized using Visual Molecular Dynamics software (VMD) 
[54].      
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As for the a'-domain, it has been suggested that the ability of Lys401 to form no bona fide 
interactions is what provides the open conformation of the active site, specifically, the 
exposure of Cys397.  Substitution of Gln in the place of Lys401 introduced hydrogen 
bonding, leading to structural changes that propagated through the active site region 
leading to the projection of Phe440 towards Cys397, limiting its accessibility. 
Active site dissimilarities accounts for the reasons why Lys57 does not seem to 
perform in a manner similar to Lys401.  The conserved Trp52 of the a-domain is free to 
participate in cation-π interactions with Lys57, whilst in the a'-domain, the equivalent 
residue, Trp395, is essentially sequestered by preferential cation-π interactions with 
Arg300.  Furthermore, the reason that residue Phe440 (n−1 to conserved cis-Pro) is the lid 
to the a'-domain, yet the equivalent residue of the a-domain (Tyr99, n−1 to conserved cis-
Pro) does not function as such is due to hydrogen bonding with the phenolic alcohol 
group, rendering Tyr99 incapable of projecting toward the a-domain CysN (refer to 
appendix B Figure B.1). 
The global conformation of PDI is redox-state dependent (refer to appendix B 
Figure B.3) [53], therefore it was important to assess the contributions of Lys57 and 
Lys401 (as well as mutations to Gln) with respect to oxPDI.  In either domain, it was 
apparent that an intramolecular disulfide between the active site vicinal cysteines elicited 
a conformational constraint.  For the a-domain, this resulted in the loss of the K57-W52 
cation-π interaction seen previously in redPDI.  Furthermore, substituting Lys57 for Gln 
indicated that the propensity for Gln to hydrogen bond with Pro51 was disrupted as a 
result of this constraint brought about by the disulfide (refer to appendix B Figures B.2 A 
and C, and B.5 A and C).  This seemed to result in a more closed conformation.  When 
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looking at the a'-domain, it was interesting to note that the large dynamic changes in 
domain organization showed a marked separation of the b'-a' domain interface, so much 
so that the R300-W395 cation-π interaction observed for redPDI was no longer present 
(refer to appendix B Figure B.2 B).  Furthermore, apparent constraints brought about by 
the disulfide-linked vicinal cysteines was supported by disrupted hydrogen bonding when 
assessing the MD simulation of the Q mutant (refer to appendix B Figure B.5 D).  As a 
result of this, only very limited backbone hydrogen bonding was able to occur, in 
comparison to that seen for redPDI WT, leading to an apparently open active site, 
irrespective of mutation.  Therefore, it is possible that for WT PDI, the a-domain active 
site transitions between open and closed conformations when reduced and oxidized, 
respectively, whilst the a'-domain active site remains apparently open, independent of 
redox state. 
We next went on to investigate the impact such structural dynamics had on the 
pKa's of the vicinal active site thiols.  Analyses indicated no meaningful perturbations to 
thiol pKa when looking at WT or K57/401Q PDI (Table 3.2).  This may suggest that the 
proposed scheme of open and closed active site dynamics is likely a factor influencing 
only substrate binding/ PDI-substrate encounter complex formation, rather than thiol-
disulfide exchange rates in relation to nucleophilic attack.  Although, it remains likely 
that the rate of exchange be ultimately attenuated simply due to the limited accessibility 
of the nucleophile (CysN) [26-28].  The unfounded, previously proposed scheme (see 
section 3.3) is further refuted by the indication that the CysN pKa's apparently increased 
slightly upon Lys mutation, rather than decreasing via electrostatic stabilization from an 
intervening His.  
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Table 3.2 Computational analyses of the reduced PDI (redPDI) active site vicinal thiols 
and lysine residues; presenting pKa estimations for WT and K57/401Q. 
 a-domain a'-domain 
redPDI pKaCys53 pKaCys56 pKaLys57 pKaCys397 pKaCys400 pKaLys401 
WT 4.4 8.7 10.0 4.7 8.5 9.6 
K57/401Q 5.0 8.5 N/A 5.3 8.2 N/A 
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3.5   A CxxCK Motif Supports Enhanced Thiol-reductase Activity as Evidence by 
Single-turnover Kinetics 
There is an important distinction to be made when describing the catalytic activity 
of PDI.  The di-E-GSSG assay as employed thus far has included an excess of the 
reducing agent DTT.  This is a vital consideration to the experiment as it is required for 
the regeneration of redPDI, thus allowing for successive catalytic turnovers and 
facilitating a steady state (Figure 3.12).  
In the absence of DTT, or other excess reducing agent, the rate of di-E-GSSG 
reduction would be solely attributed to the reductase activity of hPDI and not the entirety 
of its oxidoreductase catalytic cycle.  The inherent rate constants are thus somewhat 
attributable to not only the rate of reduction of the di-E-GSSG substrate, but also the rate 
of regeneration of redPDI by DTT.  Although, it has been described that the rate of 
oxidation of PDI by GSSG is rate-limiting (akin to the reduction of di-E-GSSG)  [83].  
This means that the steady state data (section 3.4) should be telling of the thiol-reductase 
activity of PDI as the process of enzyme regeneration via DTT likely has negligible 
contribution.  This notion was supported by varying the amount of DTT and assessing the 
impact on the rate of di-E-GSSG reduction.  Should the steady state oxidoreductase 
activity be rate-limiting with respect to DTT-mediated redPDI regeneration, one would 
expect a doubling of the concentration of DTT to result in a doubling of the rate of 
reaction.  As demonstrated in appendix B Figure B.7, this was not the case.  Instead, the 
rate was not dependent on the concentration of DTT when at or above 1 µM.  
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Figure 3.12: Schematic of PDI-catalyzed reduction of di-E-GSSG.  CysN of redPDI 
initiates the reaction by nucleophilic attack of the GSSG disulfide, resulting in the 
formation of one free EGSH molecule and a mixed disulfide intermediate with a second 
EGSH molecule.  The CysC resolving cysteine liberates PDI from the mixed-disulfide 
state, releasing EGSH.  redPDI is regenerated by the reducing agent DTT, allowing for 
successive catalytic turnovers.  Di-E-GSSG reduction results in a detectable increase of 
fluorescence (RFU).  For simplicity only the a-domain active site is depicted.     
 
 
 
 
 
 
 
 
 
 
 
 
	99 
	
In light of these findings, it still remained purposeful to examine the single turnover 
event of di-E-GSSG reduction to discern the observable rates with respect to a WT and 
mutated active site motif.  To study only the reductase portion of the oxidoreductase 
cycle, the di-E-GSSG assay was performed such that pseudo-first order kinetics 
(Equation 2.4) would be favoured as to provide an accurate estimation of reaction rate 
(kobs) with comparisons between WT and the K-Q mutants.  We chose to focus on the K-
Q hPDI mutants as it is believed that mutation to glutamine most closely mimics the 
physiologically relevant posttranslational modification of Ne-lysine acetylation (a neutral, 
yet still polar acetyllysine residue: acK).  This being the case while limited to canonical 
amino acid substitution. 
At a pH of 5.5, kobs for each enzyme was unchanged, while at pH 7.4 kobs of 
K57/401Q was only 43% that of WT, and the single domain Q mutants showed about 
68% the activity of WT (Figure 3.13 B).  With reference to the K57/401Q mutant, a 
significant decrease in kobs was also seen at pH 6.5, but not as much so at the more basic 
conditions tested.  It is interesting to note that WT PDI outperformed the mutants to the 
greatest extent at physiological pH (7.4), with an observable rate of 0.75 s-1, in 
comparison to 0.32 s-1, 0.50 s-1 and 0.52 s-1 for K57/401Q, K57Q and K401Q, 
respectively.  Furthermore, it follows that no statistically significant differences were 
observed between the respective single Q mutants.  This indicates that each active site (a 
and a'-domain) performed nearly identically under the particular in vitro conditions. 
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Figure 3.13: Single turnover reductase activity of PDI.  (A) Representative data for the 
progress of the reduction of 1000 nM di-E-GSSG by 80 nM PDI WT (black) and 
K57/401Q (blue).  Fluorescence data was related to the depletion of substrate (di-E-
GSSG) over time.  (B) The relative kobs of all K-Q mutants (K57/401Q, blue; K57Q, 
green; K401Q, orange) was plotted as a percentage of WT (black).  Kinetic data 
represents the mean ± S.D. of n = 3 experiments. 
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It is apparent that a CGHC-flanking Lys is a key residue for the function of PDI, 
both as a thiol-reductase and oxidoreductase.  More importantly, the attenuation of thiol-
reductase activity upon mutation of either or both Lys57 and Lys401 is greatest at the 
physiologically relevant pH range of 7-7.4, conditions by which PDI primarily functions 
in vivo.  By removing DTT from the assay and effectively negating the kinetic 
contributions of enzyme regeneration, the role of residues Lys57 and Lys401 has been 
shown to be substantial with regards to the initial nucleophilic attack of the di-E-GSSG 
substrate by CysN. 
 
3.6   Dithiol Oxidation by PDI is Attenuated Upon Substitution of K57 and K401 
Findings thus far have demonstrated the importance of residues Lys57 and Lys401 for 
PDI when bearing reduced active site motifs and catalyzing the reduction of substrate 
under both steady state and pseudo-first order conditions.  It remains to be seen whether 
these residues are influential to PDI activity when functioning as a thiol-oxidase.  Results 
here should shed light on the potential of these residues as participating in redox state-
dependent enzyme regulation.  The global protein conformation is largely impacted by 
the redox state of the active sites, whereby such conformational fluxionality may translate 
to stark differences for the role of the active site lysines when comparing redPDI and 
oxPDI activity; strongly suggested by MD analyses (refer to section 3.3). 
As a complement to the previous findings, the activity of WT and K-Q PDI 
enzymes were studied in relation to their thiol-oxidase activity using a self-quenching 
peptide substrate (Figure 3.14) [83].  Oxidation of a reduced, dithiol-containing peptide 
(sequence: NRCSQGSCWN) is catalyzed by oxPDI.  The decapeptide substrate was 
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designed by Freedman and coworkers [83] such that it contains two cysteine residues 
separated by a flexible linker.  A fluorescent tryptophan residue is adjacent one of the 
cysteines and a protonatable arginine is adjacent the other cysteine.  The linker region of 
the peptide satisfies the need for no propensity to form secondary structure and so, the 
allowance for thiol-disulfide redox.  The tryptophan and arginine residues allow for the 
rate of peptide oxidation to be measured by monitoring the quenching of tryptophan 
fluorescence upon peptide oxidation due to the close proximity with arginine [83]. 
Again, the distinction must be made in this instance as the measured rates are a 
result of an oxidoreductase catalytic cycle, as described previously.  This is due to the 
presence of excess GSSG required for the regeneration of oxPDI.  Despite this, 
contribution to the determined rates by peptide oxidation is substantial enough when 
compared to that of enzyme regeneration by GSSG.  This was found to be true by Alanen 
and coworkers, whom demonstrated that the overall reaction rate be governed by both 
peptide oxidation and enzyme regeneration by GSSG [188].  With this, results may 
loosely represent the dithiol-oxidase activity of PDI. 
The activity of the PDI enzymes, WT and K-Q mutants, were studied over the pH 
range of 5.5 to 8.0.  This was the determined range as conditions more acidic than pH 5.5 
were found to induce marked conformational changes of PDI (Figure 3.1 A), as well as 
markedly slow rates of peptide oxidation (Figure 3.15 A)- likely due to unproductive 
cycles with PDI or exceedingly stabile active site disulfides.  Above pH 8.0 resulted in 
substantial non-enzymatic rates of peptide oxidation (results not shown).  The peptide 
thiol-oxidase activity of all enzymes tended to increase with increasing pH, where 
maximal activity was determined to be at either pH 6.9 or 7.4 (Figure 3.15 B).  
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Figure 3.14: Schematic of PDI-catalyzed oxidation of a dithiol-containing peptide.  A 
nucleophilic thiol of the substrate peptide attacks the CxxC disulfide of oxidized PDI 
(oxPDI), resulting in the formation of a mixed disulfide intermediate state.  The peptide 
substrate autoxidizes, liberating PDI from the mixed-disulfide.  Regeneration of oxPDI is 
accomplished using the oxidizing agent GSSG, allowing for successive catalytic 
turnovers.  Peptide oxidation results in a detectable decrease of fluorescence (RFU) via 
self-quenching between the Arg and Trp side-chains.  For simplicity only the a-domain 
active site is depicted.     
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The only statistically significant difference between WT and the single Q mutants 
was found with the K401Q enzyme at pH 6.3, 6.5 and 6.9.  Here, the mutant exhibited 
82%, 77% and 79% the activity of WT, respectively.  As well, K57Q at pH 6.3 displayed 
82% the activity of WT.  The most notable change in activity was demonstrated by the 
double mutant K57/401Q enzyme, with as little as 57% the activity of WT at pH 6.9.  
This is suggestive of a need for active site residues Lys57 and Lys401 for the catalytic 
function of PDI even when catalyzing dithiol oxidation reactions, where in this case, 
mutation of Lys401 is more detrimental to PDI activity that Lys57. 
This assay is not without its inherent flaws.  The effectiveness of accurate rate 
determination is questionable in comparison to the di-E-GSSG reductase assay seen 
previously.  Optimization of the assay conditions indicated a need for a relatively high 
concentration of PDI (2 µM) and substrate (50 µM) to generate a detectable signal.  This 
is likely due to marked differences in sensitivity.  Being a method that monitors the turn-
off of fluorescence, signal acquisition is dramatically less sensitive than a comparable 
fluorescence turn-on assay, due to high background.  Furthermore, tryptophan is a 
moderate fluorophore compared to others with a reported quantum yield (F) of 0.2, 
molar absorptivity (ε) of 5600 M-1 cm-1, and lifetime of 3.1 ns in neutral pH water (λex = 
280 nm; λem = 350 nm) [189-191].  In comparison to the parameters reported for eosin in 
water (eosin Y: F = 0.2, ε = 88, 000 M-1 cm-1, lifetime = 0.95 ns; λex = 525 nm, λem = 
545nm) [192].  It can be seen that a fluorophore such as eosin is better than tryptophan 
primarily as a result of ε.  Lastly, the activity of the enzyme towards the peptide substrate 
may be inherently low in comparison to the di-E-GSSG substrate, adding to the 
abatement of sensitivity.  
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Figure 3.15: Thiol-oxidase activity of hPDI studied over the pH range 5.5 to 8.0.  (A) 
Representative data for the time-course oxidation of 50 µM peptide substrate by 2 µM 
WT PDI in the presence of 1 mM GSSG, where red dotted lines depict the half-time of 
reaction.  (B) The inverse of the half-time was reported as the quantitative kinetic 
parameter (after correction for the uncatalyzed rate) by which WT PDI (black) was 
compared to K57/401Q (blue), K57Q (green) and K401Q (orange).  (C) As a control, the 
fidelity of the peptide substrate (NRCSQGSCWN) was proven by demonstrating its 
complete oxidation by copper (II) sulfate to yield low fluorescence (red spectrum). 
Addition of DTT resulted in the regaining of fluorescence via peptide reduction.  Data in 
B represents the mean ± S.D. of n = 3 experiments. 
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It is possible that the advantages of an active site lysine to PDI activity be primarily 
through thiol-reductase and not thiol-oxidase activity.  The altered kinetics of peptide 
oxidation may be a result of PDI-mediated GSSG reduction (i.e., enzyme regeneration).  
What remains unknown is the true relative rates of dithiol-oxidation alone, in the absence 
of enzyme regeneration.  Unfortunately, it was not possible to omit GSSG from the assay 
mix to provide single-turnover rate determinations (reminiscent of those performed in 
section 3.5), as sensitivity was an issue.  
 
3.7   Mutation of K57 and K401 Impedes the Transfer of Electrons Between PDI 
and the ER-Resident Oxidase, ERO1α 
The physiological significance of a potential modification of Lys57 and Lys401 was 
examined by assessing the activity of PDI towards the well characterized ER-resident 
oxidase, endoplasmic reticulum oxidoreductin-1α (ERO1α).  It has been shown that a 
CGHCK motif facilitates the greatest rates of both oxidoreductase, thiol-reductase and 
thiol-oxidase activities of PDI using novel pseudo-substrates.  It remains to be seen 
whether this conserved motif performs in such a manner when PDI participates in redox 
interactions with the known ER-luminal interacting partner, ERO1α. 
The oxidase activity of ERO1α was assessed by monitoring the catalytic 
consumption of oxygen in the presence of PDI WT and the K-Q variants at pH 7.4 using a 
Clark type electrode [193].  The ERO1α enzyme used was a constitutively active mutant 
lacking the regulatory cysteines Cys104 and Cys131 (mutation: C104/131A) [84, 92, 97]. 
Under standard assay conditions, control rates of oxygen consumption were 
established for GSH+ERO1α in the absence of PDI (Figure 3.16 dark grey line) and for 
GSH+PDI in the absence of ERO1α (Figure 3.16 light grey line).  As for that 
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determined for ERO1 in the presence of PDI, the largest rate of oxygen consumption 
~0.12 ± 0.0057 s-1 (Figure 3.16 black line, Table 3.3) was obtained for the interaction 
with WT.  In the presence of the K57/401Q double mutant ERO1α was only capable of a 
rate of oxygen consumption that was ~ 54% of that of WT PDI (0.064 ± 0.011 s-1, Figure 
3.16 blue line, Table 3.3).  The single K-Q mutants mediated rates that were very similar, 
at 76% and 83% for K57Q and K401Q, respectively in relation to WT. 
Results indicate that an active site Lys residue is a requisite for efficient electron 
shuttling between the a-type domains of PDI and ultimately to ERO1α.  Thus, the 
CGHCK motif is favoured for the oxidation of PDI by ERO1α, a characteristic event 
during oxidative protein folding within the ER.  The oxidase activity of ERO1α was 
greatest when in the presence of WT PDI.  It is unlikely that the affected rate of oxygen 
consumption be a result of altered ERO1α binding to PDI as it has been reported that the 
primary site of binding be through the b'-domain of PDI with no indications of Lys57 or 
Lys401 as being significant in this case [89, 92, 194].  Instead, these data suggest that 
mutation may cause a hindrance to the efficiency of a-domain reduction by GSH, thiol-
disulfide exchange between PDI's a and a'-domains, and/ or the shuttling of electrons 
from the reduced a'-domain of PDI to the regulatory loop disulfide of ERO1α.  
 
3.8   Nε-lysine Acetylation of PDI May be A Potent Posttranslational Modulator 
of its Multiple Catalytic Activities 
To date, no naturally occurring mutations or disease-related single-nucleotide 
polymorphisms (SNPs) have been identified for PDI at residues Lys57 and Lys401.   
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Figure 3.16: Mutation of an active site lysine residue affects the interaction between PDI 
and ERO1α.  Oxygen consumption by 2 µM ERO1α in the presence of 5 µM WT PDI 
(black), K57/401Q (blue), K57Q (green), and K401Q (orange) with 20 mM GSH.  
Shaded regions represent the standard deviation of the mean of n = 3 experiments.  As 
controls, the rate of oxygen consumption was determined for 5 µM PDI in the presence of 
20 mM GSH and for 2 µM ERO1α in the presence of 20 mM GSH.  All experiments 
were performed in air-saturated ERO1α assay buffer at pH 7.4. 
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Table 3.3: Observed rates of ERO1α oxidase activity as determined from the slopes of 
the initial linear phase of the oxygen consumption profiles in Figure 3.16. 
hPDI kobs (s-1) %a 
WT 0.12 ± 0.0057 100 
K57/401Q 0.064 ± 0.011 *** 54 
K57Q 0.091 ± 0.011 * 76 
K401Q 0.10 ± 0.0035 * 83 
a Relative to WT 
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Thus, a possible means of naturally modulating activity may be via lysine 
posttranslational modifications, such as acetylation. 
To identify if such a modification is possible in targeting the active site lysine 
residues specifically, an in vitro acetylation procedure was performed using 
acetylsalicylic acid (ASA), the active ingredient of the popular therapeutic Aspirin.  By 
incubating 2 µM PDI with various concentrations of ASA at 37 OC for 4 hours, Western 
blot analysis revealed the presence of acetyllysine residues in a dose-dependent manner 
(Figure 3.17).  As little as 2 mM ASA was capable of acetylating PDI and providing 
detectable chemiluminescence at short exposure times (~ <7 minutes). 
Next, PDI was acetylated using 15 mM ASA by the same in vitro technique 
described, followed by mass spectrometry (MS) analysis to discern the specific sites of 
ASA-mediated acetylation.  Of the 48 lysine residues present in the PDI construct used 
(refer to appendix A Figure A.1), 18 were identified as being modified reproducibly 
(Table 3.4).  This included the active site residues Lys57 and Lys401.  To unambiguously 
confirm the presence of acK57 and acK401, the thiol-containing peptides were first 
enriched using gold nanoparticles (AuNPs) prior to performing tandem mass 
spectrometry (MSMS; refer section 2.2.13.1).  Alternative methods using mercury-
activated sepharose were also employed for thiol-enrichment.  Despite preliminary results 
indicating successful pull-down of native redPDI (appendix A Figure A.9), digested 
peptides applied to the sepharose supports exhibited high carry-over as evidence from the 
total ion chromatogram (TIC) generated from the UPLC-ESI MS analyses performed.  
This was determined by comparison to an unenriched PDI digest (results not shown).  For 
this reason, AuNPs were used exclusively for thiol-containing peptide enrichment.  The 
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MSMS data obtained was successful in unambiguously identifying the presence of 
acetylation on Lys57 (Figure 3.18) and Lys401 (Figure 3.19).  This indicated the active 
site lysine residues as being solvent accessible and capable of being modified chemically. 
All 18 acetyllysine residues identified by MS (Table 3.4) were mapped to a MD 
simulated structure of redPDI (Figure 3.20).  Each appears to be solvent accessible- 
perhaps unsurprising as lysine residues are inherently preferentially located on the protein 
surface.  Furthermore, there is a propensity for acetylation to occur on the active site 
helix (α2-helix of the a and a'-domains), with 5 total acetyllysine residues identified.  The 
a-type domains together accounted for 14 of the 18 sites of acetylation.  Alongside the 
active site residues Lys57 and Lys401, residues Lys81 and Lys424 were also acetylated by 
ASA.  These have been implicated as forming charged-ion pairs with conserved glutamic 
acid residues (E47 and E391, respectively) situated under the CxxC active sites of each 
respective domain, facilitating proton-transfer during catalysis [195].  Despite the 
presence of 8 candidate lysine residues in the b-domain (residues 138 to 243) no 
reproducible acetylation patterns were exhibited.  As for the b'-domain, only a single site 
of acetylation was determined on residue K247.  Lastly, 3 lysine residues of the x-linker 
were determined to be acetylated as well. 
 It should be noted that the acetylation reaction employed likely results in a low 
stoichiometry of acetylated lysine residues for two primary reasons.  First, in aqueous 
solution ASA is susceptible to hydrolysis (base-catalyzed deacetylation) resulting in 
salicylic acid and acetate.  This is particularly important to consider because the in vitro 
conditions for lysine acetylation used here were alkaline (pH ~8.5).   
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Figure 3.17: PDI is acetylated by Aspirin (acetylsalicylic acid, ASA) in vitro.  Purified 
hPDI WT (2 µM) was treated with varying concentrations of ASA (0.25, 0.5, 0.75, 1, 2, 5, 
10, and 15 mM) for 4 hours at 37 OC in a 0.1 M Tris-HCl buffer pH 8.5.  Immunoblotting 
was performed using anti-acetyllysine pan-specific antibody for the detection of 
acetylated lysine residues and anti-PDI RL90 antibody to determine consistent PDI 
loading. 
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Table 3.4: Acetylated peptides detected using UPLC-ESI MS for ASA-acetylated PDI.  
Peptides were identified from an un-enriched PDI digest (Glu-C protease) confirmed by 
MSe and MSMS sequencing.  Reported acetylation sites (Kac) represent those found to be 
common among n = 2 samples. 
Precursor Sequence Acetylation Site on PDI a 
48FYAPWCGHCKacALAPE62 
K57; a-domain active site; 
α2-helix 
63YAKacAAGKacLKacAE73 
K65, K69 and K71; a-
domain; α2-helix 
77IRLAKacVDATEE86 K81; a-domain; β3-sheet 
88SDLAQQYGVRGYPTIKFFRNGDTASPKacE115 K114; a-domain; β5-sheet 
240FTEQTAPKacIFGGE252 K247; b'-domain; α1-helix 
349GKacIKacPHLMSQELPE362 
K350 and K352; x-linker; 
loop 
364WDKacQPVKVLVGKNFE378 K366; x-linker; loop 
366KacQPVKacVLVGKacNFEDVAFD383 
K366 (see above). K370 and 
K375; a'-domain; β1-sheet 
and α1-helix, respectively 
385KacKacNVFVEFYAPWCGHCKQLAPIWDKacLGE412 
K385 and K386; a'-domain; 
α1-β2 loop 
K409; a'-domain; α2-helix  
392FYAPWCGHCKacQLAPIWDKLGE412 
K401; a'-domain active site; 
α2-helix 
419NIVIAKacMDSTANE431 K424; a'-domain; β3-sheet 
465GFKacKFLE471 K467; a'-domain; α4-helix  
a (residue number); (domain location); (secondary structural element location) 
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Figure 3.18: Residue Lys57 of the a-domain active site is acetylated by Aspirin in vitro.  
Peptides of GluC-digested PDI underwent gold nanoparticle (AuNP) thiol enrichment 
prior to performing UPLC-ESI MS/MS (see section 2.2.11).  
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Figure 3.19: Residue K401 of the a'-domain active site is acetylated by Aspirin in vitro.  
Peptides of GluC-digested PDI underwent gold nanoparticle (AuNP) thiol enrichment 
prior to performing UPLC-ESI MS/MS (see section 2.2.11).  
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Figure 3.20: Location of the 18 identified acetyllysine residues mapped to the lowest 
energy structure of a molecular dynamics simulation of redPDI (PDB: 4EKZ [53]).  MS 
was used to identify the acetylated lysine residues of 2 µM PDI treated with 15 mM 
ASA.  Those residues found to be acetylated are shown in red and labelled respectively.  
Hydrogens of the side chain have been omitted.  Yellow spheres represent the active site 
cysteines.  Visualized using Visual Molecular Dynamics software (VMD) [54].     
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These conditions are to promote a larger proportion of the reactive deprotonated state of 
the ε-amine of lysine residues; conditions that contrarily enhance aqueous ASA 
hydrolysis.  Secondly, ASA is not purely amine-directing.  It is possible to observe O-
acetylation of tyrosine (Tyr), serine (Ser) and threonine (Thr) residues.  The most notable 
example of this is the irreversible acetylation of the catalytic serine of cyclooxygenase 
enzymes COX-1 and COX-2, resulting in the hallmark antithrombotic (low dose) and 
anti-inflammatory (high dose) responses elicited by Aspirin [196].  For the purposes of 
this study, O-acetylation of PDI was reverted by incubation with hydroxylamine (HA) 
prior to treatment with ASA (see section 2.2.9).  Nevertheless, the possibility of O-
acetylation occurring would further limit the stoichiometry of lysine acetylation via direct 
competition for ASA. 
The effect of ASA-mediated acetylation on the steady state kinetics of PDI activity 
was assessed using the di-E-GSSG assay (Figure 3.21).  To discern the impact of 
acetylation on only the active site residues Lys57 and Lys401 in relation to the other acK 
residues generated from the in vitro treatment with ASA, the kinetics of ASA-acetylated 
WT PDI (WTASA, Figure 3.21 A, black dotted line) was compared to ASA-acetylated 
K57/401Q (K57/401QASA, Figure 3.21 A, blue dotted line).  Negative controls consisted 
of unacetylated WT (WTcontrol) and K57/401Q PDI (K57/401Qcontrol, Figure 3.21 A, black 
and blue solid lines, respectively).  By comparing the kinetics between WTASA and 
K57/401QASA it was possible to realize the kinetic contributions of only Lys57 and Lys401 
acetylation.  As discussed, the stoichiometry of acetylation is by no means perfect, 
resulting in heterogeneous mixtures of modified PDI molecules.  Thus, the results should 
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be taken as a qualitative trend because the presence of non-acetylated active site lysine 
residues will likely persist to some extent for WTASA. 
As illustrated by Figure 3.21, WTcontrol performed optimally compared to the other 
enzymes, with an apparent kcat, KM and kcat/KM of (0.688 ± 0.0277) ×10-2 s-1, 1.27 ± 
0.114 µM and 5400 ± 356 M-1 s-1, respectively. WTASA resulted in an enzyme that was 
functionally very similar to K57/401Qcontrol.  The only statistically significant difference 
was observed for KM (Figure 3.21 C), where WTASA had an apparent KM of 2.13 ± 
0.0679 µM, and K57/401Qcontrol exhibited a KM of 2.51 ± 0.0542 µM.  Both kcat and 
kcat/KM were relatively the same, with no significant difference determined: (0.307 ± 
0.0249) ×10-2 and (0.287 ± 0.0486) ×10-2 s-1, and 1440 ± 396 and 1140 ± 290 M-1 s-1 for 
WTASA and K57/401Qcontrol, respectively.  When examining kcat further (Figure 3.21 B), it 
was observed that a significant variation occurred when comparing WTASA and 
K57/401Qcontrol with K57/401QASA.  This can be concluded as being a result of 
acetylation at residues other than Lys57 and Lys401, in particular, Lys81 and Lys424.  The 
difference of the apparent KM determined for WTASA and K57/401QASA was also 
significant, with the ASA-treated mutant exhibiting a larger value of 2550 ± 55.7 µM.  A 
similar comparison between K57/401Qcontrol and K57/401QASA drew no significance, 
indicating that Lys57 and Lys401 are likely the substantiating factors in determining KM.  
Furthermore, enzyme efficiency was only nominally impacted when comparing WTASA to 
K57/401Qcontrol and K57/401QASA, consolidating the importance of Lys57 and Lys401 
(Figure 3.21 D). 
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Figure 3.21: ASA-mediated acetylation of PDI attenuates oxidoreductase kinetics for the 
reduction of di-E-GSSG.  PDI at a concentration of 2 µM was treated with 15 mM ASA 
for 4 hours at 37 OC in the presence of 0.5 mM DTT.  Untreated, parallel controls were 
also performed in the absence of ASA.  (A) Using the di-E-GSSG assay, the steady state 
oxidoreductase kinetics of 20 nM untreated control WT (black solid line, WTcontrol), ASA-
treated WT (black dotted line, WTASA), untreated control K57/401Q (blue solid line, 
K57/401Qcontrol), and ASA-treated K57/401Q (blue dotted line, K57/401QASA) was 
assayed at pH 7.4.  The apparent kinetic parameters (B) kcat, (C) KM and (D) kcat/KM were 
calculated from the Michaelis-Menten fits in A.  Statistical significance with respect to 
WTcontrol is denoted by asterisks (*).  Hashtags (#) denote statistically significant 
differences between any indicated pair of data.  Data represents the mean ± S.D. of n = 3 
experiments. 
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The prevalence of PDI (PDIA1, EC: 5.4.3.1) in human physiology and 
pathophysiology has provided evidence of a need for a better understanding of its 
multiple enzymatic and non-enzymatic functions- both in vitro and in vivo.  Despite its 
discovery and extensive study since the 1960's [37-40], disparate results have been 
observed quite recently with respect to the possible mechanisms by which PDI follows.  
For instance, it has long been understood that the multi-domain organization of PDI and 
other PDI family members is intrinsically linked to specific activities [53, 76-79].  Even 
though the catalytic centers are the CxxC motifs of the a-type domains, the non-
enzymatic b-type domains are equally as important with regards to substrate binding and 
the overall conformation. 
Conventionally, it has been shown that many potent, specific inhibitors of PDI 
function via binding (reversibly or irreversibly) to the b'-domain (substrate binding 
domain), leading to abrogated or attenuated activity.  Compounds that lead to direct 
modification of the active site thiols are unsurprisingly the most potent inhibitors; 
nonspecific in function [43].  Even still, a class of compounds has recently been 
described as inhibitory with respect to substrate binding (inhibiting platelet aggregation), 
yet hold the ability to enhance enzymatic activity.  Regarded as bepristats, these 
reversibly bind the b' hydrophobic cleft.  Using the di-E-GSSG oxidoreductase assay, 
research has demonstrated this to be positive allostery enhancing catalysis [76].  
Interestingly, bepristats were actually found to inhibit PDI activity when using the insulin 
turbidity assay, contrary to those findings with the di-E-GSSG assay.  These indications 
of inhibitor-induced positive allostery of PDI catalytic activity are in stark contrast to the 
effects imposed by the bacitracin family of inhibitory compounds, those which bind the b' 
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hydrophobic cleft and inhibit chaperone activity with no discernable impact on catalytic 
activity [43, 134].  This is a key example of how PDI activity is largely substrate-
dependent, and why the dynamics of its catalytic mechanisms are not solely dependent on 
the CxxC motif, but the entirety of the protein architecture.  For this reason, it is vitally 
important to conduct complementary PDI assays when assessing activity. 
Many highly conserved residues have been identified as important to the redox 
reactivity of PDI.  The active site sequence of hPDI is CGHC, where the N-terminal 
cysteine (CysN) is the nucleophile responsible for the initial attack of a substrate 
disulfide, and the C-terminal cysteine (CysC) is the resolving cysteine required to liberate 
PDI from a mixed-disulfide intermediate state [62-64].  The intervening residues His and 
Gly act to mediate stabilization of the CysN thiolate and provide a degree of flexibility to 
the active site, respectively [65].  An arginine residue situated away from the active site 
has been shown to effectively move in close proximity to CysC whilst PDI is occupying a 
mixed-disulfide intermediate state.  This functions to stabilize the CysC thiolate anion by 
depressing its pKa and making it a better nucleophile, thereby mediating substrate release 
[63].  Lastly, a buried K-E charged-ion pair resides below the active site vicinal thiols of 
each active site.  This has been implicated in facilitating proton-transfer during thiol-
disulfide exchange reactions [62, 195, 197]. 
   The functions of the aforementioned residues have been scrutinized extensively 
and their roles well characterized.  In this thesis, we characterize and provide evidence 
for the functional role provided by the highly conserved active site lysine residues, Lys57 
and Lys401 (of the a and a'-domains, respectively).  The primary sequence of the active 
site region of PDI is invariant and highly conserved from yeast to human: 
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FYAPWCGHCK [55, 185].  Despite such a high degree of conservation, PDI is able to 
accommodate many alterations to the amino acid sequence of this motif with only minor 
changes to redox activity.  This demonstrates that only the catalytic cysteine residues are 
required for catalysis, while the other conserved residues are non-essential, but still 
important to the specific functions of PDI.  Lu et al. studied the active site-flanking Lys 
in the first domain of rat PDI [185].  They concluded that such does not perform an 
essential, "specific" function when substituting it for Arg and measuring the relative 
kinetics for the reduction of insulin and refolding of RNase A, in vitro.  They went on to 
state that the ~15% loss of activity likely indicates that arginine may fulfill functions 
similar to that of lysine [185]; that which has yet to be elucidated (see later). 
We demonstrate here that substitution to non-conservative amino acids does indeed 
result in marked attenuation of PDI kinetics using a variety of in vitro assays.  This 
includes the indication that residues Lys57 and Lys401 are important for ERO1α-mediated 
oxidation of redPDI.  Furthermore, analysis of genetic variations of PDI did not indicate 
the presence of single nucleotide polymorphisms (SNP's) at either active site residue.  
Coupled with the kinetic data, it is apparent that a logical means of modulating PDI 
activity may potentially be via posttranslational acylation of Lys57 and Lys401.  In an 
attempt to determine acetylation as the potential acylation event, PDI was treated with 
Aspirin, and the modified lysine residues were identified unambiguously using mass 
spectrometry (MS), with reference to the impact on oxidoreductase kinetics.       
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4.1   The CxxCK Motif Enhances the Full Complement of PDI's Catalytic Activities 
The rate by which PDI catalyzes thiol-disulfide exchange reactions is of vital 
importance to cellular homeostasis.  A primary example being the ability of PDI to 
minimize the folding timescale of nascent polypeptides within the lumen of the 
endoplasmic reticulum (ER).  This effectively prevents the build-up of unfolded or 
misfolded proteins that would otherwise lead to aggregates.  Proliferating or stressed cells 
will exhibit a higher rate of protein synthesis that can become pro-apoptotic should PDI 
as well as other foldases and chaperones be unable to handle the "work load."  The 
primary result of such is chronic stress and the initiation of the unfolded protein response 
(UPR) [118, 125, 128].  Therefore, the optimal catalytic performance of PDI is required 
to prevent such detrimental processes from occurring.  It is well documented that the 
reversible oxidation of the active site thiols of PDI by S-nitrosylation abrogates activity- 
inducing the UPR, thereby resulting in neuronal cell death.  This is a hallmark of the 
neurodegenerative diseases, ALS, Parkinson's and Alzheimer's [125, 127, 130]. 
As mentioned, the mechanistic details by which PDI performs its functions 
optimally is not completely understood.  For instance, the pH-dependence of PDI activity 
has seldom been studied to date.  An investigation of the pH-dependence of PDI-
catalyzed RNase A refolding focused only on a narrow range of pH, from 7 to 9 (at 1 pH 
unit increments) [198].  Based on the data, it was concluded that the isomerase activity of 
PDI was most optimal at pH 7 [198].  Without expanding the work to more acidic 
conditions, it cannot be said for certain whether this is true of PDI or not.  Other such 
research focusing on the pH-dependent dithiol-oxidase activity of PDI indicated that the 
maximum activity be centered on about pH 7, when studying over the pH range of 4.5 to 
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7.5 [83, 188].  In this case, data were undeterminable above pH 7.5 due to exceedingly 
high uncatalyzed rates of substrate peptide oxidation. 
To our knowledge, we thus present for the first time the full pH-dependent 
oxidoreductase activity profile for hPDI over a comprehensive range of pH.  This was 
achieved utilizing the di-E-GSSG assay [82] as the pseudo-substrate was deemed stable 
over the employed range (Figure 3.1 B).  The determined pH range was 5.5 to 8.5, with 
the indication that PDI undergoes substantial pH-induced global conformational changes 
below pH 5.5 (Figure 3.1 A).  Intrinsic tryptophan fluorescence was used to monitor the 
conformational stability of redPDI, where an increase of the emission peak at pH 4.5 was 
the indication of denaturation.  This emission increase was likely a result of the altered 
solvent accessibility of residue Trp364, with the active site neighbouring residues Trp52 
and Trp396 being a non-factor due to their close proximity to the respective catalytic sites, 
leading to quenching [199, 200].     
Full bell-shaped activity vs. pH profiles were generated and fitted to a double-
ionization model (Equation 2.2).  Estimation of the apparent macroscopic ionization 
events leading to PDI activation (apppK1, ascending limb) and inactivation (apppK2, 
descending limb) provided interesting findings suggesting that the enzyme functions over 
a relatively narrow range of pH as an oxidoreductase (Figure 3.1 C and Table 3.1).  WT 
PDI displayed optimal activity at pH 6.77.  This is in close agreement with previous 
studies using differing assay methods [83, 188, 198].  This further demonstrates that 
catalysis is optimal at near-neutral to slightly acidic pH in vitro, conditions similar to the 
in vivo environment of the secretory compartments (ER lumen and Golgi) where PDI is 
found to primarily localize and function [44, 175, 201]. 
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The breadth of oxidoreductase activity was determined as the difference between 
apppK1 and apppK2.  For WT PDI this was just 1.21 pH units.  Mutation of the conserved 
residues Lys57 and Lys401 simultaneously to either Gln, Ala or Glu, resulted in mutant 
PDI enzymes with narrower ranges of activity, at only ~0.6 to 0.85 pH units.  The factor 
at play here was the shift of apppK2, whilst apppK1 remained relatively unchanged at ~6.16, 
with only nominal deviations brought about the varying mutations.  This was suggestive 
of there being no discernable alterations to the pKa of the active site CysN and CysC thiols 
as apppK1 likely represents a combination of the ionization of both.  This was further 
supported by molecular dynamics (MD) simulations that estimated the active site thiol 
pKa's as being ~4.5 and ~8.5 for CysN and CysC of WT PDI, respectively.  When 
substituting both Lys57 and Lys401 to Gln, the CysN thiol pKa of each active site increased 
slightly by ~0.6 units, while the CysC pKa exhibited no significant perturbation (Table 
3.2). 
The shift of the descending limb midpoint (apppK2) by ~0.5 units as a result of 
mutation indicated an important role for residues Lys57 and Lys401 in modulating the pH-
dependence of PDI activity.  It was speculated that the apparent inactivation of PDI be a 
result of the ionization of key residues, such as the intervening His of the CGHC motifs.  
Should an active site Lys be functioning to modulate the pKa of this residue in either a 
direct or indirect fashion, a decrease of apppK2 brought about by mutation would indicate 
that its orientation be important for favouring the cationic state of the imidazolium side 
chain.  The intervening His residue is known to stabilize the thiolate state of CysN, 
thereby increasing E (redox potential); rendering PDI a more effective thiol-oxidase in 
comparison to other TRX enzymes [64, 65, 97, 99].  Additionally, apppK2 may represent a 
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macroscopic ionization event that is a combination of the intervening His, the Lys side 
chain, as well as other residues that cannot be inferred upon at this time.  Although, the 
pKa of residues Lys57 and Lys401 were estimated to be ~10 using MD analyses (Table 
3.1).  It can thus be speculated that under the in vitro conditions employed, ionization of 
either active site lysine of WT PDI would have been negligible, therefore likely not being 
a factor in directly contributing to apppK2. 
The pH-dependent activity profiles at a single substrate concentration did not 
provide a complete picture of the pH effects on the kinetic parameters.  To circumvent 
this, the kinetic parameters: turnover number (kcat), KM and catalytic efficiency (kcat/KM) 
were determined as a titration of pH from 6.0 to 8.0.  The substitution of residues Lys57 
and Lys401 indicated that mutation to either domain of PDI was nearly equivalent on the 
basis of kinetics.  In general, both kcat and KM were only marginally variable when 
comparing K57X and K401X variants (where X is Q, A or E) at any given pH (appendix 
B Tables B.1 to B.5).  Despite the understanding that each active site is actually 
inequivalent in vivo [56, 61], as well as under saturating conditions in vitro [60], our 
results show that they may perform very similarly.  Such has been observed elsewhere as 
well [59].  This is further supported when assessing the activity of active site thiol 
mutants (CxxC-AxxA, appendix A Figure A.4). 
Over the pH range of 6.5 to 8.0, WT PDI was determined to be the most efficient 
enzyme.  The double mutant PDI variants were unsurprisingly less efficient than the 
respective single mutants.  Despite being apparently most efficient at pH 6.5, WT PDI 
outperformed all mutant variants to the greatest extent under physiologically relevant 
conditions, pH 7.4.  Here, the single mutant enzymes were ~40 to 55% as efficient, while 
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the double mutants were ~20 to 34% as efficient in relation to WT (Figure 3.1 and 
appendix B Table B.4).  The kinetic parameters kcat, KM and kcat/KM for WT PDI at pH 
7.4 were determined to be 0.0347 s-1, 777 nM and 44.6×103 M-1 s-1, respectively (Figure 
3.1 and appendix B Table B.4).  This is in fairly close agreement with previous reports 
[81].  
It was realized that the large determinant for enzyme efficiency was the trend 
observed for KM in relation to pH.  KM exhibited a consistent increase, with a net change 
of ~165-fold.  This is in contrast to the ~5-fold variation of kcat, which did not increase 
consistently across the pH range- rather, it approached a maximum at pH 7.0 before 
declining at pH 7.4 and 8.0 (this was true of all PDI enzymes tested; Figure 3.1 A and B, 
and appendix B Tables B.1 to B.5).  This likely indicates the optimal pH for the balance 
with thiol nucleophilicity of both CysN and CysC [27].  The result was WT PDI being an 
apparently more efficient enzyme across the entirety of the pH range, except for at pH 6.0 
where no statistically significant differences were observed as compared to the mutants 
(appendix B Table B.1).  These data indicate that at pH 6.0, the activity of PDI was not 
significantly reliant on either Lys57 or Lys401, as mutation to Gln, Ala or Glu did not 
affect KM or kcat (thereby not altering enzyme efficiency).  It is possible to explain this 
result when examining Figure 3.3.  Under acidic conditions the rate of substrate release 
was exceedingly slow, rendering PDI trapped in a mixed-disulfide state.  This was likely 
a result of slowed kinetics of the resolving cysteine, CysC.  It is therefore possible that the 
kinetics of PDI activity are most influenced by this acid-induced substrate trapping event, 
thereby negating any possible contributions brought about by the neighbouring lysine 
residues, Lys57 and Lys401 (or any residue in these positons, for that matter).   
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No statistically significant differences in KM were observed at pH 8.0.  
Furthermore, this was also true at pH 6.0, with the exception of the K57/401Q variant, 
which exhibited a near 2-fold increase.  Between pH 6.5 and 7.4 the single mutant 
enzymes displayed KM values about 1.5 to 2-fold greater than WT, whilst the double 
mutant enzymes were 2 to >3-fold larger.  This is consistent with the notion that mutation 
to residues Lys57 and Lys401 results in diminished substrate (di-E-GSSG) binding to the 
active site. 
It was interesting to note that, in relation to the differences of KM between WT and 
the mutant PDI enzymes, kcat was also impacted.  The significance, though, was much 
less so.  Across the range of pH, only some mutants displayed altered kcat values that were 
deemed statistically significant, but none at pH 6.0 (with the exception of K57/401E, see 
appendix B Table B.1).  In general, the single mutant variants displayed nominal changes 
to kcat in relation to WT.  On the other hand, the double mutants K57/401(Q/A/E) 
exhibited markedly attenuated turnover rates.  This provides an indication that mutation 
to Lys57 and Lys401, simultaneously, retards PDI substrate turnover significantly, likely a 
result of changes to the environment of the CysN nucleophile (see later).  Surprisingly, at 
pH 8.0 kcat was the only parameter affected by mutation, while KM was relatively 
unchanged (appendix B Table B.5).  It is possible that under these conditions the ability 
of PDI to accommodate and bind the di-E-GSSG substrate is limited to such an extent 
that mutation to the active site region likely does not invoke structural variations that 
dictate substrate binding to the same extent in comparison.  At basic conditions such as 
this, the surface charge of PDI (and the substrate for that matter) may be altered, leading 
to the observed result. 
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Taken together, kcat may be telling of the possible mutation-induced changes to 
cysteinyl pKa and/ or nucleophilicity that affect the kinetics of substrate attack and 
release, whilst the KM data may be a valid reporter of active site steric hindrance 
mediated by the substitution of an active site lysine residue to non-conservative amino 
acids.    
Interpretation of the thermodynamic and kinetic effects of the respective single and 
double mutations can provide insight to the relatedness of residues to substrate binding 
and catalysis.  Results indicate that the effects to KM by double mutation are apparently 
additive or partially additive with respect to the single mutations.  This means that the 
sum of the contribution of the K57X and K401X single mutants is about equal to that 
observed for the respective K57/401X double mutants [202].  The observation for kcat, is 
only partial additivity (where significant).  This makes sense as these residues are non-
interacting yet likely help mediate similar steps of catalysis [202]; localized to either of 
the two distinct active sites of PDI that act in a near-equivalent, yet individual manner in 
vitro [59, 60].  Furthermore, the impact on PDI activity is such that Lys57 and Lys401 are 
non-catalytic residues that likely do not largely hinder the rate-limiting steps of catalysis- 
that is, they facilitate non-rate-limiting steps [83, 202].  Interestingly, additivity with 
respect to KM was not consistently seen over the entire pH range, or with each substituted 
residue (Gln, Ala and Glu).  At pH 6.5 and 7.0 (appendix B Tables B.2 and B.3) both Gln 
and Ala mutants were additive, with partial additivity for Gln and nearly complete 
additivity for Ala at pH 7.4 (appendix B Table B.4).  In contrast, mutation to Glu 
displayed only partial additivity from pH 6.5 to 7.4.  This, taken together with the varied 
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enzyme efficiencies, suggests possible residue-specific effects at these flanking regions 
within the PDI active sites.  
Mutation to Gln is the least detrimental to activity (enzyme efficiency).  This makes 
sense as it is most similar both structurally and chemically to lysine (compared to Ala and 
Glu).  An Ala mutation removes both the steric bulk and charge of lysine in place of a 
small, hydrophobic residue.  The impact on activity brought about by this substitution is 
less still when compared to Glu.  Mutation to Glu results in an anionic side chain which 
presents the most drastic alteration in microenvironment. 
The di-E-GSSG pseudo-substrate takes on a net negative charge (appendix B 
Figure B.6 for structure and estimated pKa's [203, 204]).  It is possible that mutation to 
Glu may effectively result in electrostatic repulsion of the substrate from either the active 
site or the general encounter-complex association with PDI.  All the while, Lys may take 
on a stabilizing role in this regard.  As for Ala, it would present somewhat of an 
intermediate effect, supported by the observed kinetics of di-E-GSSG reduction.  It is 
interesting to note that an Ala mutation may also out-perform Glu in certain other cases, 
such as thiol-disulfide exchange reactions and chaperone interactions between PDI and 
larger substrates, perhaps nascent polypeptides.  This can be speculated as Ala could 
potentially complement the hydrophobic surface of the substrate binding surface of PDI 
[53]. 
In order to characterize the functional role of the active site-flanking residues Lys57 
and Lys401, we first sought to examine the NMR solution structures of homologous 
mammalian PDI family members PDIA3 (PDB: 2DMM [176]) and PDIA6 (PDB: 2DML 
[177]) (Figure 3.2).  For the PDB entry 2DMM, this was 20 structural overlays of the a'-
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domain active site of human PDIA3, bearing a CGHCK motif that is reminiscent of WT 
PDI (Figure 3.2 A).  For the PDB entry 2DML, this was 20 structural overlays of the a-
domain active site of mouse PDIA6, bearing a CGHCQ motif that is reminiscent of our 
designed K-Q mutants (Figure 3.2 B).  It was interesting to note the apparent flexibility 
of the WT-like CGHCK active site motif (2DMM/ PDIA3) in relation to the apparently 
ordered and rigid active site region of the CGHCQ motif (2DML/ PDIA6). 
It was initially theorized that the flexibility of the Lys side chain propagated 
through the active site, leading to the mobilization of the intervening His imidazolium 
moiety.  This was supported by the solution structures showing that when Gln was in 
place of K, the His side chain was within hydrogen bonding distance with the active site 
CysN (2.6 Å away) [205].  The WT CGHCK motif seemed to maintain the His side chain 
at >5.6 Å form CysN.  This may indicate that a CGHC-flanking Lys residue mediates an 
active site conformation that allows for CysN thiolate stabilization via long-range 
electrostatic interactions with the intervening His, at the same time preventing the 
imidazolium from being too near to form unfavourably strong ion pairs and/ or steric 
hindrance [65, 102].  The attenuated activity observed by the K-Q mutants was thus 
initially believed to be a result of the intervening His over-stabilizing the CysN thiolate 
(decreasing its pKa) due to its close proximity.  This would effectively result in a 
concomitant decrease of nucleophilicity [27, 28, 31]; a less reactive enzyme.  Though, 
this was unfounded when looking at the MD-estimated thiol pKa's that were nearly 
unchanged as a result of mutation, and if anything, the CysN thiol pKa's actually increased 
slightly as a result of substituting Lys57 and Lys401 to Gln (Table 3.2).  When looking at 
the entirety of the domain overlays, rather than just the active site motifs as shown in 
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Figure 3.2, it was apparent that 2DMM (PDIA3 a'-domain) as a whole is slightly more 
disordered than 2DML (PDIA6 a-domain).  Therefore, the proposed active site 
"floppiness" of 2DMM may simply be an artifact of data acquisition during the NMR 
experiment itself.  The reader should note that depositions 2DMM or 2DML originate 
from unpublished research.   
Due to the controversial results observed when assessing the NMR solution 
structures of CGHCK and CGHCQ PDI motifs, we next performed full MD simulations 
of red- and oxPDI: WT and K57/401Q.  Here, the role of either active site flanking Lys 
was not identified as being related to any dynamic changes of the active site intervening 
His.  Should the previous hypothesis have held fidelity, the mutation-induced movement 
of the intervening His in closer proximity to the CysN thiol would have resulted in a 
better thiol-oxidase.  This is because the thiolate state of PDI would have been stabilized 
and favoured.  Meaning, mutation of Lys57 and Lys401 should have resulted in an enzyme 
with attenuated thiol-reductase activity (as has been observed, see later and Figure 3.13), 
yet augmented thiol-oxidase activity, that which was not observed (see later and Figure 
3.15).  Furthermore, if apppK2 (Table 3.1) were an estimation of the ionization of the 
intervening H, then it's closer proximity to the active site thiolate as a result of mutation 
would have actually increased this parameter instead of decreasing it.  Instead, residues 
Lys57 and Lys401 were found to apparently modulate the accessibility of CysN in very 
distinct ways.  Following this, it was realized that such processes may be redox-state 
dependent for the a-domain, but not the a'-domain. 
For the a-domain of redPDI, Lys57 was observed to participate in cation-π 
interactions with the indole side chain of an upstream tryptophan, Trp52 (Figures 3.3 and 
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3.4) [186].  When mutating Lys57 to Gln this interaction was lost, resulting in the 
translation of the indole moiety over the active site CysN (Cys53), acting as a sort of "lid" 
(Figure 3.5).  Based on this, it was suggested that the interactions between Lys57 and 
Trp52 be important for mediating an open active site as determined from the apparent 
accessibility of Cys53.  The accessibility/ exposure of CysN is particularly important as 
this residue is required for the initiation of catalysis [62-64].  When assessing the 
structure of oxPDI, this same interaction was not observed, rendering the a-domain active 
site apparently closed (appendix B Figure B.2 A).  It is likely that the Cys53-Cys56 
disulfide introduced some degree of constraint on the active site, leading to this result.  
By comparing the ability of the mutant Gln57 residue to hydrogen bond with the active 
site backbone in the simulations of redPDI (appendix B Figure B.4 C) and oxPDI 
(appendix B Figure B.5 C), an apparent disruption was observed in the oxPDI 
simulation.  This may be telling of the speculated conformational constraints brought 
about by the active site disulfide. This strongly suggests that the a-domain active site of 
PDI undergoes redox state-dependent open and closed conformations as mediated by the 
cation-π interactions between Lys57 and Trp52. 
The work of Lu et al. [185] may suggest the presence of cation-π interactions as 
being a factor in determining PDI activity.  In their work, substitution of Lys57 for Arg 
indicated that Lys performed no "specific" function as alterations to activity were only 
minor.  Although this may be true, a similarity between Lys and Arg is the shared ability 
to form strong cation-π interactions within protein ensembles [186].  Therefore, the semi-
conservative mutation of K57R is likely not a large detriment to PDI activity as the 
proposed cation-π interaction with Trp52 remains, thereby rendering the active site of the 
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a-domain open [185].  Furthermore, studies of the equivalent (conserved) active site-
flanking Lys in E. coli TRX showed that mutation to Glu did not greatly attenuate the 
efficiency of ribonucleotide reductase activity at pH 7.0 [206].  Our kinetic data oppose 
this finding, yet it is likely a result of the obvious amino acid sequence and structural 
differences between TRX and hPDI, as well as the assay conditions and substrate used.  It 
is widely understood that the various structural differences between TRX and PDI family 
members is what accounts for the variety of specific functional roles and mechanisms of 
substrate recognition [26, 43, 207].  Thus, an active site flanking residue in TRX may not 
be as important as it is for PDI, as evidence from the hPDI kinetic data herein.  
The active site Trp is a highly conserved residue of a vast majority of prokaryotic 
and eukaryotic TRX enzymes and PDI family members [208-210].  Its role has been 
debated in research, with the general conclusion that in TRX (from E. coli and S. aureus), 
it is important to the protein's thermodynamic stability [209, 211, 212].  Computational 
modelling and theoretical calculations coupled with experimental results proved that the 
active site Trp of TRX was unimportant for catalysis in the sense that mutation to A did 
not result in the perturbation of the active site thiol pKa's, nor did it affect the 
regioselectivity of the CysN thiolate [212].  Furthermore, the structures of both redTRX 
and oxTRX display the indole ring as projecting toward, and partially covering the 
dithiol/ disulfide active site [208].  This is similar to that observed in the crystal structures 
of red- and oxPDI (PDB: 4EKZ and 4EL1, respectively [53]), as well as for the solution 
structures of PDIA3 [176] and PDIA6 [177] (Figure 3.4).  The proposed cation-π 
interaction between Lys57 and Trp52 was not observed in the available crystal structures 
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of PDI.  In all cases, it appeared as though the postulated closed active site conformation 
of the a-domain persisted in relation to the open. 
Disparity between the MD simulated structures here, and that of experimentally 
determined crystal structure data may lie in the dynamic low-energy minima populated 
by a given protein ensemble.  At times, there can be considerable structural variation 
when comparing theoretical models (based upon experimentally determined structures), 
crystal structures and NMR solution structures [213].  Although the core-regions of 
proteins are well ordered and relaxed, rendering a high degree of agreement between the 
various methods of structural analyses, the more solvent-exposed loop regions often show 
greater disorder and variability in backbone and side chain conformations [213].  The a-
domain active site of PDI (as well as the a'-domain active site, for that matter) is located 
on a loop region where such disorder may occur.  Therefore, it remains probable that the 
observed open-closed phenomena determined here using computational modelling may 
still be realistic despite little indication of such when assessing experimentally 
determined structures.  This notion may be further supported by the observation that the 
PDI molecule in solution is structurally quite different from that obtained in solid crystal 
form.  This was confirmed by MD analyses and small angle X-ray scattering (SAXS; an 
in-solution procedure) experiments where PDI was found to adopt a more compact 
conformation [70, 214].   
The MD simulated structures of the a'-domain provided interesting insight as to its 
inequivalent nature in comparison to that of the a-domain.  The accessibility of CysN was 
modulated by Lys401, not via cation-π interactions with the upstream Trp396 (equivalent to 
Trp52), but through its inability to form any bona fide interactions.  The side chain was 
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found to predominantly project into the solvent, thereby mediating an open conformation 
(Figure 3.9).  This was deemed so as mutation to Gln resulted in the introduction of 
backbone hydrogen bonding, similar to that observed for the a-domain (Figure 3.11 and 
appendix B Figure B.4 D).  As a result, dynamic changes in the active site conformation 
occurred, allowing residue Phe440 (of the conserved cis-Pro loop) to project toward the 
active site and impede the apparent solvent accessibility of CysN.  Residue Lys401 of WT 
PDI may still form transient hydrogen bonds [178], similar to those of Gln, and it was 
interesting to note that when such occurred, the closed conformation was favoured 
(Figure 3.10 and appendix B Figure B.4 B).  The oxidized conformation of the a'-
domain was different from that of the a-domain.  Here, the active site appeared open, 
irrespective of mutation, with a more solvent exposed CysN (Cys396, appendix B Figure 
B.2 B and D).  This is in contrast to the closed conformation observed for the oxidized a-
domain.  Unlike the a-domain, the a'-domain active site did not appear to exhibit redox 
state-dependent open and closed conformations.    
As discussed, the K57Q mutation resulted in the introduction of hydrogen bonding 
within the active site region.  This was due to the amide-Nδ of Gln being positioned 
perfectly in relation to the peptide carbonyl of the upstream active site Pro55 (Figure 3.5 
and appendix B Figure B.4 C).  It is unlikely that this interaction be a player in defining 
the kinetic contributions of a residue at this position (residue 57) simply because 
mutation to Ala and Glu also resulted in attenuated kinetics, and to greater extents.  It 
should be noted, though, that the structural similarities between Gln and Glu suggest that 
it may be possible for Glu to participate in similar hydrogen bonding interactions with the 
backbone of the active site (with the peptide N-H rather than the peptide carbonyl).  
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Unfortunately, the structural data observed for the a'-domain, and the speculated 
mechanism of open-closed dynamics, may only satisfy a K401Q and potentially a K401E 
substitution.  This hypothesis falls short of providing reasoning for the attenuation of 
kinetics observed for the K401A variant of PDI (appendix B Tables B.1 to B.5).  This is 
because, unlike Gln or Glu, Ala cannot participate in the backbone hydrogen bonding that 
lead to a closed active site (Figure 3.11).  Mutagenesis of Lys401 may present other 
structural effects that cannot be concluded upon at this time.   
 Even though the degree of burial of cysteine residues is high in proteins, it is not 
hydrophobic; displaying similar polarity to that of serine [36].  CysN is in a more 
hydrophobic microenvironment when the active site is in the closed conformation (i.e., 
mutated).  This likely accounts for both the variations of KM as well as kcat observed for 
the PDI variants.  Steric hindrance to the active site results in an increase of KM.  
Furthermore, a more hydrophobic microenvironment could effectively raise thiol pKa, 
and destabilize the thiolate state [36].  Despite this not being discernable with the 
experimentally determined pKa (apppK1, Table 3.1), computational estimations did 
support this (Table 3.2).  The pKa increase estimated for CysN was modest, but it may 
support the steady state oxidoreductase kinetic data that indicated KM to be much more 
affected by mutation in relation to kcat.  Therefore, changes in active site accessibility as 
mediated by mutation of Lys57 and Lys401 modulate substrate binding to the active sites of 
PDI, with slight attenuation of substrate turnover due to the altered accessibility and 
microenvironment of CysN. 
The single-turnover reduction of di-E-GSSG was also impeded as a result of 
mutating the active site flanking Lys residues (Figures 3.12 and 3.13), this was 
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determined under pseudo-first order conditions.  An interesting feature of this assay was 
the ability to negate the kinetic contributions of enzyme regeneration.  This provided 
further insight into the effects imposed by the K-Q mutation.  Because single turnover 
reductase activity was being monitored, the rate of substrate release as mediated by CysC 
was able to be ruled out.  This is because signal acquisition is obtained upon the initial 
nucleophilic attack of the di-E-GSSG self-quenching substrate by CysN (Figure 3.12).  
An increase of fluorescence in this case is not reliant on CysC.  At pH 7.4 the WT enzyme 
outperformed the mutant variants to the greatest extent, a similar result to that observed 
for the steady state oxidoreductase kinetics (Figure 3.2 C and appendix B Tables B.1 to 
B.5).  These data suggest that the mutation of active site flanking residues Lys57 and 
Lys401 affects the rate of thiol-reductase activity as a result of impeded accessibility and 
changes to the microenvironment about CysN. 
Going further, the peptide thiol-oxidase activity of PDI was assessed (Figure 3.14).  
Here, oxPDI oxidizes a dithiol-containing peptide substrate.  Results indicated that across 
the range of pH, substantial attenuation of kinetics was observed for the double mutant 
K57/401Q variant, while the respective single mutants displayed only nominal alterations 
(Figure 3.15 B).  MD simulations pointed to a redox-regulated open and closed 
conformation of the a-domain active site; open when reduced and closed when oxidized, 
irrespective of mutation.  Based on this, it would be anticipated that the K57Q variant 
function very similarly to WT.  This was indeed observed, with the exception at pH 6.3 
(82% of WT).  In contrast, the K401Q single mutant deviated from WT more, with 
significant changes to thiol-oxidase rate at pH 6.3, 6.5 and 6.9 (82%, 77% and 79% with 
respect to WT, respectively).  A caveat to this assay is that the altered kinetics of peptide 
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oxidation may be a result of oxPDI regeneration mediated by GSSG.  Unfortunately, 
single turnover thiol-oxidase activity was not attainable.  It therefore cannot be concluded 
if the observed results are due to the oxidation of the peptide substrate or if this assay 
simply provides an alternative approach to measuring the oxidoreductase activity of PDI, 
similar to the steady state experiments using di-E-GSSG.   
During oxidative protein folding of nascent polypeptides within the ER, PDI may 
participate in PDI-1st, PDI-2nd or a mixture of PDI-1st/2nd pathways [26, 75].  The transfer 
of oxidizing equivalents by oxPDI to a reduced substrate is what defines PDI-1st 
pathways.  The opposite is true of PDI-2nd pathways, where PDI does not introduce 
disulfides to some reduced substrate, rather it functions as a thiol-disulfide isomerase to 
correct mispaired disulfides.  During PDI-1st oxidative folding in vivo, endoplasmic 
reticulum oxidoreductin-1α (ERO1α) is the interacting partner required to regenerate 
oxPDI from the growing pool of redPDI (Figure 1.10).  We speculated that our K-Q 
mutant enzymes- having displayed markedly attenuated oxidoreductase kinetics towards 
smaller pseudo-substrates, would also exhibit decreased rates of thiol-disulfide exchange 
with ERO1α.  It was observed that the rate of oxygen consumption by the oxidase, 
ERO1α, was greatest when in the presence of WT PDI, indicating the most rapid rate of 
thiol-disulfide exchange.  The PDI variants K57Q, K401Q and K57/401Q resulted in 
relative rates of oxygen consumption that were 76%, 83% and 54% of WT, respectively 
(Figure 3.16 and Table 3.3). 
The transfer of disulfides begins with active ERO1α (ox1) [96].  PDI accepts these 
disulfides and in turn transfers oxidizing equivalents to some substrate.  Resultantly, 
electron flow occurs in the opposite direction, from said (reduced) substrate to PDI (first 
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the a-domain then a'-domain), then terminating at ERO1α where reduction of the FAD 
cofactor to FADH2 results in a transfer of electrons to molecular oxygen (O2), thereby 
generating hydrogen peroxide (H2O2) [91, 92].  The in vitro reaction here utilized GSH as 
the initial electron donor source.  The apparently attenuated rates of oxygen consumption 
by ERO1α in the presence of mutant PDI is likely telling of the impedance of electron 
flow between the reduced a-domain active site of PDI and the oxidized a'-domain active 
site.  As well, kinetic slowing may be occurring between the subsequently reduced a'-
domain active site and the C94-C99 electron shuttling disulfide of ERO1α.  This would 
make sense as previous in vitro oxidoreductase and thiol-reductase kinetics indicated that, 
when in the reduced state, the kinetics of PDI-catalyzed reduction were greatly attenuated 
when bearing a mutant CGHCQ motif (Figures 3.2 and 3.13).  This being a result of the 
hindered accessibility to CysN of the mutant redPDI active sites (Figures 3.7 and 3.11).  
It is therefore clear that such a mechanism is also relevant when assessing the redox-
regulated interactions between PDI and ERO1α. 
It is unlikely that mutation of either Lys57 or Lys401 impacted the binding of ERO1α 
to PDI, thereby leading to the attenuated rates of oxygen consumption observed.  Binding 
has been found to occur between a β-hairpin loop of ERO1α and the hydrophobic pocket 
of the b'-domain of PDI [89, 92].  There is no indication of the active site flanking Lys 
residues as mediating this interaction [89].  Furthermore, mutation of all active site Cys 
residues of PDI to Ala was shown to display similar binding kinetics as that of WT PDI; 
further highlighting the non-covalent association as being relatively independent of the 
active site motif [92]. 
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With this understanding, it is most plausible to say that the 24% decrease to the rate 
of oxygen consumption observed for ERO1α in the presence of the K57Q PDI variant be 
a result of the inaccessibility of Cys53 (CysN of the a-domain).  Thus, when the 
interdomain thiol-disulfide exchange reaction occurs between the reduced C53GHCQ 
motif of the a-domain and the oxidized C397GHCK motif of the a'-domain, it is slowed 
due to the closed active site and limited accessibility of the nucleophilic thiolate of Cys53 
[26-28]. 
The observed 17% decrease of rate for ERO1α in the presence of the K401Q PDI 
variant was likely not a result of any impedance to the interdomain thiol-disulfide 
exchange reaction as noted above.  Recall that the MD simulations of WT and mutant PDI 
showed the oxidized a'-domain active site open, irrespective of the residue at position 
401 (appendix B Figure B.2 B and D).  Therefore, the only differentiating factor between 
the WT and mutant K401Q a'-domain active sites are seen when in the reduced state; that 
which would follow the interdomain thiol-disulfide exchange.  The reduced mutant active 
site was determined to be closed, with a less solvent exposed CysN (C397, Figure 3.11).  
As a result, the thiol-disulfide exchange reaction between PDI and the C94-C99 electron 
shuttling disulfide of ERO1α was likely the hindered step. 
As for the double mutant K57/401Q PDI variant, a combination of the 
aforementioned mechanisms of the single mutants occurs.  This lead to drastically 
reduced rates of oxygen consumption by 46%.  Simply put, substitution of active site 
flanking residues Lys57 and/ or Lys401 of PDI resulted in markedly slowed rates of 
electron transfer between redPDI and ERO1α.  These active site residues can be viewed 
as highly important for the ERO1α-mediated regeneration of oxPDI, whereby absence of 
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the native CxxCK motif may effectively form a kinetic bottleneck, limiting the efficiency 
of electron transfer.  Interestingly, the effects imposed by the single mutant enzymes are 
nearly additive with respect to the K57/401Q double mutant.  In support of this, it is 
understood that each active site flanking residue (Lys57 and Lys401) helps to mediate the 
same step of catalysis, that being the net transfer of electrons to ERO1α, yet are non-
interacting [202]. 
This implies a potential for the build-up of redPDI within the ER lumen, in vivo, 
should a modification of the active site neighbouring residues Lys57 and Lys401 occur.  
Such a modification is likely to be Nε-lysine acetylation.  The resulting kinetic bottleneck 
of oxPDI regeneration can most certainly extend to other pathways outside of the PDI-
ERO1α interaction, such as the H2O2-driven oxidation of PDI by peroxiredoxin 4 
(PRDX4) [215, 216] and PDI peroxidases GPRx7/8 [217].  Although accurate 
estimations of the glutathione redox poise (GSH:GSSG = ~35:1) of the ER lumen 
indicates that redPDI largely predominates, there is an inkling that oxidative "hot spots" 
exist [26].  These may present themselves in the form of intraluminal concentration 
gradients whereby PDI does not equilibrate with GSH, thus exhibiting temporal increases 
of oxPDI [26].  It is therefore interesting to theorize possible upstream and downstream 
perturbations to the redox equilibria that may occur between a kinetically abated PDI 
(modified Lys57 and Lys401) and equilibrium partners within a given cellular redox 
environment [26].  These perturbations may reflect dynamic signalling events required by 
the cell, all stemming from the modulation of PDI activity as centered on the active site 
Lys residues. 
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A recent review by Hudson et al. provides curious speculation as to the existence 
and importance of redox-equilibria directly within protein networks (i.e., PDI-ERO1α) 
and/ or with small molecules such as glutathione [26].  Not only may the pool of redPDI 
increase as a result attenuated thiol-disulfide exchange kinetics, but reductive stress to the 
ER lumen may also persist due to compromised GSSG production.  This likely implies 
detrimental effects to protein folding, including a build-up of improperly folded proteins 
containing mispaired disulfides.  This would be particularly damaging within 
professional secretory cells such as pancreatic β cells [218].  Further, an increase of 
redPDI may ultimately lead to enhanced levels of active ERO1α (Ox1).  The implication 
here being the hyperactivity of ERO1α as activated by redPDI.  In short, this may lead to 
the hyperoxidaiton of other PDI family members, such as ERp57.  The end result of such 
being UPR signaling, as demonstrated by Hansen et. al. [219].  
 
4.2   Acetylation of K57 and K401 is a Means of Modulating PDI Activity 
Site directed mutagenesis of Lys57 and Lys401 provided a framework for resolving 
the mechanisms by which an active site-flanking Lys facilitated enhanced rates of 
catalysis by mediating the solvent accessibility of CysN.  These results do not directly 
relate to what may be expected to occur naturally in vivo.  This is because, to our 
knowledge, there has been no research to date that has identified any naturally occurring 
mutations of these residues.  It is therefore more relevant to assess the possibility of 
lysine posttranslational modifications with respect to Lys57 and Lys401.  Here, we 
investigate PDI as a target for Nε-lysine acetylation.       
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The optimal catalytic activity of PDI is not an absolute requirement for a healthy 
physiology.  The indication that many cancers are associated with its upregulation 
demonstrates that there exists a need for modulating PDI activity [43].  Using 
acetylsalicylic acid (ASA), the active ingredient in Aspirin, an in vitro shotgun approach 
lead to the identification of many lysine residues as being candidate targets of acetylation.  
In total, 18 acetyllysine residues (acK) were identified by mass spectrometry (MS) in a 
reproducible manner (Table 3.4).  This included active site-flanking residues Lys57 and 
Lys401 (Figures 3.18 and 3.19, respectively).  As well, the key catalytic residues Lys81 
and Lys464 were found to be acetylated.  The implication is that those residues determined 
to be acetylated by ASA may present themselves as viable targets of in cellulo acetylation 
either in Aspirin-treated cultures, via chemical interactions with cellular acetyl-CoA 
[144], or enzymatically through the work of N-acetyltransferase enzymes [138]. 
Quite recently it has been realized that reversible Ne-lysine acetylation is a 
posttranslational regulatory mechanism that goes beyond that of histone modification.  
Research has linked this PTM to various cellular compartments, including the ER and 
Golgi intermediate complex [141, 151].  It has, for the first time, been shown that an 
acetyl-CoA transporter and two distinct ER-luminal transmembrane acetyltransferases 
exist [148, 152].  Proteomic assessment has identified PDI and many other ER-resident 
proteins as being acetylated [141, 153, 154].  Specifically, the efforts of Pehar et al. 
identified residue Lys401 of hPDI as being acetylated when examining purified ER 
preparations from human neuroglioma (H4) cells [153].  Other proteomic studies probing 
for various lysine acylation events (such as acetylation, succination, etc.) have found PDI 
to be extensively modified in vivo [141, 220].  These studies were unable to characterize 
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any modifications to residues Lys57 or Lys401, despite the use of enrichment strategies.  
The absence of such may be attributed to either an exceedingly low stoichiometry, or a 
lack of resolution in comparison to other, more readily modified peptides.  In either case, 
the use of whole-cell, global proteomics may explain this, as the prepared samples are 
complex in nature.    Furthermore, the use of deacylase inhibitors was omitted during cell 
lysis and sample preparations.  This may also have a negative impact on the detectable 
levels of PDI acylation.  It should be noted that, to our knowledge, specific examination 
of the modifications to hPDI lysine residues has yet to be performed.  Therefore, our in 
vitro experimentation using ASA provide important insights to the kinetic effects of 
acetylation. 
The kinetic activity of PDI was determined under steady state conditions using the 
di-E-GSSG assay as described previously.  By comparing ASA-treated and untreated WT 
PDI (WTASA and WTcontrol, respectively) it was evident that global lysine acetylation was 
detrimental to activity (Figure 3.21). WTASA exhibited a near 75% decrease of enzyme 
efficiency (Figure 3.21 D).  This was attributable to a ~68% increase of KM and a 66% 
decrease of kcat (Figure 3.21 B and C).  As mentioned above, MS analysis identified 18 
acK sites.  Importantly, this included acK57 and acK401, as well as acK81 and acK424 
(Table 3.4).  The importance of Lys81 and Lys424 to PDI activity has been identified 
previously, with the indication that each facilitates proton transfer during thiol-disulfide 
exchange reactions [195].  For this reason, a comparison of the kinetics between WTASA 
and WTcontrol cannot be conclusive in elucidating the impact of acetylation to Lys57 and 
Lys401 specifically.  The concomitant acetylation of Lys81 and Lys424, and others, likely 
infers contribution to the observed differences in kcat. 
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To circumvent this, the double mutant K57/401Q was either treated with ASA 
(K57/401QASA) or left untreated (K57/401Qcontrol).  By comparing the kinetics of WTASA 
to that of K57/401QASA and K57/401Qcontrol, the kinetic contribution of acK81 and acK424 
in relation to acK57 and acK401 was able to be determined.  Focusing on KM, that 
determined for WTASA was lower- albeit marginally, yet statistically so- than both 
K57/401Qcontrol and K57/401QASA (~16 to 18%, Figure 3.21 C).  This is because the 
closed active site configurations brought on by mutation (Figures 3.7 and 3.11) can be 
anticipated to occur similarly for acK57 and acK401.  Introduction of an Nε-acetyl group to 
Lys57 would result in the loss of cation-π interactions with Trp52, resulting in a closed a-
domain active site.  Furthermore, acK401 would lead to a closed a'-domain active site due 
to the introduction of backbone hydrogen bonding between the acetyl oxygen and the 
peptide N-H group.  Therefore, the mutant K57/401Q enzyme may be viewed as PDI 
with a perfect stoichiometry (homogenous acetylation) of acK57 and acK401. 
The modest variation of KM observed is likely due to the stoichiometry of the ASA-
mediated acetylation reaction.  Seeing as the in vitro reaction was performed at alkaline 
pH (8.5), ASA was susceptible to hydrolysis (base-catalyzed deacetylation) resulting in 
salicylic acid and acetate [221].  Additionally, ASA is capable of producing O-acetylated 
Ser, Thr and Tyr residues [196, 222].  Although O-acetylation was later reverted by 
incubation with excess hydroxylamine (HA) [162-167], this form of acetylation coupled 
with aqueous hydrolysis means an overall depletion of the ASA reagent available for 
modifying the lysine residues of PDI.  Therefore, the ASA-treated and untreated 
K57/401Q enzymes each displayed similar KM values that were increased ~16 to 18% as 
compared to WTASA.  This is because all PDI molecules of these mutants exhibit closed a- 
	148 
	
and a'-domain active sites as induced by mutation.  In contrast, WTASA represents a 
heterogeneous acetylation of PDI, with some molecules displaying no acetylation (K57 
and K401), partial acetylation (acK57 and K401, or K57 and acK401) and full acetylation 
(acK57 and acK401) of the active site-flanking Lys residues.  This means a mixture of 
natively open active sites as well as acetylation-induced closed active sites.  This was 
confirmed by the presence of unacetylated active site peptides (m/z 564.93 (z = 3) for the 
a-domain and m/z 616.30 (z = 4) for the a'-domain, results not shown).  Thus, acetylation 
of Lys57 and Lys401 can be concluded as the substantiating factor in the 68% increase of 
KM between WTcontrol and WTASA. 
Although a statistically significant difference between K57/401Qcontrol and 
K57/401QASA was not seen in relation to KM, it was observed for kcat (Figure 3.21 B).  
Treatment of the mutant resulted in a 55% decrease.  This decrease was relatively the 
same when compared to WTASA.   Comparing WTASA and K57/401Qcontrol (enzymes that 
are kinetically similar) to K57/401QASA indicated that acetylation of Lys57 and Lys401 is 
by-and-large the factor that influences PDI activity in comparison to the other 16 
identified acK residues.  Again, the heterogeneity of the in vitro acetylation reaction is 
most likely the reason WTASA and K57/401QASA do not corroborate more closely, 
kinetically (see enzyme efficiency, Figure 3.21 D).  Yet, it remains that other residues, 
including Lys81 and Lys424, are important for enhancing enzyme turnover, and acetylation 
of such decreases kcat. 
Enzymatic acetylation of PDI has yet to be observed directly.  Lundby et al. 
described in vivo tissue and organelle-specific acetylation patterns in rats [141].  They 
identified compartment-specific acetylation motifs which may point to the existence of 
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compartment-specific lysine N-acetyltransferase enzymes (KATs) [141, 223].  As 
discussed previously, earlier studies by Puglielli and coworkers identified two ER-
resident KATs, N-acetyltransferase 8B (ATase-1) and N-acetyltransferase 8 (ATase-2) 
[148].  Acetylation was found to generally be favoured in lysine-rich regions [141].  
Granted, this may simply be an artifact of there being a greater potential of acetylation to 
occur in these regions.  Within the ER specifically, a tendency for negative and 
hydrophobic amino acids at the −1 and −2 positions in relation to acK was observed 
[141].  The flaking sequence to residues Lys57 and Lys401 of PDI do not satisfy these 
findings (refer to appendix A Figure A.1).  The apparent acetylation motifs described 
may be biased by compartment-specific protein expression, or mediated by lysine 
deacetylase enzymes, seeing as acetylation is a dynamic, reversible modification [141, 
146]. 
ER-luminal acetylation is a very new phenomenon only just being evaluated now.  
Pehar and Puglielli offer interesting insight as to the likelihood of acetylation signaling 
playing a role in quality control mechanism of the ER [224].  A key finding being that 
knockout of the ER-based acetyl-CoA transporter (AT-1) resulted in cell death, an 
indication that ER-luminal acetyl-CoA (and thus protein Nε-lysine acetylation) is required 
for cell viability [153, 224, 225].  Additionally, it could be that acetylation of nascent 
polypeptides is required to help facilitate the native fold by alleviating the charge of 
lysine, making it more favourable for it to be buried within the protein conformation.  
Under conditions that promote the UPR, acetyl-CoA influx is increased as a result of AT-
1 upregulation.  This event occurs as a result of both transient and chronic stress-
associated UPR response [224].  Therefore, under such conditions the likelihood of PDI 
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acetylation increases.  Events that result in the hyperacetylation of PDI may be associated 
with pathophysiological states.           
Research has demonstrated that PDI is extensively acylated in vivo [141, 153, 220].  
Despite not exhibiting a favoured motif sequence, the active site-flanking residue Lys401 
of the a'-domain was identified as being acetylated in vivo [153].  Taken together with the 
kinetic data herein, evidence infers that an active site-flanking Lys may act as a regulator 
of PDI activity via its reversible, posttranslational acetylation.  Results point to a role for 
these residues in maintaining the appropriate microenvironment for the nucleophilic 
active site cysteine, CysN. 
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CHAPTER 5 
 
CONCLUSION AND FUTURE DIRECTIONS 
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The discovery of PDI in the 1960's [37, 40] was ground-breaking for the 
understanding of protein folding and cellular redox biology.  Since that time PDI has 
been identified as a multifunctional chaperone of the ER, linked to a variety of 
physiological and pathophysiological processes, including cancer [43, 111-113, 115].  
Despite this, many characteristics regarding substrate recognition and details of the 
enzymatic mechanisms remain enigmatic.  A variety of features have been identified as 
important for the specific activity of hPDI, such as domain organization [76-79], active 
site redox potential [97-100], and many conserved catalytic and non-catalytic residues.  It 
remains that the conserved active site-flanking residues Lys57 and Lys401 have been 
seldom studied [55, 185]. 
The present study explored the roles of residues Lys57 and Lys401 in relation to a 
full complement of PDI activities.  We demonstrated that mutation lead to attenuated 
rates of oxidoreductase, thiol-reductase and thiol-oxidase catalysis.  Furthermore, a 
mutant CxxCQ motif at either or both active sites abated electron transfer during ERO1α-
mediated oxidation of redPDI.  The implication here is a kinetic bottleneck that likely 
translates to the impedance of oxidative protein folding in vivo.  MD simulation studies 
established the importance of these active site-flanking Lys residues.  It was determined 
that each function to mediate the solvent accessibility of CysN in distinct manners.  
Conclusively, a WT CxxCK motif resulted in an open active site, with a more solvent 
exposed CysN residue.  A mutant CxxCQ motif, on the other hand, promoted a closed 
active site, with a less accessible CysN.  As a result, enzyme efficiency was markedly 
reduced, with the indication that substrate binding (KM) be largely compromised. 
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Nε-lysine acetylation of Lys57 and Lys401 was investigated as a potential 
posttranslational regulatory mechanism of PDI.  Aspirin-mediated acetylation was 
capable of reproducibly generating 18 unique acK sites, including acK57 and acK401.  
Interestingly, acetylated WT PDI performed catalytically very similarly to the K57/401Q 
control variant, with a near 75% loss of efficiency in relation to unacetylated WT.  Data 
here further pointed to residues Lys57 and Lys401 as being important for maintaining an 
optimal active site conformation with respect to CysN.  Overall, these data, coupled with 
previous reports indicating the acylation of PDI in vivo, implicate the active site-flanking 
Lys residues as important to PDI activity.  Acetylation of such is likely a viable 
regulatory mechanism of PDI, never before described. 
Further studies are required to provide added insight to roles of Lys57 and Lys401.  
For instance, the kinetic data obtained is not telling of the thermodynamic implications 
these residues may have on the chemistry of the PDI active sites.  Does mutation or 
acetylation result in altered redox potentials?  This may be most simply investigated 
using a semi-quantitative in vitro gel-shift assay [31, 91, 106].  It is recommended that 
each active site be investigated individually, therefore active site cysteine mutants 
(CxxC-AxxA, appendix A Figure A.4) have been designed.  Additionally, it may be 
useful to perform kinetic assays as a titration of ionic strength to further scrutinize the 
proposed cation-π interaction between Lys57 and Trp52.  In this case, shielding of the 
cationic amine of Lys57 by increasing salt concentrations may eliminate the interaction 
between with Trp52, thereby rendering the a-domain active site closed; exhibiting similar 
kinetics to that of the K57(Q/A/E) PDI variants.  Lastly, the non-catalytic chaperone 
activity of PDI should be assessed in relation to Lys57 and Lys401.  A promising technique 
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that can be utilized is the refolding of acid-denatured green fluorescent protein (GFP, 
Figure 1.9 I and appendix A Figure A.6) [80]. 
    In terms of acetylation, results provided by this thesis are quite rudimentary.  The 
enzymatic acetylation of PDI has yet to be investigated.  A first effort should be centered 
on identifying whether or not PDI is acetylated in vitro by the ER-resident KATs, ATase-
1 and ATase-2.  Preliminary trials have been performed using affinity purified ATase 
enzymes conjugated to maltose binding protein (MBP) at the N-terminus.  Despite the 
KATs exhibiting in vitro lysine acetyltransferase activity towards human histone H3 
peptide (appendix A Figure A.7), PDI has not yet been identified as a target.  Cleavage 
of the cumbersome MBP affinity tag prior to performing reactions with PDI could 
provide a solution to this problem.  Moreover, in cellulo acetylation of PDI should be 
investigated.  First, one should determine the acetylation state of endogenous and/ or 
overexpressed PDI in a variety of cell types.  It may be useful to employ deacylase 
inhibitor cocktails as a cell-treatment strategy to enhance the levels of acetylation.  By 
Western blot analysis, it has been determined that a combination of pan-specific 
inhibitors, tricostatin-A (TSA, 5 µM), nicotinamide (NAM, 10 mM) and sodium butyrate 
(NaBut, 1 mM) effectively elevate levels of cellular acetylation in HeLa, human 
embryonic kidney (HEK-293) and human retinal pigmented endothelium (ARPE-19) cell 
cultures when treated for 6 hours (results not shown).  It may prove useful to also 
incubate cells with varying amounts of Aspirin to provide an indication of the chemical 
acetylation of PDI upon drug treatment.  A last avenue to explore is genetically encoding 
site-specific acetyllysine residues.  This avoids the possibility of heterogeneous and 
undesirable acetylation patterns observed with in vitro chemical procedures [226, 227]. 
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APPENDICES  
Appendix A (Chapters 1, 2 and 5 supplementary material) 
	
	
MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRDPNSDAPE EEDHVLVLRK 
SNFAEALAAH KYLLVEFYAP WCGHCK57ALAP EYAKAAGKLK AEGSEIRLAK 
VDATEESDLA QQYGVRGYPT IKFFRNGDTA SPKEYTAGRE ADDIVNWLKK 
RTGPAATTLP DGAAAESLVE SSEVAVIGFF KDVESDSAKQ FLQAAEAIDD 
IPFGITSNSD VFSKYQLDKD GVVLFKKFDE GRNNFEGEVT KENLLDFIKH 
NQLPLVIEFT EQTAPKIFGG EIKTHILLFL PKSVSDYDGK LSNFKTAAES FKGKILFIFI 
DSDHTDNQRI LEFFGLKKEE CPAVRLITLE EEMTKYKPES EELTAERITE 
FCHRFLEGKI KPHLMSQELP EDWDKQPVKV LVGKNFEDVA FDEKKNVFVE 
FYAPWCGHCK401 QLAPIWDKLG ETYKDHENIV IAKMDSTANE VEAVKVHSFP 
TLKFFPASAD RTVIDYNGER TLDGFKKFLE SGGQDGAGDD DDLEDLEEAE 
EPDMEEDDDQ KAVKDELKLA AALEHHHHHH 
Figure A.1: Amino acid sequence of the recombinant N- and C-terminally His6-tagged 
human PDI used in this study.  Active sites (CGHCK) of the a- and a'-domains are 
underlined.  
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Table A.1: PCR primers for site-directed mutagenesis of hPDI.  Substituted nucleotides 
are in bold and underlined.  Ta represents primer annealing temperature.   
Primer Sequence (5' – 3') Ta (OC) 
a-domain rev. AGG GGC CAG AGC CGC GCA GTG GCC ACA CCA AGG 61-68 
K57A a-domain fwd. AGG GGC CAG AGC CGC GCA GTG GCC ACA CCA AGG 65 
K57Q a-domain fwd. AGG GGC CAG AGC CTG GCA GTG GCC ACA CCA AGG 68 
K57E a-domain fwd. AGG GGC CAG AGC CTC GCA GTG GC 61 
a'-domain rev. CCA TGG GGC ATA GAA TTC CAC AAA GAC 57-60 
K401A a'-domain fwd. TGT GGT CAC TGC GCA CAG TTG GCT CCC 57 
K401Q a'-domain fwd. TGT GGT CAC TGC CAA CAG TTG GCT CCC 60 
K401E a'-domain fwd. TGT GGT CAC TGC GAA CAG TTG GCT C 58 
CxxCK57–AxxAK57 fwd. AGG GGC CAG AGC CTT GGC GTG GCC AGC CCA AGG 
GGC ATA G 
58 
CxxCQ57–AxxAQ57 fwd. AGG GGC CAG AGC CTG GGC GTG GCC AGC CCA AGG 
GGC ATA G 
58 
CxxCK401–AxxAK401 fwd. CTA TGC CCC ATG GGC TGG TCA CGC CAA ACA GTT 
GGC TCC 
54 
CxxCQ401–AxxAQ401 fwd. CTA TGC CCC ATG GGC TGG TCA CGC CCA ACA GTT 
GGC TCC C 
54 
CxxC–AxxA a'-domain rev. AAC TCC ACA AAG ACG TTT TTT TTC TCA TC 54 
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Figure A.2: Purity of isolated His6-PDI; wild-type (WT) and mutant variants was 
assessed via SDS-PAGE using a 10% polyacrylamide gel and visualized by Coomassie 
staining.  N- and C-terminally His6-tagged PDI (~59 kDa) is indicated with reference to a 
standard molecular weight ladder. 
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Figure A.3: The concentration of catalytically active PDI as determined by burst-phase 
analysis.  In a cuvette, 10 uL of purified enzyme (16.9 µM stock) was incubated with 800 
nM di-E-GSSG in PDI assay buffer (final volume 500 uL).  (B-K) An increase in 
fluorescence (RFU) was monitored over 20 min.  (A) The y-intercept of each respective 
plot represents the concentration of functional enzyme determined by relating the 
fluorescence of enzyme-mediated EGSH production to that of a standard curve.  The 
standard curve was generated by fully reducing di-E-GSSG with 1 M DTT in PDI assay 
buffer.  Burst-phase data are representative of an experiment performed in triplicate.  The 
standard curve represents the mean ± S.D. of n = 3 experiments.  
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Figure A.4: Purity of affinity purified hPDI active site thiol mutants (CxxC-AxxA) was 
assessed via SDS-PAGE using a 10% polyacrylamide gel and visualized by Coomassie 
staining.  N- and C-terminally His6-tagged PDI (~59 kDa) is indicated with reference to a 
standard molecular weight ladder.  Using the di-E-GSSG (500 nM) assay the activity of 
10 nM of each mutant was assayed in relation to an un-mutated control PDI; WT (A) or 
K57/401Q (B) as a simple reporter of active site inactivation due to cysteine – alanine 
mutation of the vicinal thiols of the respective motif(s).  Mutation of a single active site 
resulted in a near-loss of 50% activity (A and B), while mutation of both active sites 
rendered PDI inactive (CxxCK57/401 -AxxAK57/401, A). 
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Figure A.5: Purity of affinity purified endoplasmic oxidoreductin 1α (ERO1α) was 
assessed via SDS-PAGE using a 10% polyacrylamide gel and visualized by Coomassie 
staining.  N-terminally His6-tagged ERO1α (~55 kDa) is indicated with reference to a 
standard molecular weight ladder. 
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Figure A.6: Purity of affinity purified green fluorescent protein (GFP) was assessed via 
SDS-PAGE using a 10% polyacrylamide gel and visualized by Coomassie staining.  N-
terminally His6-tagged GFP (~29 kDa) is indicated with reference to a standard molecular 
weight ladder.  The fluorescence spectroscopic properties of GFP (400 nM) was found to 
exhibit the characteristic excitation spectrum; primary peak at 395 nm, with secondary 
excitation at 480 nm (constant emission wavelength: 509 nm).  The emission spectrum 
was also as expected for intact GFP, with a peak at 509 nm and a shoulder at 540 nm 
(constant excitation wavelength: 395 nm). 
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Figure A.7: Purity of affinity purified (A) N-acetyltransferase 1 (ATase-1) and (B) N-
acetyltransferase 2 (ATase-2) was assessed via SDS-PAGE using a 10% polyacrylamide 
gel and visualized by Coomassie staining.  ATase enzymes were fused to a maltose 
binding protein (MBP) epitope at the N-terminus.  The fusion protein (~60 kDa) and free 
MBP (a product of degradation; ~40 kDa) are indicated with reference to a standard 
molecular weight ladder.  The activity of the isolated enzymes was assayed using a 
commercially available fluorescent kit (ATase-1, A; ATase-2, B). 
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Figure A.8: UV-visible absorption spectra of gold nano particles (AuNPs).  The 
concentrated reaction mixture was diluted 1:3 prior to spectral acquisition. 
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Figure A.9: SDS-PAGE analysis of the efficiency of thiol-mediated pull down of 
reduced PDI by gold nanoparticles (AuNPs), sepharose 6B, CNBr-activated Hg-
sepharose, and Epi-activated Hg-sepharose.  A consistent loading volume of 25 µL was 
used to compare the various fractions from the affinity enrichment procedure (see section 
2.2.11.1).  Control lane represents reduced PDI prior to affinity pull down (13 µg 
loading); FT, flow through following incubation with AuNPs or sepharose matrices, 
respectively; W1 and W3, washes 1 and 3; Elution, elution fraction resulting from 
treatment with 100 mM DTT. 
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Appendix B (Chapters 3 and 4 supplementary material) 
	
	
Table B.1: Apparent steady-state kinetic parameters at pH 6.0.  Results are representative 
of the mean ± S.D. of n = 3 experiments.  Data is also presented as the percentage of WT 
at each respective pH. 
hPDI kcat (´10-2 s-1, %a) KM (nM, %a) kcat/KM (´103 M-1 s-1, %a) 
WT 0.627 ± 0.043, 100 10.7 ± 1.50, 100 588 ± 31.5, 100 
K57/401Q 0.720 ± 0.028, 115 20.3 ± 2.65, 190 * 355 ± 63.4, 60 
K57Q 0.719 ± 0.056, 115 13.6 ± 3.34, 128 529 ± 118, 90 
K401Q 0.695 ± 0.010, 110 10.3 ± 2.25, 97 675 ± 220, 115 
K57/401A 0.610 ± 0.099, 92 11.3 ± 3.31, 106 539 ± 57.0, 92 
K57A 0.640 ± 0.050, 84 13.0 ± 6.63, 122 492 ± 110, 84 
K401A 0.695 ± 0.021, 117 10.1 ± 5.40, 95 687 ± 220, 117 
K57/401E 0.434 ± 0.012, 76 *** 9.65 ± 0.95, 94 449 ± 65.4, 76 
K57E 0.598 ± 0.041, 89 11.4 ± 2.23, 107 525 ± 86.4, 89 
K401E 0.715 ± 0.048, 92 13.2 ± 2.94, 124 540 ± 97.2, 92 
a Relative to WT 
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Table B.2: Apparent steady-state kinetic parameters at pH 6.5.  Results are representative 
of the mean ± S.D. of n = 3 experiments.  Data is also presented as the percentage of WT 
at each respective pH. 
hPDI kcat (´10-2 s-1, %a) KM (nM, %a) kcat/KM (´103 M-1 s-1, %a) 
WT 1.79 ± 0.0133, 100 20.3 ± 2.79, 100 882 ± 90.9, 100 
K57/401Q 2.30 ± 0.0807, 128 **** 67.8 ± 10.47, 334 **** 340 ± 57.0, 39 **** 
K57Q 2.56 ± 0.0848, 143 **** 47.7 ± 6.95, 235 *** 537 ± 78.3, 61 *** 
K401Q 2.30 ± 0.140, 128 **** 42.8 ± 7.01, 211 *** 537 ± 55.7, 61 *** 
K57/401A 1.77 ± 0.0611, 99 42.7 ± 8.63, 210 *** 414 ± 75.9, 47 **** 
K57A 1.68 ± 0.0001, 94 29.0 ± 0.25, 143  579 ± 44.0, 66 ** 
K401A 1.89 ± 0.0477, 105 31.8 ± 3.96, 157 590 ± 79.0, 67 *** 
K57/401E 1.42 ± 0.0880, 79 ** 31.1 ± 4.14, 153 455 ± 83.5, 52 **** 
K57E 1.89 ± 0.233, 105 30.8 ± 2.94, 152 612 ± 70.2, 69 ** 
K401E 2.04 ± 0.0672, 113 * 35.7 ± 2.39, 176 * 571 ± 83.2, 65 *** 
a Relative to WT 
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Table B.3: Apparent steady-state kinetic parameters at pH 7.0.  Results are representative 
of the mean ± S.D. of n = 3 experiments.  Data is also presented as the percentage of WT 
at each respective pH. 
hPDI kcat (´10-2 s-1, %a) KM (µM, %a) kcat/KM (´103 M-1 s-1, %a) 
WT 3.64 ± 0.164, 100 0.191 ± 0.0178, 100 190 ± 8.05, 100 
K57/401Q 3.08 ± 0.0479, 85 **** 0.522 ± 0.0134, 273 **** 59.0 ± 5.61, 31 **** 
K57Q 3.97 ± 0.123, 109 * 0.347 ± 0.0235, 181 **** 114 ± 5.08, 60 **** 
K401Q 4.21 ± 0.0338, 116 **** 0.374 ± 0.0227, 195 **** 113 ± 7.40, 59 **** 
K57/401A 2.48 ± 0.0522, 68 **** 0.397 ± 0.0131, 207 **** 62.4 ± 2.48, 33 **** 
K57A 3.31 ± 0.0313, 91 * 0.288 ± 0.0106, 150 *** 115 ± 3.50, 60 **** 
K401A 3.46 ± 0.193, 95 0.306 ± 0.0468, 160 **** 113 ± 12.2, 59 **** 
K57/401E 1.98 ± 0.0541, 54 **** 0.379 ± 0.0253, 198 **** 52.1 ± 2.01, 27 **** 
K57E 3.08 ± 0.131, 85 **** 0.288 ± 0.0123, 166 **** 96.8 ± 5.79, 51 **** 
K401E 3.08 ± 0.164, 85 **** 0.306 ± 0.0133, 174 **** 92.4 ± 6.28, 49 **** 
a Relative to WT 
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Table B.4: Apparent steady-state kinetic parameters at the physiological pH 7.4.  Results 
are representative of the mean ± S.D. of n = 3 experiments.  Data is also presented as the 
percentage of WT at each respective pH. 
hPDI kcat (´10-2 s-1, %a) KM (µM, %a) kcat/KM (´103 M-1 s-1, %a) 
WT 3.47 ± 0.0435, 100 0.777 ± 0.0593, 100 44.6 ± 4.00, 100 
K57/401Q 2.74 ± 0.344, 79 *** 1.83 ± 0.285, 235 *** 15.0 ± 0.590, 34 **** 
K57Q 3.63 ± 0.129, 105 1.69 ± 0.264, 218 *** 21.5 ± 1.91, 48 **** 
K401Q 4.03 ± 0.0955, 116 ** 1.65 ± 0.179, 212 ** 24.5 ± 1.43, 55 **** 
K57/401A 2.26 ± 0.103, 65 **** 1.92 ± 0.252, 247 **** 11.8 ± 1.97, 26 **** 
K57A 3.24 ± 0.103, 94 1.41 ± 0.288, 181 * 23.0 ± 3.39, 52 **** 
K401A 3.41 ± 0.104, 98 1.45 ± 0.0858, 186 * 23.6 ± 0.876, 53 **** 
K57/401E 1.68 ± 0.141, 48 **** 1.84 ± 0.256, 237 ** 9.12 ± 0.489, 20 **** 
K57E 2.94 ± 0.284, 85 ** 1.66 ± 0.296, 214 ** 17.7 ± 1.56, 40 **** 
K401E 3.23 ± 0.154, 93 1.33 ± 0.148, 171 * 24.3 ± 1.56, 54 **** 
a Relative to WT 
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Table B.5: Apparent steady-state kinetic parameters at pH 8.0.  Results are representative 
of the mean ± S.D. of n = 3 experiments.  Data is also presented as the percentage of WT 
at each respective pH. 
hPDI kcat (´10-2 s-1, %a) KM (µM, %a) kcat/KM (´103 M-1 s-1, %a) 
WT 3.07 ± 0.396, 100 2.22 ± 0.271, 100 12.94 ± 0.695, 100 
K57/401Q 1.17 ± 0.109, 38 **** 2.46 ± 0.156, 111 5.74 ± 0.483, 34 **** 
K57Q 1.70 ± 0.0974, 56 **** 2.13 ± 0.0440, 96 8.37 ± 0.277, 58 **** 
K401Q 2.20 ± 0.258, 72 ** 2.46 ± 0.245, 111 9.78 ± 0.737, 65 **** 
K57/401A 1.17 ± 0.166, 38 **** 2.53 ± 0.188, 114 4.26 ± 1.07, 33 **** 
K57A 1.35 ± 0.121, 44 **** 1.60 ± 0.0159, 72 8.44 ± 0.745, 61 **** 
K401A 2.01 ± 0.256, 66 *** 2.11 ± 0.607, 95 9.45 ± 1.17, 69 **** 
K57/401E 0.473 ± 0.0541, 15 **** 2.32 ± 0.264, 105 2.01 ± 0.763, 15 **** 
K57E 1.20 ± 0.485, 39 **** 1.99 ± 0.325, 90 4.26 ± 0.983, 44 **** 
K401E 1.99 ± 0.353, 65 *** 2.33 ± 0.164, 105 8.54 ± 1.10, 62 **** 
a Relative to WT 
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Figure B.1: Residue Tyr99 of the a-domain cis-Pro loop is immobilized by hydrogen 
bonding (dotted line) to the peptide carbonyl of A84.  Interaction found to be present in all 
representations of the a-domain (red/oxPDI WT and K57/401Q); depicted is that of 
redPDI WT.  Visualized using Visual Molecular Dynamics software (VMD) [54].       
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Figure B.2: MD simulations of the active site structural dynamics of oxPDI.  (A) WT 
PDI a-domain, (B) WT PDI a'-domain, (C) K57/401Q PDI a-domain, and (D) K57/401Q 
PDI a'-domain.  Visualized using Visual Molecular Dynamics software (VMD) [54].       
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Figure B.3: Redox-state dependent structural dynamics of the PDI ensemble as 
determined from MD simulations of WT PDI.  redPDI takes on a much more closed 
conformation in relation to oxPDI.  Note the dramatic rotation about the a'-domain of 
oxPDI, that not observed with redPDI.  Visualized using Visual Molecular Dynamics 
software (VMD) [54]. 
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Figure B.4:  Plots of distance vs. frame of the redPDI MD simulation for the estimation 
of hydrogen bonding.  Distances were taken as the measurement between hydrogen bond 
donor and acceptor heavy atoms; (A) Lys57 ε-amine to the peptide carbonyl oxygen of 
Pro51, (B) Lys401 ε-amine to the peptide carbonyl oxygen of Pro395, (C) mutant Gln57 δ-
amide nitrogen to the peptide carbonyl oxygen of Pro51, (D) mutant Gln401 δ-amide 
nitrogen to the peptide carbonyl oxygen of Pro395.  Red dotted lines represent the 
threshold distance of 3.5 Å for moderately strong hydrogen bonds, distances smaller than 
this would indicate strong hydrogen bonds and those larger would be weak to non-
existent hydrogen bonds [205].  Plots generated using Visual Molecular Dynamics 
software (VMD) [54].       
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Figure B.5: Plots of distance vs frame of the oxPDI MD simulation for the estimation of 
hydrogen bonding.  Distances were taken as the measurement between hydrogen bond 
donor and acceptor heavy atoms; (A) Lys57 ε-amine to the peptide carbonyl oxygen of 
Pro51, (B) Lys401 ε-amine to the peptide carbonyl oxygen of Pro395, (C) mutant Gln57 δ-
amide nitrogen to the peptide carbonyl oxygen of Pro51, (D) mutant Gln401 δ-amide 
nitrogen to the peptide carbonyl oxygen of Pro395.  Red, dotted lines represent the 
threshold distance of 3.5 Å for moderately strong hydrogen bonds, distances smaller than 
this would indicate strong hydrogen bonds and those larger would be weak to non-
existent hydrogen bonds [205].  Plots generated using Visual Molecular Dynamics 
software (VMD) [54].       
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Figure B.6: Structure of dieosin glutathione disulfide (di-E-GSSG).  In boxes are the 
ionizable groups and their respective pKa's [203, 204]. 
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Figure B.7: Dependence of the rate of PDI oxidoreductase activity on the concentration 
of DTT.  Using the same steady state conditions from before (see section 3.1) the 
concentration of DTT was varied and the rate of reduction of di-E-GSSG was monitored 
and reported as the production of EGSH. 
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